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Background: Dengue is an important public health problem with an estimated 390 million 
infections annually worldwide, and an estimated 1.6 million infections annually in Cambodia. 
Due to the rise in dengue cases, and the current lack of widely available effective vaccines and 
therapeutics there is an urgent need to come up with more effective, sustainable, and locally 
appropriate vector control methods.  
 
Methods: A cluster randomized trial with three arms was designed to assess the impact of guppy 
fish (Poecilia reticulata), in combination with the larvicide pyriproxyfen (PPF), and 
Communication for Behavioural Impact (COMBI) activities, on entomological indices over one 
year in Cambodia. In addition, entomology data was used to determine the ability of the Premise 
Condition Index (PCI) to predict Aedes mosquito density and prioritize vector control 
interventions.  
 
Results: The guppy only intervention arm was able to decrease the number of Aedes females 
(Density Ratio (DR)=0.49) and Pupae Per Person (DR=0.56) by roughly half compared to the 
control arm. There were no statistical differences identified between the two intervention arms. 
All other entomological indices showed similar statistically significant reductions in intervention 
arms compared to the control arm. Data from the KAP and qualitative assessments showed 
community acceptance of interventions. Despite statistically significant associations between 
PCI scores and adult and immature Aedes densities, receiver operating characteristic curves 
suggest the PCI was a poor predictor of whether premises had higher densities of immature and 




Conclusions: The effectiveness of interventions demonstrated in the trial along with community 
acceptance suggests guppies should be considered as vector control tools in Cambodia as long as 
the benefits outweigh any potential environmental concerns. The PCI results suggest caution is 
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Chapter 1: Introduction 
 
Dengue is transmitted through bites of infected Aedes mosquitoes, principally Aedes aegypti [1].  
Although dengue virus infection in humans is clinically apparent in only approximately 25% of 
cases, it can lead to wide range of clinical manifestations from mild fever to potentially fatal 
shock syndrome [1]. Despite current research devoted to drug discovery and supportive 
treatments there is currently no effective antiviral cure for dengue and therefore treatment 
remains supportive [2]. Dengue infections are caused by four closely related viruses named 
DEN-1, DEN-2, DEN-3, and DEN-4. Research suggests lifelong immunity is developed after 
infection but is type-specific [3]. The occurrence of severe symptoms is frequently associated 
with a secondary infection of a different serotype [1]. 
 
Approximately 3.9 billion people in 128 countries are at risk of dengue infection [4]. The disease 
affects most of the world’s tropical and sub-tropical regions and has become the most rapidly 
spreading mosquito-borne viral disease [1,5]. There were an estimated 390 million infections in 
2010, of which 96 million were clinically apparent [4]. These estimates are based on data from 
various sources including published literature, surveillance data, news reports, and consultations 
with experts [5]. As the data themselves are of varying quality and completeness the estimates 
have large confidence intervals. However, the estimates do represent a global consensus of 
experts that suggests the number of infections is increasing over time and expanding 
geographically [4]. Between 2010 and 2020 the World health Organization (WHO) is aiming to 





In 2015, the first commercial dengue vaccine, Dengvaxia® (Sanofi-Pasteur), came on the market. 
However, the vaccine had less than ideal overall efficacy (67%) and extremely low efficacy 
against serotype DENV-2 (35%) [7,8]. Additionally, safety concerns led the WHO to 
recommend only offering the vaccine to those who (1) are aged 9-45 years, and (2) live in areas 
with high seroprevalence (>80%) or who are seropositive [9]. Due to the limitations of the 
vaccine, the WHO recommended that vaccination should be “part of an integrated dengue 
prevention and control strategy together with well executed and sustained vector control” [9]. 
Academics and leading dengue control experts have said that regardless of the efficacy of future 
vaccines, there is growing consensus that no single intervention will be sufficient to control 
dengue disease [10]. Vector control therefore remains a key part of any dengue control program, 
and the integration of locally accepted and effective methods is needed [11].  
 
Determining which vector methods are best for any locality can be complicated as there are 
many options and insecticide resistance is growing in many locations [12]. WHO separates 
vector control methods into three groups: biological controls, chemical controls, and 
environmental management [13]. Interventions within each group can target immature or adult 
mosquitoes. The most common chemical controls include larvicides such as temephos, 
adulticides used in indoor residual spraying and space sprays (deployed by backpack portables, 
trucks, and aircraft), and personal protection adulticides such as DEET or Picaridin [13]. 
Biological controls have been the focus of many new research and control projects focused on 
container treatment (e.g. larvivorous fish, copepods, dragonfly larvae) [13]. Environmental 
management most often focuses on improvement of water supply and water storage systems, 




container management, and improving building structures. A recent expert working group 
convened by the Partnership for Dengue Control reviewed all the evidence available on vector 
control tools and recommended the following tools for sustained management of dengue vectors: 
1) the use of Indoor spraying (preferably with residual insecticides) and perifocal spraying with 
residual insecticides for adult control, 2) comprehensive container larvicide treatment and 
container removal, and 3) social mobilization campaigns, environmental management [10].  
 
In addition to the currently commercially available tools, there are several promising 
technologies focusing on genetic engineering of mosquitoes. The first category of these is the 
release of genetically modified male mosquitoes which carry a dominant lethal gene, such as the 
Aedes aegypti strains developed by Oxitec [14,15]. However, questions remain of feasibility due 
to logistic challenges and concerns over costs [16]. In addition, even once the intervention was 
successful there remains the possibility of mosquito populations returning from nearby areas, 
necessitating the need for releases indefinitely or until mosquitoes could be eradicated 
throughout entire continents [17]. Another category is the release of mosquitoes infected with the 
intracellular bacterium Wolbachia, which can establish itself in mosquito populations and 
suppress arbovirus replication in mosquitoes [18]. The advantage of this method is that 
continuous releases are not required when the local frequency of Wolbachia in wild Aedes 
aegypti mosquitoes surpasses an unstable equilibrium point, and no potential ecological harms 
would come from eradicating the mosquito. Recent trials of this technique in Australia concluded 
that the deployment of Wolbachia into Aedes aegypti populations can be readily scaled quickly 




techniques hold great promise, however more evidence is needed to confirm if the results are 
generalizable and scale up will take time and require large monetary investments.  
 
Multi-sectorial approaches and community involvement are important as the failure of dengue 
vector control strategies has often been associated with the absence or lack of active community 
involvement [20]. Integrated Vector Management (IVM) is a rational decision making process 
used to optimize, and improve the efficacy and cost-effectiveness of vector control 
resources [11]. IVM strategies guide control programs to move away from single-intervention 
approaches and promote multi-sectoral approaches to human health. The IVM approach also 
encourages community engagement and stakeholder involvement in designing and implementing 
dengue control strategies. Communities take the lead in the project design, planning and decision 
making which helps to create community acceptance, ownership and ensure sustained 
community participation in the dengue program [21,22].  
 
In addition to IVM strategies to optimize tools and program design, the Communication for 
Behaviour Impact (COMBI) toolkit can help develop risk communication, development 
communication strategies, and health promotion/education materials [23]. The COMBI strategy 
provides a social mobilization and communication approach that connects knowledge and 
behaviour, addresses the cost and value of engaging in healthy behaviours, recognizes the 
gradual stages of behaviour change, and creates a supportive environment for behaviour 
change [24]. Culturally appropriate, well-informed and multipronged behaviour change 
communication approaches increase awareness and address the misperceptions surrounding 




strategies and integrating communities into the selection of tools, program design, and 
communication strategies and materials can help improve the effectiveness of dengue control 
programs. 
 
1.1 Dengue situation in Cambodia  
 
Asia records 70% of the global disease burden due to dengue [4] and Cambodia has one of the 
highest per-capita incidence rates in the region [28]. First identified in Cambodia in 1963 [29], 
dengue is now considered endemic. A total of 194,726 cases were reported to the National 
Dengue Control Program (NDCP) between 1980 and 2008 [30]. Between 2003 and 2008, dengue 
incidence ranged between 0.7 and 3.0 per 1,000 person years [31]. The numbers of suspected 
cases reported to WHO in 2018 was 9,885 and in the first 23 weeks of 2019 was 2,490 [32,33]. 
Additionally, 21 deaths were reported during the first 20 weeks of 2019 [34].  
 
However, data reported by NDCP come from a maximum of five hospitalized patients per week 
in each of the seven sentinel provincial hospitals, and few sentinel health centres, and the 
National Paediatric Hospital [35]. The restriction on number of patients included is due to 
funding constraints. Therefore, the surveillance data are useful in monitoring which serotypes are 
circulating and identifying seasonal patterns, but it is not meant to be a true estimate of dengue 
burden. The real number of cases has estimated by comparing cohort data to the NDCP 
surveillance number and estimated to be between 3.9 and 29.0 times higher than those reported 
by NDCP [36,37]. The most recent modelling data based off published literature, surveillance 
data, news reports, and consultations with experts estimated an alarming 1.6 million cases or 119 





Even with the underreported number of cases, the annual cost to society was estimated to be 
between $3.3 - $14.4 million between 2006-2008 [38]. Since most of this cost falls onto the 
family, it resulted in 67% of households falling into debt to pay for medical bills [39]. A more 
recent study showed the average cost of illness per patient in 2016 was $134, and the average 
monthly household income was $245 USD [40]. Therefore, the cost to households is not 
negligible and there is a strong need to identify control methods.  
 
1.2 Dengue vector control in Cambodia  
Dengvaxia® is licensed in Cambodia, but is only available in a small number of private clinics 
who choose to purchase it through the producer [41]. Due to the lack of therapeutics or a widely 
available vaccine, the majority of individuals rely on vector control as the primary means of 
dengue prevention. Larval surveys have shown that large concrete water jars, drums, and tanks 
contained over 91% of Aedes aegypti larvae in Cambodia [42]. Therefore, much of the focus has 
been on interventions that could target these household water storage containers.  
 
Since the early 1990s, the primary means of vector control by the Cambodian NDCP has been 
the use of the organophosphorous larvicide temephos (under the trade name Abate ®) applied in 
large water storage containers [43]. However, increasing resistance to temephos has been found 
in Cambodia [12,43,44] and in other parts of Southeast Asia over the last 20 years [6,45–47]. In 
addition to larviciding regularly, the NDCP uses thermal fogging with pyrethroids (most 
commonly permethrin and deltamethrin) during outbreak responses. Recent experiments showed 




seven out of eight showed resistance to deltamethrin [12]. The resistance data show that using 
temephos for larval control may even be counterproductive possibly fixing resistance in the 
Aedes population, and very few effective adulticides are available for use in general dengue 
control programs or outbreak response. As suggested by researchers in Cambodia it is imperative 
that “we must quickly find an alternative” [12].  
 
1.3 Alternative vector control methods  
Several alterative vector-control methods have been studied in Cambodia including chemical and 
biological substances. One of the first was a Mesocyclops (type of copepod or group of small 
crustaceans) project in Kratie province from 2002 to 2004 [48]. Initial results showed a reduction 
in the Aedes population in the intervention area, but by the end of the project larval densities in 
the intervention area had increased by 62% from baseline. In addition, Mesocyclops from the 
local water sources had various parasites and colonizing them parasite-free required special 
training that was difficult for the villagers. Another limitation was that many participants did not 
accept Mesocyclops to the same extent as other interventions that were provided by the NDCP 
such as temephos [49]. Therefore, the NDCP did not attempt any further projects using 
Mescoclops. 
 
In 2004, an evaluation of Bacillus thuringiensis israelensis (Bti), a Gram-positive, soil-dwelling 
bacterium showed positive results with significant reductions in the number of pupae for at least 
2 and 2.5 months in containers with river and well-water, respectively [18]. Further evaluation 
from 2005-2011 showed pupal suppression of 91% for eight weeks, and authors claimed a 




two separate studies included in one manuscript with the entomology indicators being evaluated 
in 2005 and 2006 in two communes (one treated and one untreated), and the number of dengue 
cases recorded in 2010 and 2011 in 11 communes (six treated and five untreated). However, two 
large unreported limitations exist. The first being that in the initial study the two communes were 
literally across the street from each other, and therefore it is difficult to tell if the difference was 
due to the intervention or other differences between the communes. The second is that in the 
later study the communes were not randomized and those which had a higher number of dengue 
cases in 2010 were selected for treatment in 2011. Therefore, it is likely that villages with more 
cases one year will have greater immunity and less cases the following year. In fact, the 
reduction in cases within the treatment arm (in 2011) was greater in the pre (60%) versus post 
(53%) Bti treatment phase. Additionally, the data used for dengue cases were the numbers 
reported to NDCP, which have their own limitations discussed earlier. Regardless, there is data 
from several years to show that Bti did have statistically significant decreases in immature 
mosquitoes and could be considered for future control efforts. 
 
In 2006, jar covers with long-lasting insecticidal netting treated with deltamethrin were found to 
have significantly fewer pupae per house, and a three-fold decline in Aedes aegypti adult females 
per house [42]. However, the magnitude of the reduction diminished over time due to a gradual 
reduction of insecticidal effect of the jar covers and a residual deltamethrin life of 22 weeks [42]. 
Another reason for low effectiveness may have been children not always keeping the jar 
covering on after extracting water, and using the covers as toys around the house [49] as Khun et 




egress of mosquitoes, especially when the container is used, and an increase the insecticidal 
effectiveness may be needed for jar covers to be cost-effective public health interventions [42]. 
 
The use of larvivorous fish (Poecilia reticulata) was evaluated in 14 Cambodian villages in 
2006-2007 [51], and subsequently in a larger study of 28 Cambodian villages in 2009-2011 [52]. 
Results from the initial study found guppies in 56% of eligible containers, and a 79% reduction 
in Aedes infestation compared to the control [51]. These results led a larger scale-up in 2009–
2011. Results showed 88% guppy fish coverage in eligible water containers and a Container 
Index (CI) and the number of indoor resting adult females near zero at the end of the project 
(while the control had a CI of 30%) [52]. Container Index is the percentage of water-holding 
containers infested with larvae or pupae. However, there were additional miscellaneous breeding 
sites including containers too small for guppy survival. Therefore, additional tools beyond 
larvivorous fish are required to target these smaller miscellaneous, hard-to-reach and cryptic 
breeding containers or sites. 
 
Poecilia reticulata, commonly known as the guppy, is one of the most widely distributed tropical 
fish found on every continent except Antarctica and has even made it to space aboard the USSR 
biosatellite Cosmos [53]. Guppies were first described in 1859 in Venezuela, and their natural 
range appears to be Trinidad, Venezuela, Guyana, and Surinam and probably Tobago. Their first 
documented introduction was from Hawaii to the Philippines in 1905 for mosquito control, 
however little is known about introductions before that time. They are poeciliids, a group of fish 
characterized by internal fertilization, viviparity, and the male intromittent organ, the 




1.5-3 cm. All wild male guppies have different colour patterns which is important in attracting 
females, while females are mostly grey in body colour (Figure 1.1). Females can store sperm in 
the folds of their ovaries and gonoducts and can continue to fertilize ova for up to eight months. 
The number of offspring can vary from one to a hundred or more, and at birth guppies are 
independent and no further parental care is needed [53].  




An alternative that can reach all containers is pyriproxyfen (PPF). PPF is a juvenile hormone 
analogue that interferes with the metamorphosis of juvenile Aedes mosquitoes, preventing their 
development into adults [54]. The results of the first study in 2003 were so promising – at higher 




study was designed [55]. This showed that a novel 5% controlled-release formation led to IE 
above 90% for 20 weeks, and above 80% for 34 weeks [56]. A slow-release PPF matrix release 
formulation (Sumilarv® 2MR) has since been developed and is also suitable for containers 
uninhabitable by guppy fish. The added benefit of Sumilarv® 2MR is that it only requires one 
distribution every 6 months (the entirety of the rainy season) and cuts down on operational costs 
as compared to temephos or Bti which have a residual efficacy of 2–3 months [57,58]. However, 
one limitation is that as PPF inhibits immature mosquitoes from become adults, and confusion 
has been reported over effectiveness due to the presence of live larvae in the water containers 
(Shafique et al., submitted manuscript). 
 
1.4 Identifying key premises 
The identification of key premises is crucial to inform vector control operations – an activity 
which can be conducted through pupal/demographic surveys of household water containers. 
However, the ubiquity of water containers tends to make pupal/demographic surveys 
laborious [59]. Therefore, additional methods have been explored to identify key premises 
without needing to do extensive pupal/demographic surveys, or enter premises, because owners 
refusing access to premises has been reported as a key challenge [60]. The Premise Condition 
Index (PCI) is one such approach that could help prioritize outbreak response in terms of Aedes 
infestation risk [61]. This index evaluates the shade, house, and yard conditions of premises to 
produce risk strata. In addition to targeting treatment of key premises, this method could 
potentially be used to prioritize villages or other geographical areas when funding or human 
resources are insufficient to treat all outbreak areas. Results have varied by geography and 




greater Aedes densities PCI could potentially be used to prioritize interventions when funds are 
insufficient to treat all areas/houses. 
 
1.5 Overall aims and objectives 
The overall aim of the PhD was to determine which new vector control approaches (beyond 
larviciding with temephos or using pyrethroid sprays) would be most effective in Cambodia. 
This involved speaking with key stakeholders and designing a trial that could properly evaluate 
new alternatives. Negotiations with NDCP and other stakeholders in 2014 concluded that, based 
on past research reported above, the use of larvivorous fish, PPF, and Bti held the most promise 
for the country. Due to limited funds available in Cambodia for dengue control, the use of 
larvivorous fish (Poecilia reticulata) sourced from the original government established colony 
was recommended for larger water containers (>50 litres) as it was effective, cheap, and easily 
available. However, as approximately 10% of Aedes larvae were in small or miscellaneous 
containers that are not easily targeted with fish, the use of new controlled release version of PPF 
(Sumilarv® 2MR) in smaller containers (<50 litres) was recommended and those in which 
guppies could not survive. The use of Sumilarv® 2MR was suggested over Bti or other 
formulations of PPF as it is long-lasting thereby obviating much of the operational costs involved 
in larviciding in Cambodia. Integrating IVM and COMBI strategies into any potential project 
was also recommended. 
 
Although there is evidence suggesting that the use of guppy fish can be beneficial in dengue 
vector control, a recent review showed that there has never been a cluster randomized trial to 




designing a trial which could have the potential to inform the strategic application of community-
based distribution of larvivorous fish and PPF in an outbreak, during inter-epidemic periods or 
for broad-scale application. The specific objectives of the PhD study are outlined below: 
 
1. Perform a systematic literature review on the impact of PPF on Aedes mosquitoes 
including to (1) Determine the effect of PPF on a range of endpoints including percentage 
inhibition of emergence, larval mortality, and resistance ratios; and (2) Determine the 
different uses, strengths, and limitations of PPF in vector control of Aedes.  
2. Design a cluster randomized trial in which villages were randomized to either (1) three 
interventions (guppies, Sumilarv® 2MR, and COMBI activities), (2) two interventions 
(guppies and COMBI activities), or (3) control (standard vector control). 
3. Carry out the results of the trial and report on all outcomes mentioned in the protocol. 
4. Determine the ability of the PCI to predict premises with adult and immature Aedes 
mosquitoes in Cambodia.  
 
1.6 Thesis outline	
The thesis is presented in a research paper style submitted in accordance with London School of 
Hygiene and Tropical Medicine regulations. The prepared and published articles are included 
without adaptation and there is therefore some repetition between chapters on the study context. 
This has been minimized where possible. Where research papers included supplementary 
material for publication these have been included either at the end of the relevant chapter, or in 
the Appendix section. The thesis contains six chapters, which include one published paper and 





• Chapter 1 is an introduction to the global and country specific dengue situations, vector 
control tools, and methods for prioritizing vector control activities. This section also 
includes thesis aims and objectives of the PhD.  
 
• Chapter 2 is a systematic literature review on the impact of PPF on Aedes mosquitoes. 
The results of the review will be used to provide evidence to control programs on the 
suitability of PPF as a vector control tool. This study helped in determining 
recommendations for Cambodia following the results of the main cluster randomized trial 
discussed in Chapter 3 and 4 and can inform control strategies in other interested 
jurisdictions across the world. 
 
• Chapter 3 is the protocol for the main cluster randomized trial presented in this thesis. 
This protocol was registered in the ISRCTN registry and published in the journal Trials.  
 
• Chapter 4 reports the results of the trial described in Chapter 3. The interventions 
included in the trial are listed above in Section 1.5. It also includes some results reported 
in Chapter 2 to further strengthen the recommendations around PPF use in Cambodia.  
 
• Chapter 5 reports the results of the association between the PCI and presence of immature 
and adult Aedes aegypti. It also evaluates the ability of the PCI to accurately predict 
households with higher Aedes densities. This work utilizes entomology and PCI data 




produced could potentially identify strategies for prioritization of vector control activities 
where resources are scarce. 
 
• Chapter 6 provides further discussion and future directions relating to each of the results 
chapters. In addition, the chapter provides an overall summary which brings in evidence 
from other fields such as ecology and discusses public and stakeholder engagement in the 
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Background: Dengue is the most rapidly spreading arboviral disease in the world. The current 
lack of fully protective vaccines and clinical therapeutics creates an urgent need to identify more 
effective means of controlling Aedes mosquitos, the principal vector of dengue. Pyriproxyfen 
(PPF) is an increasingly used hormone analogue that prevents juvenile Aedes mosquitoes from 
becoming adults and being in capable of transmitting dengue. The objectives of the review are to 
(1) Determine the effect of PPF on endpoints including percentage inhibition of emergence, 
larval mortality, and resistance ratios; and (2) Determine the different uses, strengths, and 
limitations of PPF in control of Aedes. 
 
Methodology/Principle Findings: A systematic search was applied to PubMed, EMBASE, Web 
of Science, LILACS, Global Health, and the Cochrane database of Systematic Reviews. Out of 
1,369 records, 91 studies met the inclusion criteria. Nearly all fit in one of the following four 
categories 1) Efficacy of granules, 2) Auto-dissemination/horizontal transfer, 3) use of ultra-low 
volume thermal fogging (ULV), thermal fogging (TF), or fumigant technologies, and 4) 
assessing mosquito resistance. PPF granules have consistently efficacious results of 90-100% 
inhibition of emergence for up to 90 days. The evidence is less robust but promising regarding 
PPF dust for auto-dissemination and the use of PPF in ULV, TF and fumigants. PPF has a very 
favourable mammalian toxicity profile, and its safety is the product are well established in the 
literature. Several studies also found that while mosquito populations were still susceptible to 







Conclusions/Significance: The evidence is strong that PPF does increase immature mortality and 
adult inhibition in settings represented in the included studies, however future research should 
focus on areas where there is less evidence (e.g. auto-dissemination, sprays) and new use cases 
for PPF. A better understanding of the biological mechanisms of cross-resistance between PPF, 







Many important diseases are spread by Aedes mosquitoes including dengue, chikungunya, Zika, 
and yellow fever. Dengue cases are increasing worldwide and there is a lack of effective 
vaccines and therapeutics. Additionally, mosquitoes have become resistant to commonly used 
insecticides. Pyriproxyfen (PPF) is an insecticide that prevents juvenile Aedes mosquitoes from 
becoming adults. The objective of this review was to determine the effect of PFF on immature 
and adult mosquitoes and determine different use cases, strengths, and limitations. A systematic 
search was applied to scholarly databases where 91 full text articles met the inclusion criteria. 
Nearly all included studies fit in four categories, 1) granules, 2) auto-dissemination, 3) ultra-low 
volume spray, thermal fogging, and fumigant formulations, and 4) mosquito resistance. While 
mosquito populations were still susceptible to PPF, the concentrations needed to kill a majority 
of mosquitoes increased among those resistant to temephos (a commonly used insecticide). The 
evidence is strong that PPF granules do increase immature mortality and adult inhibition, 
however evidence for other forms and uses is still weak or could be increased. Better 
understanding of the cross-resistance between PPF, temephos, and other insecticides will allow 






Dengue is the most rapidly spreading mosquito-borne viral disease in the world, with a 30-fold 
increase in incidence over the past 50 years and an expansion into new geographic areas [1]. 
Dengue infection is caused by bites of infected Aedes mosquitoes, principally Aedes aegypti. 
Dengue has a wide clinical spectrum that ranges from asymptomatic infection to severe disease 
that manifests with vascular leakage and end-organ failure and is associated with a high rate of 
morbidity and mortality [1]. With an estimated 3.6 billion people in 124 countries at risk of 
contracting the disease [2] and 390 million dengue infections occurring each year (of which 96 
million develop clinical symptoms) [3] the dengue virus has become a leading cause of illness in 
the tropics and subtropics [4]. 
 
Academics and leading dengue control experts have expressed that regardless of the efficacy of 
future vaccines, there is growing consensus that no single intervention will be sufficient to 
control dengue disease [5]. Vector control therefore remains a key part of any dengue control 
program, and the integration of locally accepted and effective methods is needed [6].These 
methods together with the development of new vaccines [7], genetic control of mosquitoes [8,9], 
and new therapeutic drugs [10] will be essential in reducing dengue incidence. One insecticide 
that has been increasingly used is pyriproxyfen (PPF). PPF is a hormone analogue that interferes 
with the metamorphosis of juvenile Aedes mosquitoes, preventing their development into adults 
capable of transmitting the dengue virus [11]. A recent systematic review assessing the 
community effectiveness of PPF found it is highly effective in controlling the immature stages of 
dengue transmitting mosquitoes, and to a smaller degree adult mosquito population, however 
they excluded field studies without a control and any efficacy studies performed under laboratory 





identifying all evidence (including lab and semi-field studies and use in combined or novel 
products) on the effect of PPF on Aedes mosquitoes. 
 
Objectives: 
The objectives of the review were to (1) Determine the effect of PPF on survivorship of Aedes 
life stages; and (2) Determine the different uses, strengths, and limitations of PPF in vector 




Search strategy and eligibility criteria  
This review follows the guidelines as laid out in the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) statement [13] (Appendix 2.1). It was carried out 
between July 2016 and October 2016, with an update in March-April 2019. All data were 
extracted by two independent researchers, and discrepancies were resolved by consensus. All 
studies reporting on the use of pyriproxyfen in control of Aedes or Stegomyia as a single agent or 
combined with other control measures were eligible for inclusion.  
 
Data sources and search strategy 
Studies were identified by searching electronic databases, scanning reference lists of articles and 
consultation with experts in the field. No limits were applied for language in case there was an 
available English translation. If no translation was available only English and Spanish articles 
were evaluated. The search was applied to PubMed, EMBASE, Web of Science, LILACS, 
Global Health, and the Cochrane Database of Systematic Reviews. The International 





zoological taxonomy changed the name of the genus Aedes to Stegomyia [14]. However, here we 
follow the suggestion of the American Journal of Tropical Medicine and Hygiene, made in 
consultation with several other journals [15], to continue to use Aedes as the genus name. 
Nevertheless, we have also searched based on Stegomyia. The search terms in Table 2.1 were 
applied to all databases. 
Table 2. 1: Search Terms Used for Systematic Review 
Pyriproxyfen AND Mosquito Control [MESH] 
Pyriproxyfen AND Insect Control [MESH] 
Pyriproxyfen AND Insect Vectors [MESH] 
Pyriproxyfen AND Disease Vectors [MESH] 
Pyriproxyfen AND Communicable Disease Control [MESH] 
Pyriproxyfen AND Dengue 
Pyriproxyfen AND Aedes 
Pyriproxyfen AND Stegomyia 
 
Study selection 
For each search, titles and abstracts were imported into Endnote (Thompson Reuters, 
Philadelphia, PA, USA), duplicates were removed, and the remaining records were screened. 
Full texts of potentially relevant records were retrieved and assessed for eligibility, contacting 
the author of the report as necessary. Reference lists of all potentially eligible articles and 
reviews were also searched.  
 
A data extraction sheet was developed, and pilot tested on a random selection of included studies 





different concentrations, formulations, or combinations of insecticides) a meta-analysis was not 
attempted. The review protocol was registered with the International Prospective Register of 
Systematic Reviews (CRD42016046772).  
 
2.3 Results  
Search results 
The search results are illustrated in Figure 2.1. Initially 1,352 records were identified through 
database searches and 17 additional records were identified through other sources. After 
screening of title and abstracts, the remaining 108 papers were assessed and reviewed in full, 
after which 17 articles were excluded. The most common reasons for exclusion was that PPF 
only data from previous publications were included or PPF was not the main focus of the paper 
and no useful data were reported. A total of 91 studies were then included in the review. 
 
Study characteristics 
The included studies were published between 1989 and 2018. Six studies were written in 
Spanish, and the others in English. The studies came from many regions including South 
America (30%), North America (28%), Asia (17%), Europe (9%), Caribbean (17%), Middle east 
(5%), and Australia (3%). Out of all the 91 studies included, 72 (79.1%) were related to one of 
the following four core topics and one was related to two of the core topics: 
• Efficacy of PPF granules (30 studies) [16–45]; 
• Auto-dissemination or horizontal transfer of PPF (19 studies) [37,46–64]; 
• Use of PPF ultra low volume, thermal fogging, and fumigant technologies (15 studies) 
[65–78]; 





Other less common topics were: the use of PPF in novel products (bed nets [63,89], paints [90], 
release blocks [91], sugar baits [92,93], candles [94], topical treatments [95–97] ovitraps [98,99], 
resin sticks [100–102], and controlled release mesh [103]; the effect of PPF on the termination of 
the diapause process [104]; and PPF's environmental persistence and effect on non-target 
organisms [105]. There was also a review written in 2008 by a PPF manufacturer that focused on 
the different uses for PPF as a larvicide against nuisance mosquitoes and vectors of dengue and 
malaria [106].  
 
Efficacy of PPF granules 
PPF granules have been shown to be efficacious in a wide range of lab and field tests in countries 
across the world. Most studies showed Inhibition of Emergence (IE) near 100% for 90 days at 
higher concentrations (1-10 parts-per-million (ppm)), and a steady reduction with time post-
treatment or with decreasing concentration of active ingredient (Figure 2.2). Vythilingam et al. 
found that adult emergence was completely inhibited for four months even with removal and 
addition of water [30]. However, Richie et al. found that residual PPF detected in water one 
week later represented just 1.2-1.4% of the total doses applied regardless of the concentration, 
and the authors highlighted the need to integrate the quick deterioration into any concentration 
planned for vector management programs [23]. Berti et al. found that increasing the number of 
larvae treated at 0.05 ppm did not decrease mortality of pupae or adult IE [39].  
 
Studies also suggested that the use of PPF as an alternative to other commonly used insecticides 
such as temephos or in an integrated method with other means of mosquito control will increase 
the efficacy with subsequent reduction in the development of resistance [42,81]. Darriet et al. 





insecticide based on compounds found in the bacterial species Saccharopolyspora spinosa) along 
with the ability of PPF to kill any pupae that emerged in their trial. Using PPF in combination 
with other vector control tools (Aquatain© AMF or larvicidal oil) was also suggested for 
emergency control programs [31]. Even using very low doses for short periods has been 
suggested as a strategy to reduce wild populations before the introduction of genetically 
modified mosquitoes [23].  
 
Auto-dissemination or horizontal transfer of PPF 
Auto-dissemination or horizontal transfer of PPF is the concept that exploits female mosquitoes 
to transfer lethal concentrations of an IGR to breeding or resting sites during oviposition, 
resulting in a reduction of mosquito population [46–49,57–64]. The possibility was first tested by 
forcing adult female and male mosquitoes into contact with PPF coated surfaces in the 
laboratory [47,58,61]. Studies showed that auto-dissemination occurred, and it successfully 
increased the mortality rate of larvae that were exposed (Figure 2.3).  
 
Devine et al. [59] tested the theory in the field by distributing 1-liter plastic pots lined with damp 
black cloth dusted with pulverized PPF granules and achieved overall reductions in adult 
emergence of 42-98% thus achieving high coverage of aquatic mosquito habitats. Around the 
same time, Suman et al. [49], trialled the ability of mosquitoes to auto-disseminate PPF from 
Ultra-Low Volume (ULV) surface treatments and achieved 15.8% pupae mortality from six 
weeks in the first year and 1.4% pupae mortality in the second year. ULV spraying is defined as 
spraying of pesticides at a volume application rate of less than 5 litres/hectare to provide 
maximum efficacy in killing target vector mosquitoes. Both authors detected that auto-





dissemination. Similar results were found in more recent studies using PPF sprays which found 
no difference in sentinel containers between intervention and control areas [54]. Better 
formulations and delivery methods that could load higher doses of PPF and last longer were 
tested [57,60] with varying degrees of efficacy.  
 
Abad-Franch et al. used these auto-dissemination stations in a field trial and found greater than 
ten-fold rise and greater than a ten-fold decrease in juvenile mosquito mortality and adult 
mosquito emergence, respectively [46]. However, many of the field studies lacked assays 
sufficiently sensitive to detect the parts-per-billion concentrations of PPF, therefore limiting the 
direct evidence of PPF contamination [46]. However, a recent paper reporting on five different 
studies done in New Jersey, USA was able to detect PPF by residue analysis in field samples 
confirming the transfer of PPF by mosquitoes for up to 200 meters [55]. The study used auto-
dissemination stations in different contexts and environments and found the stations performed 
effectively for 8-12 weeks and were able to contaminate 40% of sentinel containers in tire piles 
50% in a junkyard. This resulted in the highest pupal mortality in peri-domestic habitats (50%), 
and sites contaminated with PPF 82%, although the efficacy reduced over time [55].  
 
Snetselaar et al. [48] found 100% IE with the use of a black polyethylene device (In2Care 
mosquito trap) coated with PPF dust and Beauveria bassiana. A subsequent semi-field study 
using the product in Florida found the trap to be attractive to gravid mosquitoes, ability to 
transfer PPF to sentinel containers, reduce emergence of adult mosquitoes, and reduce 






Main et al. evaluated the use of the "Auto-Dissemination Augmented by Males" (ADAM) 
approach which used a black plastic device to attract adult females, but also introduces directly 
treated males (who were exposed to PPF by an insufflator for approximately 5 sec) to transfer 
PPF to both larval sites and uninfected females during oviposition. Results showed 50% 
reduction in immature mortality rates compared with controls [62]. However, the decrease was 
not as large as shown by Abad-French et al., which may be due to different environments, 
susceptibility of the vectors to PPF, different mosquito targets, or different PPF sources and 
concentrations.  
 
The benefit of auto-dissemination is the potential to effectively counter the main challenge to 
conventional larviciding approaches by targeting the myriad of cryptic breeding sites that these 
mosquitoes utilize [46,57]. However, area-wide use requires large amounts of labour when 
deploying and maintaining numerous stations [61]. Lastly, auto-dissemination efficacy can be 
affected by several factors such as insecticide resistance, coverage of treated areas, treatment 
methods, geographical variations and rainfall [49].  
 
Use of PPF ultra-low volume spray, thermal fogging, and fumigant technologies  
Studies investigating the use of PPF in ULV, thermal fogging (TF) and fumigant techniques 
found IE declining from 100%-50% for 4-6 weeks respectively in treated areas and steadily 
decreasing with the distance from the sprayer, the length of time from treatment, and type 
(cold/thermal) of fogging (Figure 2.4) [65,66,71–77]. Beyond simply having an effect on larval 
mortality, the sublethal dose of PPF was found to have effects on the fertility and fecundity of 
adult females. Therefore, even if the lethal dose is not achieved, treatment over the long-term 






Harburguer et al. suggested a strategy including fumigant tablets placed indoors and mixed ULV 
formulation (including permethrin) for outdoor application [71]. The fumigant they developed 
showed a high level of recovery of PPF in fumes and resulted in high levels of IE even at low 
concentrations, as well as an effective knockdown of adults from the permethrin. One limitation 
of the study data presented above was that they treated only a reduced area (200 houses in each 
of three different treatment areas) and there could have been infestation from adults in nearby 
households [71].  
 
More recently, studies in Thailand and the USA have shown that multiple spraying machines 
using combinations of insecticides including PPF were unable to achieve high mortality among 
Aedes mosquitoes placed in hidden (protected) cages, and that the ULV sprays provided better 
emergence inhibition than the thermal foggers likely due to larger droplet size [68–70].  
 
Assessing resistance and dose-response relationship of Aedes mosquitoes to PPF 
Understanding resistance profiles of juvenile and adult mosquitoes is key in public health control 
programs. Numerous papers reviewed the susceptibility of Aedes to PPF and examined cross 
resistance among PPF and other insecticides (especially temephos). Data show IE levels of 70-
100% for 250 days among higher concentrations with levels decreasing with lower 
concentrations and extended post-treatment time (Figure 2.5) [36,79–81,83–85,107].  
 
Even among temephos-resistant mosquito populations IE levels show susceptibility to PPF at 
higher concentrations with the exception of a Florida population already resistant to two other 





their data showed standard larvicides and pyrethroids used for mosquito control were still 
effective [84]. Indeed, this is opposite of most other studies reviewed here showing resistance of 
Aedes populations to standard larvicides and pyrethroids and susceptibility to IGRs. 
 
Rodriguez Coto et al. [108] and Teran Zavala et al. [85] both showed that temephos-resistant 
strains had similar resistance ratios to reference strains and worked well even at concentrations 
below World Health Organization (WHO) recommended levels (Resistance Ratio is the measure 
of resistance in an insect population, calculated by dividing the lethal dose of a study population 
by the lethal dose of the susceptible population) However, three other studies [81,107,108] found 
that while mosquito populations were still susceptible to PPF, the lethal concentrations increased 
among temephos resistant mosquitoes compared to reference strains. Marcombe et al. [84] noted 
that as PPF has never been used in public health programs in the United States, it is possible the 
cross-tolerance of mosquito larvae to IGRs has arisen through the extensive use of temephos for 
vector control.  
 
Safety 
PPF has a very favourable mammalian toxicity profile [47]. Even treatment of drinking water at 
a dosage of 0.01 ppm may be used, which is 30,000 times the lethal dose for mosquitoes and six 
times the recommended field application rate [30,109,110]. However, as with any chemical there 
are still concerns regarding environmental impact of the long-term application of PPF in 
permanent water bodies highlighting the need for environmental studies supporting such 







The results of this systematic review, which we believe to be the most comprehensive to date 
including lab and semi-field data, suggest that PPF can effectively control the emergence of adult 
Aedes mosquitoes across a wide variety of environments and in a variety of forms (e.g. granules, 
ULV sprays, TF, and fumigants). Utilizing a product with a favourable safety profile is 
especially important in settings where dose recommendations may not always be followed 
strictly. 
 
Unsurprisingly, the results show the most common use of PPF in granule form results in near 
100% (IE) for 90 days at higher concentrations even with removal and addition of water and 
regardless of the larval density [39]. Integrating PPF with other means of mosquito control (e.g. 
spinosad) can increase the efficacy with reduction of the risk of resistance 
development [111,112]. In areas where the main sources of larval biomass are identifiable and 
accessible, such as in rural areas with large water storage jars, controlled release PPF granules or 
matrixes could be quite effective.  
 
Although PPF works well in large water containers, other cryptic or subterranean breeding sites 
may require significant additional work of control teams to reach. One potential solution is to 
utilize auto-dissemination or horizontal transfer of PPF. Evidence shows that auto-dissemination 
occurs, and it successfully increases the mortality rate of larvae that were exposed while 
reducing the number and viability of eggs from exposed females. Field trials suggest that PPF 
can increase juvenile mosquito mortality and reduce adult mosquito emergence, however the 





used in combination (e.g. granules or controlled release devices for key containers). Significant 
work has been published on this topic the past two or years illuminating the preferable methods 
of employment, and the design and spacing of devices. However, there are still no WHO 
prequalified auto-dissemination devices that can be purchased at large scale for control programs 
to use, even were they to be recommended. Future studies should look further at defining 
optimum design of devices and standardized approach for application of PPF dust. 
 
In areas where Aedes breeding is located in large outdoor areas where key containers are not 
present or easy to identify, the use of PPF in ULV, TF and fumigants may be appropriate. 
Results show IE in treated areas near 100% and steadily decreasing with the distance from the 
sprayer, the length of time from treatment, and type (cold/thermal) of fogging. Sublethal doses of 
PPF were also found to have effects on the fertility and fecundity of adult females, suggesting 
positive effects may reach greater distances away from the sprayer.  
 
Regardless of how effective different PPF products are at distributing the active ingredient, 
effectiveness can be reduced or lost if the mosquito develops resistance. The results suggest that 
even among temephos-resistant mosquito populations IE levels show susceptibility to PPF at 
higher concentrations, with the exception of one Florida population [84]. Many studies found 
that while mosquito populations were still susceptible to PPF, the lethal concentrations increased 
among temephos-resistant mosquitoes compared to reference strains. This is even true in areas 
where PPF has not been used, suggesting the possible cross-tolerance of mosquito larvae to IGRs 
has arisen through the extensive use of temephos. Therefore, in areas where there is already 





in synergy. Regular entomological surveillance to monitor the susceptibility status of Aedes 
mosquitoes can help provide evidence and prevent development of resistance [81].  
 
One of the limitations reported is the issue of compliance by community in areas where top-
down government control programs are not distributing PPF [12]. This is due to false perceptions 
by the community that PPF is ineffective as it mainly acts on late instars and people may 
continue to observe live early instar larvae [113]. Qualitative studies are required to better 
understand what communication methods and materials would be most effective to increase 
community participation in vector control activities.  
 
One of the limitations of this review is the intentionally broad scope and focus on the effect of 
PPF on Aedes rather than the community effectiveness of PPF products on the reduction of 
dengue. However, a recent review of the community effectiveness of pyriproxyfen as a dengue 
vector control method found “community participation and acceptance has not consistently been 
successful and needs to be further assessed. While all studies measured entomological endpoints, 
only two studies measured the reduction in human dengue cases, with inconclusive results.” [12] 
 
Future studies can focus on further evaluating new PPF products and new use cases for 
established products. It will also be important to understand the effectiveness of these products in 
Africa. The majority of studies represented here come from Central/South America and Asia, 
and none from India or Africa. However, global estimates suggest Africa’s dengue burden to be 
equivalent to that of the Americas (16%) and together Africa and India contribute 50% of dengue 
cases [3]. It will be important to document the effectiveness of these products in these highly 






In conclusion, the evidence for the effectiveness of PPF to increase Aedes larval mortality and IE 
is strong and consistent. However, the strength of the evidence of different product formulation 
and use cases varies considerably. PPF granules have highly documented and consistent results 
that suggest it is very effective especially when used in slightly higher doses and distributed 
every 30-40 weeks. The use of PPF dust for auto-dissemination and the use of PPF in ULV, TF 
and fumigants are encouraging although the evidence in favor of them is not as strong or 
consistent. Many additional novel products have been evaluated (e.g. bed nets, paints, candles, 
ovitraps), however evidence for these products is very weak at the moment. Future research 
should focus on these areas where the evidence is less strong and include additional use cases 
that may become developed in the future. Additional research is also needed to elucidate the 
biological mechanisms of cross-resistance between PPF, temephos, and other insecticides to 
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Figure 2. 2: Summary of 30 studies investigating the effect of PPF granules  
 
First Author Year Country Study Type Product/Concentration (PPM) Combination % Larval Mortality 
% Inhibition of Emergence 
(Concentration in ppm, Time Post-
Treatment) Other
Al-Azab 2013 Saudi Arabia Lab Sumilarv® 0.5G (NA) Diflubenzuron 5-18% -  
Al-Ghamdi 2008 Saudi Arabia Lab Sumilarv® 0.5G  (0.001, 0.01) Baycidal (IGR) - 20% (0.001), 80% (0.01)
Al-Solami 2014 Saudi Arabia Lab Sumilarv® 0.5G (0.002, 0.02) None 10-24% 24.7(0.002) - 89.2 (0.02)
Ali 1995 USA Lab TG 97% PPF (NA) None 50% (0.00011 ppm); 90% (0.000376) -
Berti 2013 Venezuela Lab Sumilarv® 0.5G (000.2, 0.01) None - 77% (N/A, 8 weeks)  
Da Silva 2018 Brazil Field Sumilarv® 0.5G  (0.01) Grass Infusion - - 70 Egg Denstity Index, 120 in Control
Darriet 2006 France Lab TG 98.6% PPF (NA) Spinosad 90% (PPF alone)   100% (Combination) -
 
De Resende 2006 Brazil Lab Sumilarv® 0.5G (0.01,0.05) None -
41-98% (0.01, 90 Days)                                          
97.5-100% (0.05, 90 Days)  
Kamal 2010 Saudi Arabia Lab Sumilarv® 0.5G (0.02) Diflubenzuron 14% 91.3% (0.02)   
Khan 2016 Pakistan Lab
Sumilarv® 0.5G (0.01-0.05) &            
Sumilarv® 1.0G (0.01-0.05)
None 16%-78% 78% -100% (0.01-0.05)
Lee 2001 South Korea Field Sumilarv 0.5G® (0.01 - 0.5) None - 61-96% (0.01, 70 days)                                           
100% (0.05, 70 days)
Loh 1989 Malaysia Lab TG 96.2% PPF (0.00004-0.01) None 1.4 - 6.7%
5.7% (0.00004, 6 hours)                                       
100% (0.01, 6 hours)
Lab 50% (0.020 ppm) -
Field - -
Lab - 100% ( 90 days) - 16% ( 120 Days), 
Field -  99-100% (45 days) -  1.1% (60 days)
Morales 1997 Japan Field NA (0.1, 1, and 10) None - 47% (0.1), 95.2% (1), 100% (10)  
Lab - 100%/100% (0.2/0.5, 6 Weeks)
Field - 100%/100% (0.2/0.5, 6 Weeks)
Ocampo 2014 Colombia Field NA - (50) None - 100%  
Ochipinti 2014 Venezuela Lab
Sumilarv® 0.5G (0.01, 0.02, 0.03, 0.04, 
and 0.05)
None - 78.-91.8 (N/A, 90 Days)
 
Overgaard 2016 Colombia Field Sumilarv 0.5G® (NA) None - -
Together with deltamethrin treated curtains and jar 
covers/lids no effect on adult index, but reduction in 
breteau index compared to control 
Ritchie 2013 Australia Lab Sumilarv® 0.5G (0.1, 1, 10, and 100) None -
100% (100, 0-40 days), 100% (10, 0-8 
days), 100% (1, 0-4 days), 45% (0.1, 2 days)  
Romeo 2009 Italy Field Sumilarv 0.5G® (NA) None - 70-100% (N/A, 5 weeks)
Sallehudin 2004 Malaysia Lab Sumilarv® 0.5G (1 and 5) None -
100% (1, 22-28 Days) 100% (5, 36-42 Days) 
90% (1, 43-49 Days) 90% (5, 64-70 Days) 
 
Satho 2002 Japan Lab TG 99% (0.0001, .0001, 0.001) None -
Agypti (Tanzania) - 2-3% (0.00001),                      
17-36% (0.0001), 58-94% (0.001)                                   
Albo (Japan1) - 11-27% (0.00001)                        
52- 66% (0.0001), 91-98% (0.001)                                   
Albo (Japan2) - 23-30% (0.00001)                         
41 - 77% (0.0001), 86-88%(0.001)  
Seccacini 2008 Argentina Lab 97.8% PPF - 0.1% sand, 1% surfactant None -
100% (N/A, 45 Days)  -  80% (N/A, 180 
Days)  
Suarez 2011 Venezuela Lab Sumilarv® 0.5G (0.01, 0.05) None -
66-73.5% (0.01, 4 Weeks)                                           
77-95.7, (0.05, 4 Weeks)  
Tuten 2016 Switzerland Lab 5%  I.N.D.I.A. (0.01, 0.5, 2.5, 5) None - 74% (0.01), 83% (0.5), 86% (2.5), 92% (5)
Vythilingam 2005 Venezuela Lab Sumilarv® 0.5G  (0.01, 0.02) None -
100% (0.1, 4 Months), 100%  (0.2, 4 
Months), 40% (0.2, 6 Months)  
Wang 2013 Taiwan Lab Sumilarv® 0.5G (NA) None - 100% (N/A, 14 Days)  
Webb 2012 Australia Lab Sumilarv® 90CS (NA) None - 100%  (10), 20% (1)  
Lab 100%
Semi-field 99%  
Xu 2010 China Sumilarv® 0.5  (0.06, 0.12) None -
Nayar 2002 USA Sumilarv 0.5G® (0.02, 0.05) None
 
None 0% positive ovitraps until 7 weeks in dry season (5 weeks 
in wet season) about 50% by week 12
2018
Mehmood 2015 Pakistan Predator 0.5® (0.01) None





Figure 2. 3: Summary of 19 studies investigating the effect of auto dissemination or horizontal transfer of PPF  
 
Reference Year Country Type of Study Product/concentration (g/m2) # of Devices % Larval Mortality (Time) % Inhibition of Emergence Other
Abad-Franch 2015 Brazil Field Sumilarv® 0.5G (5) 100 90% -  
Buckner 2017 USA Semi-Field In2Care 5 - Intervention: 80% (agypti)  90% (albo) ; Control: 20%-30%
Italy Lab Sumilarv® 0.5G (0.5) 10 20% -
Italy Lab Sumilarv® 0.5G (5) 10 50-71% -
Semi-Field/open TG PPF (60% a.i.) 4 15% (mean - 8 weeks in 2013)/ 30% (mean 12 weeks 2014) -
Semi-Field/cryptic TG PPF (60% a.i.) 8 10% (mean - 8 weeks in 2013)/ 10% (mean 12 weeks 2014) -
USA Lab TG PPF  (0.3) - 10-30% -
USA Field TG PPF  (0.4) -  50-90% -
Devine 2009 Peru Field Sumilarv® 0.5G (5) 30 50% - 80% (Two Sites) -  
Gaugler 2012 USA Lab TG PPF/NyGuard® (NA) - - Cages-100%; Small Room-80%
 
Itoh 1994 Thailand Lab 95.2% TG PPF (1.0) - - 23%-95%; Control 3%  
Lab Esteem® (NA) 2 45% inervention - 1% control -
Field Esteem® (NA) 20 Site 1 (1%), Site 2 (4-30%,              Site 3 (0-12%), Site 4 (0-10%) -
Llyod 2017 USA Field Nyguard®- 10% PPF - - - Overall, there were no differences in pupal mortality 
between the control and autodissemination vases 
Mains 2015 USA Field Esteem® 35 WP IGR/DayGlo® (NA) -  70% (Female Experiment)                     95% (Male Experiment) -  
Japan Semi-Field TG Sumlarv® 1.0%  (w/v) (0.35) - Intervention: 50% (20 Days), Control 20% (20 Days) -
Japan Semi-Field  TG Sumlarv® 0.1% (w/v)  (0.035) - 50% (6 Days), Control 0% (6 Days) -
Semi-Field - - 25% treated, 10% control  
Field 4 - -
The post-treatment rate ratio (0.4) for treatment area 
indicated the pyriproxyfen-treated device significantly 
reduced adult counts during the study period.
Peru Field Sumilarv® 0.5G (NA) - 75% -
Peru Lab Sumilarv® 0.5  G - 50, 67, and 83 ppb (direct application) - 100% (5 Months) -
Suman 2014 USA Field NyGuard® (NA") - -
The sentinel containers for autodissemination showed 
15.8% pupal mortality (week 1–6) in the first year, and 
1.4% pupal mortality in the second year. No 
significant difference was detected among the 
distances and direction for pupal mortality.
Field (Essex) -2012 6 - - Pupae Mortality  of 15-20% over 12 weeks compared 
to 3% in Control 
Field (Hudson) - 2014 24 - - Pupae Mortality of 13.9-20.3% over 8 weeks 
compared to 1% in Control 
Field (Hudson) - 2012 1,2,4 - - Pupae Mortality of 10-25% over 12 weeks compared 
to 5% in Control 
Field (Middlesex) - 2013 1 - - Pupae Mortality of 50.4% over 8 weeks compared to 
5% in Control 
Field (Mercer) -2012 1 - - Pupae Mortality of 5-10% over 12 weeks compared to 
2% in Control 
Snetselaar 2014 Netherlands Lab NA 4 -   95%; Control 2%  
Tuten 2016 Switzerland Semi-Field 5% PPF powder - I.N.D.I.A. 5 - - 3 of 4 trials had staticailly significant difference in pupae between intervention/control
Unlu 2017 USA Field 20% PPF oil & 60% powder 81
- -
Pupal Mortality 12.4%  control 0.58% after 50 days, 
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Figure 2. 4: Summary of 15 studies investigating the effect of PPF ULV spray, thermal fogging, and fumigant technologies 
 
  
Reference Year Country Type of Study Product/Concentration Combination % Larval Mortality 
% Inhibition of Emergence 
(Time-Post Treatment) comment
Dantur Juri 2013 Argentina Field ULV treatment - 3% PPF, 
Fumigant - 0.2% PPF 
Permethrin
100% -
Doud 2014 USA Field Nyguard®- 10% PPF None  81.6%-87.4% 93.13-97.97%  
Harburguer 2011 Argentina
Field
ULV treatment - 2% PPF, 
Fumigant - 2% PPF
Permethrin, Methyl 3
95.5% 92.60%  
Harburguer 2011 Argentina Field Fumigant - 2% PPF Permethrin 100% 89.50%  
Harburguer 2012 Argentina
Field
ULV treatment - 2% PPF, 
Fumigant - 2% PPF
Permethrin
-
47-52% Inside,                                 
59.2-71.0% Outside  
Argentina Lab 0.2 g/kg PPF None - 20%
Argentina Lab 2 g/kg PPF None - 40%
Harburger 2009 Argentina Confirmatory 2 g/kg PPF Permethrin - 95-97% (30 min)  
Harwood 2016 USA Field Nyguard®- 10% PPF ULB BP-300 - -
 Sprayers producing larger droplets (misters and cold foggers) were more 
effective in controlling immature mosquitoes indoors and outdoors. 
Thermal fogging was more effective in controlling adults indoors, whereas 
cold fogs and misters were more effective for outdoor control
Harwood 2014 USA Semi-Field Nyguard®- 10% PPF ULB BP-300
-
ULV - 50-80% (0-4 Weeks),                         
TF 25-50% (0-4 Weeks)  
Lloyd 2017 USA Field Nyguard®- 10% PPF None
- -
The tire pile samples had significantly more mortality (P , 0.0001) out to 4 
wk when compared to autodissemination and control vases.
Lucia 2009 Argentina Field 3% PPF Permethrin -
65-100% (2-37 Days), 3% (44 
Days)  
Field 1 (Patriot) -
3.94-21.33 (1 day); -3.35-12.10 
(7 days), 1.55-19.78 (14 days)
Field 1 (Twister) -
-4.72-100 (1 day); 1.2-99.29      
(7 days), -4.83-97.27 (14 days)
Field 1 (Patriot) -
-9.8-99.57 (1 day); -10.25-
68.08 (7 days), -2.99-67.47 (14 
days)
﻿Fiorenzano 2013 USA Semi-Field Nyguard®- 10% PPF None
-
Direct Treatment -50-100%;                       
Indirect -70%-100%  
Unlu 2018 USA Field Archer IGR - 1.3% PPF AI lambda-cyhalothrin - -
 Applications resulted in significant decreases in adult mosquito 
abundance post- treatment of 74% compared with the untreated control. 
Both insecticides exceeded the 70% reduction threshold considered as 
effective for Ae. albopictus control for 2 to 4 wk. However, applications of 
Archer IGR alone did not reduce adult mosquito abundance.
Unlu 2018 USA Field Nyguard®- 10% PPF Sumithrin, prallethrin, and Bti - -
The adult emergence inhibition was significantly higher in the treatment 
bioassay cups t (z=4.65, P<0.0001) and field control bioassay cups (z=8.93, 
P<0.0001) than controls. They observed a lower trend in adult numbers 
following the seasonal long combined application of pyriproxyfen and 
adulticide, with numbers of adult Ae. albopictus in the treatment site up 
to five times lower than in the control site.
ULB BP-3002017
2014Harburger





Figure 2. 5: Summary of 10 studies investigating resistance of Aedes mosquitoes to PPF 
 
*Additional information on comparisons and resistance ratios can be found on page 50 
Reference Year Country Type of Study Product/Concentration (ppm)
Additional Prodcuts Used 
for Comparison with PPF
Resistance Ratios 
(Lethal Dose 
Suceptable / Resistant 
Strains)
% Inhibition of Emergence 
(Concentration in ppm, Time Post-
Treatment)
Adrighetti 2008 Brazil Lab/Semi-Field TG 98.5%/Sumilarv® 0.5G (0.05) Temefós Fersol 1G 1.4-6.5 100% (N/A,44 Days)
Martinique Semi-Field Sumilarv® 0.5G (0.02) Spinosad -
80% (N/A, 150 days),                               
Combination - 80% (N/A, 250 days)
Martinique Field Sumilarv® 0.5G (0.02) Spinosad -
 80% (N/A, 21 days),                                  
Combination - 80% (N/A, 126 Days)
Gomez 2011 Argentina Lab TG 97.8%  (NA) Temephos, Bti , Permethrin - 50% (0.01642-0.00774)
Lau 2015 Malaysia Lab Sumilarv® 0.5G (NA) None 1.4 -




Leyva 2010 Cuba Field 97% PPF (NA) None 0.5-3.4 -
Martinique Lab TG 98.7% (NA)
Bti , Temephos, Spinosad, 
and Diflubenzuron
2.2 -
Martinique Semi-Field/Field Sumliarv® 0.5G (0.2, 0.5)
Bti , Temephos, Spinosad, 
and Diflubenzuron
-
Semi-field - 80% (0.05, 250 days), 
80% (0.02, 160 days), Field - 80% 
Marcombe 2014 USA Lab TG 99.1% (NA)
Bti , Temephos, Propoxur, 
Spinosad, Methoprene
0.38-2.36 -
Leyva 2013 Cuba Lab TG 97% (NA) None - 30-40% (1) to 100% (10)
Teran Zavala 2014 Ecuador Lab TG 97% (NA) Temephos 4.2-9.2
 Temephos Resistant  - 40% (1), 100% 
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Background: Evidence on the effectiveness of low-cost, sustainable biological vector control 
tools for Aedes mosquitoes is limited. Therefore, the purpose of this trial is to estimate the impact 
of guppy fish, in combination with the use of the larvicide Pyriproxyfen (Sumilarv® 2MR), and 
Communication for Behavioural Impact (COMBI) activities to reduce entomological indices in 
Cambodia. 
 
Methods/Design: In this cluster randomized, controlled superiority trial, 30 clusters comprising 
of one or more villages each (with approximately 170 households) will be allocated, in a 1:1:1 
ratio, to receive either a) three interventions (guppies, Sumilarv® 2MR, and COMBI activities), 
b) two interventions (guppies and COMBI activities), or c) control (standard vector control). 
Households will be invited to participate, and entomology surveys among 40 randomly selected 
households per cluster will be carried out quarterly. The primary outcome will be the population 
density of adult female Aedes mosquitoes (i.e. number per house) trapped using adult resting 
collections. Secondary outcome measures will include the House index, Container index, Breteau 
index, Pupae Per House, Pupae Per Person, mosquito infection rate, guppy fish coverage, 
Sumilarv® 2MR coverage, and percentage of respondents with knowledge about Aedes 
mosquitoes causing dengue. In the primary analysis, adult female Aedes density and mosquito 
infection rates will be aggregated over follow-up time points to give a single rate per cluster. 





Discussion: This trial is expected to provide robust estimates of the intervention effect. A 
rigorous evaluation of these vector control interventions is vital to developing an evidence-based 
dengue control strategy and to help direct government resources. 
 
Trial Registration: Current Controlled Trials ISRCTN85307778; October 25, 2015 








Dengue is one of the most rapidly spreading mosquito-borne viral disease in the world, and is 
caused by bites of infected Aedes mosquitoes, principally Aedes aegypti [1]. Dengue infection is 
a systemic and dynamic disease with a wide clinical spectrum that includes both severe and non-
severe manifestations and, in some cases, can lead to death [1]. With an estimated 3.6 billion 
people in 124 countries at risk of contracting the disease [2] and 390 million dengue infections 
occurring each year (of which 96 million are clinically apparent) [3] the dengue virus has 
become a leading cause of illness in the tropics and subtropics [4]. Asia records 70% of the 
global disease burden due to dengue [3], and Cambodia has one of the highest per-capita 
incidence rates in the region [5].  
 
Identified in Cambodia in 1963 [6], a total of 194,726 dengue cases were reported to the National 
Dengue Control Program (NDCP) between 1980 and 2008 [7]. Between 2003 and 2008, annual 
dengue incidence ranged between 0.7 and 3.0 per 1,000 persons, the cost to society estimated at 
between $3,327,284 and $14,429,513 [8]. Since most of this cost falls onto the family, it is 
estimated that 67% of affected households fall into debt to pay for medical bills [9]. However, it 
is likely that the real number of cases and cost to society is much greater, with some studies 
suggesting the real case numbers are between 3.9 and 29.0 times higher than those of the 
National Dengue Surveillance System [10, 11]. 
 
Although a number of promising vaccine candidates are in preclinical and clinical 
development [12], and methods of genetic control of mosquitoes are being developed [13-15], 




protection. Without a cure or vaccine, the most appropriate dengue control measures are vector 
control and the avoidance of mosquito bites. Several vector control methods have been studied in 
Cambodia including chemical and biological substances (temephos, pyriproxyfen, and Bacillus 
thuringiensis israelensis) [16-19], jar covers [20], distribution of larvivorous copepods and 
fish [21-23].  
 
Past research 
Ae. aegypti is highly anthropophilic (preference for human beings), endophilic (resting indoors), 
endophagic (preference for feeding indoors) [19]. This partially explains why previous studies 
showed that household water storage jars contained over 80% of Ae. aegypti larvae in Cambodia, 
and why these jars became the main target for dengue vector control activities [20]. Since the 
early 1990s, NDCP has used the larvicide temephos (distributed with brand name Abate®) to 
target large (200-400L) household water containers as the primary means of vector control [19]. 
This has continued despite susceptibility tests in 2001 showing resistance of Ae. aegypti in urban 
Phnom Penh and incipient resistance in a rural province in Cambodia [24]. An evaluation of the 
effectiveness of temephos control programs to control larvae in 2007 concluded that control 
strategies emphasizing the use of temephos should be reconsidered [19]. Although temephos was 
only distributed during the rainy season, there were still containers found positive for immature 
Aedes during the dry season; and the program ignored discarded containers - which had twice the 
number of larvae as water storage containers. Khun and Manderson (2007) concluded that 
“continued reliance on temephos creates financial and technical problems, while its inappropriate 





Following the success of Mesocyclops (a genus of copepod crustaceans) programs in locally 
eliminating Aedes mosquitoes in Vietnam [25-27], the Cambodian NDCP implemented a two-
year Mesocyclops project in Kratie province from 2002-2004, searching for an alternative vector 
control option [23]. Initial results showed a reduction in the Aedes population in the intervention 
area, but by the end of the project larval densities in the intervention area had increased by 62% 
from baseline. This apparently lower effectiveness in Cambodia may be because Mesocyclops 
from the local water sources had various parasites and colonizing them parasite-free requires 
special training beyond what is possible in most rural Cambodian villages. The environment 
could have played a role as Northern Vietnam (where programs were most successful) has four 
distinct seasons and has different flora and fauna. Additionally, people did not accept 
Mesocyclops to the same extent as other interventions that were provided by the NDCP such as 
temephos (To Setha, personal communication, 2015). 
 
The search for other vector control options continued with an evaluation of Bacillus 
thuringiensis israelensis (Bti), a Gram positive, soil dwelling bacterium used a biological control 
agent [18]. The evaluation of Bti in Phnom Penh showed positive results with significant 
reductions in the number of pupae for at least 2 and 2.5 months in containers with river and well 
water, respectively [18]. More extensive usage and evaluation of Bti by the Cambodian 
government are currently occurring in Kandal and Kampong Thom Provinces (Personal 
communication, Bunleng Sam, 2015).  
 
Jar covers with long-lasting insecticidal netting (LN) treated with deltamethrin were found to 




house and adult mosquito survival [20]. However, the magnitude of the reduction diminished 
over time, due to a gradual reduction of insecticidal effect of the jar covers and a residual 
deltamethrin life of 22 weeks [20]. Interestingly, this is less than the average residual life of 
deltamethrin in treated bed nets [21]. Another cause may have been children not always keeping 
the jar covering on after extracting water and using them as toys around the house (Personal 
communication with To Setha, 2015) as Khun et al. noted in Cambodia before [28]. 
Improvements in engineering and design to prevent entry and egress of mosquitoes, especially 
when the container is used, and an increase the insecticidal effectiveness may be needed for jar 
covers to be cost-effective public health interventions [20].  
 
The use of a larvivorous guppy fish (Poecilia reticulata) was evaluated in 14 Cambodian 
villages [21], and subsequently in a larger study of 28 Cambodian villages [22]. Results from the 
initial study done from 2006-2007 were extremely encouraging with guppies in 56% of eligible 
containers, and a 79% reduction in Aedes infestation compared to the control. Guppy fish are not 
able to colonize all potential Aedes breeding sites, especially those which are polluted or with 
volume of less than 50L (To Setha, personal communication, 2015). However, despite not 
having guppies, the smaller or discarded containers in the intervention villages had 51% less 
infestation than those in the control, suggesting a community-wide protective effect [21]. This 
could partly be due to spill over effect from treatment villages as no results of guppy coverage 
were reported in the paper. These results led the WHO and the Asian Development Bank (ADB) 
to fund a larger scale-up in 2010-2011 which included Communication for Behavioural Impact 
(COMBI) activities. Results showed 88% guppy fish coverage in eligible water containers and a 




indoor resting adult females of near zero (while control had a CI of 30) at the end of the 
project [22]. Similarly encouraging results were found in Laos as a part of the same project. 
However, there were additional miscellaneous breeding sites including containers too small for 
guppy survival. Additional tools beyond larvivorous fish are required to target these varied, hard-
to-reach and cryptic breeding containers or sites. 
 
One such alternative that has been evaluated in Cambodia is pyriproxyfen (PPF) [16, 17]. PPF is 
a juvenile hormone analogue that interferes with the metamorphosis of juvenile Aedes 
mosquitoes, preventing their development into adults [29]. The results of the first study in 2003 
were so promising — at higher doses, inhibition of adult emergence (IE) greater than 87% for six 
months — that a larger second study was designed [16]. This showed that a novel 5% controlled 
release formation led to IE above 90% for 20 weeks, and above 80% for 34 weeks [17]. A slow-
release PPF matrix release formulation (Sumilarv® 2MR) has since been developed and is 
suitable for containers uninhabitable by guppy fish. The added benefit of this product is that it 
only requires one distribution every six months (the entirety of the rainy season) and cuts down 
on operational costs as compared to temephos or Bti which have residual efficacy of 2-3 
months [18, 30].  
 
The effective implementation of Integrated Vector Management requires mobilization and 
coordination of the resources needed to achieve and sustain behaviour changes among 
populations at risk of dengue [31]. The COMBI strategy provides a social mobilization and 
communication approach that connects knowledge and behaviour, addresses the cost and value 




creates a supportive environment for behaviour change [32]. The challenge for vector control is 
how community participation can be integrated into vector breeding source reduction 
efforts [22]. Community Health Workers (CHWs) are a vital part of successful COMBI 
communication and social mobilization activities. A recent review of 22 studies found that 
educational messages embedded in a community-based vector control approach were effective at 
reducing Ae. aegypti measured through entomological indices [33]. A separate systematic review 
found that community-based control strategies in addition or together with biological and 
chemical vector control tools reduced classical Aedes larval indices in five of six field trials [34]. 
Two cluster randomized trials published after the reviews showed that a community 
empowerment strategy embedded in a routine dengue vector control program drastically reduced 
entomological indices [35, 36]. These past studies show the importance of having a strong 
community-based COMBI strategy, and the important contribution it can add when integrated 
into the vector management strategy. 
  
Need for a trial 
Although there is evidence suggesting the use of guppy fish can be beneficial in dengue vector 
control, recent reviews show there has never been a cluster randomized trial to evaluate their 
effectiveness to reduce mosquito indices [37]. Although some studies have evaluated the use of 
community-based communication programmes for dengue control, a recent review found that 
none had assessed their costs [34]. This trial has the potential to inform the strategic application 
of community-based distribution of Pyriproxyfen and larvivorous fish in an outbreak, during 
inter-epidemic periods or for broad scale application. This trial will also be the first to our 




(personal communication, John Lucas, 2015). Although guppies, Pyriproxyfen (PPF), and 
COMBI activities have all been evaluated, some of these evaluations were methodologically 
flawed. Furthermore, they have never been tested in combination. Therefore, our study is 
intended to fill the knowledge gaps identified above. 
 
Hypothesis 
This trial aims to demonstrate community effectiveness of guppies, PPF, and COMBI activities. 
The main hypotheses are: 
1. Use of guppies, Sumilarv® 2MR and COMBI activities will reduce numbers of Aedes 
mosquitoes, and their infection rates, more than guppies and COMBI alone, or usual 
ministry of health activities (including larval control and information and education 
material dissemination during outbreaks) as assessed through entomology surveys; 
2. COMBI activities will improve the community’s knowledge, attitudes, and behaviour 
around water use and vector borne disease prevention (such as burning or burying 
discarded containers, cleaning the environment around the house, and sleeping under a 
bed net) as assessed through baseline/endline surveys and Focus Group Discussions 
(FGDs); 
3. Guppies and pyriproxyfen will be acceptable among the target villages as assessed by an 
endline survey and FGDs. 
 







This protocol is reported following the criteria of the Standard Protocol Items: Recommendations 
for Interventional Trials (SPIRIT) [38]. For the completed SPIRIT checklist see Appendix 3.1. 
 
Study setting 
The study has 30 clusters in two operational districts (ODs) (one OD includes the jurisdiction of 
10 health centres (HC) or roughly 100,000-200,000 individuals) within Kampong Cham 
province. Each cluster has on average 200 households or 1,000 individuals. The rainy season 
runs from April to November, and the peak dengue season is from May-July. Kampong Cham 
was selected as it has one of the highest dengue incidence rates of 1.6 cases per 1000 people in 
Cambodia and the environmental characteristics are similar to most dengue-endemic areas of 
Cambodia (Personal communication, Hai Ra, 2016). The clusters (containing one or more 
villages) were selected based on availability of entomological surveillance data from previous 
surveys. To avoid spill over effects, clusters had to be at least 200 meters from the nearest 
household outside the cluster since Ae. aegypti in this region have an average flight range of 50-
100m [39] (Figure 3.1). 
 
Eligibility criteria 
Every house within the cluster boundaries will be invited to participate in the trial. 
 
Interventions 
Selected villages will be randomized into one of three study arms (See Table 3.1). Study arm one 




activities, and arm three will receive only the standard vector control activities from the Ministry 
of Health. The total trial period for the interventions will be 11 months (See Figure 3.2 and 
Figure 3.3). 
Table 3. 1: Interventions randomized to each study arm 
Intervention Arm 1 Arm 2 Arm 3 
Guppy Fish in key containers (>50L) X X  
COMBI activities X X  
Direct PPF application (Sumilarv® 2MR) in 
smaller containers (10-50 L) 
X   
 
 
Study arm one was chosen to evaluate the effectiveness of all three interventions in combination. 
Application of any insecticide can be expensive when taking into account procurement and 
operational costs. Arm two was selected to evaluate the effectiveness of less expensive 
interventions (guppies and COMBI), although all strategies are expected to be less expensive 
than current strategies. As COMBI related activities have been shown to have a significant 
impact on coverage of interventions in Cambodia and elsewhere [21, 22, 34] a guppy only arm 
was not included. Therefore, the trial will not give separate estimates of the effects of guppies 
and COMBI. Larvicide only arms were not included because larvivorous fish are more 
sustainable and cost effective than larviciding [16, 17, 21, 22, 40, 41], and if larviciding was 








In rural Cambodia, more than 80% of the Aedes mosquito breeding is detected in key containers 
such as large water jars, cement tanks and other large containers used for the storage and 
collection of water for human and animal consumption and washing [20]. To target these 
containers, two guppy fish (Poecilia reticulata) will be placed into each water container greater 
than 50L in intervention villages (Arm 1 and 2). This is based on larval consumption of guppies 
determined by Seng et al. [21] and past experiences using guppies in vector control in 
Cambodia [22]. The guppy fish from the colony established by NDCP will be distributed after 
the baseline activities through a local community network managed by provincial government 
authorities. Guppy banks will be set up at the corresponding health centres and consist of twenty 
500L jars. Guppy banks will be colonized and can provide fish at any time to CHWs in 
implementation villages. One CHW will be assigned to monitor 30 Households (HHs) each 
month. They will each have two 500L jars which they can colonize with guppies to provide for 
their assigned households. When CHWs need more guppies, they can return to the guppy bank 
for them. Each month CHWs will conduct visual checks and ensure all their assigned households 
have guppies in all large containers and replace them if necessary. Adult guppies are on average 
1.5–3.5 cm long (males) or 3–6 cm long (females) [42].  
 
Pyriproxyfen matrix release (Sumilarv® 2MR) 
Each device or disc is designed to provide coverage for 40 L of water (Figure 3.4). It is also 







Table 3. 2: Dosage application rate of Sumilarv® 2MR discs 
Container capacity, L No. of 2MR discs Target ppb 
10 1/5 27 
20 1/2 27 
30 2/3 27 
40 1 27 
50 1 27 
 
PPF devices will be distributed after the baseline survey in the same manner as described above 
and replaced after 6 months. Additional devices will be left at the health centre for CHWs to 
distribute during their monthly monitoring visit if some have been lost or need to be replaced. 
 
Although there have not been any studies evaluating the safety of PPF in humans, toxicity to fish 
is induced at 450 ppb, which is approx. 45 times greater than the target ppb (10) of Sumilarv® 
2MR [43]. The LD50 in rats is 5,000,000 ppb, or 500,000 times the target concentration [44]. 
These data suggest a very favourable mammalian toxicity profile, and extremely low risk for 
humans using this product. 
 
Communication for behavioural impact activities 
An initial rapid assessment consisting of FGDs and In-Depth Interviews (IDIs) regarding 
knowledge, attitudes, and behaviours of community members was completed. The results were 
used in a message and material development workshop held with key community and district 




communication materials and come up with key messages. The results were used to understand 
the common social gathering locations for health education sessions, culturally appropriate 
channels of communication, and to create communication materials: flip charts to guide CHW 
education sessions, posters and banners for display in the villages, songs, and CHW materials 
such as hats, t-shirts, bags, and rain coats.  
 
A two-day training will be given to CHWs on communication and facilitation skills, following 
which they will take the lead role in conducting health education sessions in their community. A 
monthly meeting will also be conducted with CHWs to assess progress, address issues and 
challenges, and provide them continuous training to develop their confidence and skills. The 
health education sessions will occur twice per month and will be participatory, as Khun and 
Manderson [28] found that health educations sessions where participants actively identify 
breeding sites and practice positive behaviours can be more effective and less costly than the 
didactic classroom-based sessions. In addition to health education sessions we will use locally 
available media such as loud speakers fixed to local transport to play songs, street theatre 
performances, and role playing to reinforce the messages.  
 
Adherence 
In order to improve adherence to the intervention protocols, CHWs will perform monthly 
monitoring checks on each household within the intervention arms. The presence or absence of 
guppy fish and PPF Sumilarv® 2MR in each container within the household will be recorded 
along with any replacements the CHWs provide. The entomology surveys will also record the 




non-domestic use) within the surveyed households. Project staff will also randomly visit CHWs 
and intervention households to confirm the reliability of data provided. 
 
Primary outcome measures 
The primary outcome measure is the population density (i.e. number of mosquitoes per unit of 
time spent aspirating) of adult female Aedes trapped using adult resting collections. 
 
Secondary outcome measures 
The secondary outcomes for the trial include: 
• Dengue virus infection rate in adult female Aedes mosquitoes 
• House index (HI): Proportion of houses surveyed positive for Aedes larvae and/or pupae 
in any water container 
• Container index (CI): Proportion of surveyed containers containing Aedes larvae and/or 
pupae 
• Breteau index (BI): Number of containers positive for Aedes larvae and/or pupae per 100 
houses surveyed 
• Pupae Per House (PPH): Number of Aedes pupae per household 
• Pupae Per Person (PPP): Number of Aedes pupae per person 
• Guppy fish coverage: proportion of eligible water containers with ≥1 guppy fish 
• Sumilarv® 2MR coverage: proportion of eligible water containers with ≥1 MR 







The guppy fish and pyriproxyfen interventions will be assessed by an entomology survey. A 
sample size of 10 clusters per arm and 40 HHs per cluster for the survey was devised using the 
Hemming and Marsh method [45]. The distribution in each cluster is assumed to be Poisson, and 
the between-cluster variation is assumed to be Gaussian (normal). The calculation assumed a 
mean of 0.1 adult female resting Aedes per household in the intervention arms compared to 0.25 
in the control arm for each collection. This assumption was based on the results from the earlier 
World Health Organization/Asian Development Bank guppy fish project in the same province 
[22], and to be conservative assumed no impact from the PPF in arm 1. The households will be 
randomly selected each collection. The intra cluster correlation (ICC) was assumed to be 0.01 
based on previous studies [46-48]. Additionally, a sensitivity analysis was conducted up to the 
median value of ICCs for outcome variables (0.03) as found by an analysis conducted by 
Campbell et al [49]. Our analysis determined that we would have between 91 to 75 percent 
power at ICC values between 0.01 to 0.03. Under these assumptions the study will have 91-75% 
power to detect a difference at the 5% significance level. 
 
COMBI activities will be evaluated through Knowledge, Attitudes, and Practice (KAP) surveys. 
A sample size of 10 clusters per arm and 20 HHs per cluster was devised, again using the 
Hemming and Marsh method [45]. The calculation assumed a 22.5% change in primary outcome 
indicators from 40% to 62.5% in intervention villages and no change in the control villages over 
the course of one year. Outcome indicators include:  





This calculation was based on the results from the earlier projects done by Malaria Consortium 
(MC) in the region, and a recent unpublished MC KAP survey completed in 6 provinces and 30 
villages in 2014. In terms of variation in cluster size (as opposed to between-cluster variation in 
the outcome), the coefficient of variation was assumed to be 0.1 and is expected to be small as 
we plan to sample the same number of houses from each cluster.  Although the total number of 
houses varies between cluster, as shown in the flowchart (Figure 3.2), the sample size is based on 
the number of houses sampled for Aedes, which is under the control of the investigators. Under 




Clusters will be randomly assigned with a 1:1:1 allocation through a public randomization 
process. Village chiefs from all clusters and HC chiefs from all HCs will be invited to a central 
point along with local and national authorities. Locally the concept of “lucky draw” is very 
popular, so this method will be used to randomize clusters. Each cluster representative will 
choose one paper labelled arm one, two, or three from a bowl. The numbers on the papers will be 
printed and concealed by folding the paper in half four times. Three large labelled sheets of 
paper were put on the wall. As each representative selected their study arm, MC staff will write 
the cluster names on the corresponding sheet. 
 
Data collection methods 
Data will be collected at 0, 4, 8, 12 months post-intervention, unless otherwise mentioned. The 






A baseline survey was conducted prior to start of interventions. An endline survey will be 
conducted one year after the baseline. Two additional surveys during the dry season (4 months 
post intervention) and light rain (8 months post intervention - peak dengue season) will also be 
conducted. The schedule of the surveys took into account data from the previous guppy fish 
project [22]. The survey methodology was developed following the WHO guidelines for 
entomological collections [1]. Surveys will include indoor adult resting catches and larvae/pupae 
collection from water containers. The survey team consisted of experienced government staff 
who received three days training before beginning. All tools and materials were pre-tested during 
training. The same team will be used for each entomology survey. Houses within each cluster 
were selected using a random number generator [50] applied to the village list managed by the 
village head.  
 
The adult resting catch will be completed using a battery-powered, portable aspirator (Camtech, 
Phnom Penh, Cambodia) for 10 minutes per house in the bedrooms and living spaces, starting in 
the bedroom and aspirating up and down the wall (from floor to 1.5 m) around the home in a 
clockwise manner. The mosquitos will be kept in a screw top container inside a cold box and 
transported to the provincial laboratory for identification to the species level for Aedes, otherwise 
to genus. All Aedes mosquitoes will be sexed. After identification they will be stored in a -20 
degree Celsius freezer and taken to the United States Naval Medical Research Unit 2 (NAMRU-




rRT-PCR screening [51]. Flavivirus positive pools will be further tested for dengue typing by 
semi-nested RT-PCR assay targeting the C and pre-M regions within the viral genome [52]. 
Larvae and pupae collection will be completed using the five-sweep net method [53] for 
containers larger than 50 litres. The size of the net is 20 cm by 33 cm. Surveyors will turn the net 
in an anti-clockwise manner 5 times, then wait 1 minute and perform one sweep from the 
bottom. This method can sample around 35 percent of larvae and 31 percent of pupae, and the 
total number estimated by an adjustment factor [53]. For containers less than 50 litres, all the 
water will be poured through the sweep net. All containers within selected households will be 
inspected. All pupae and ten larvae per container will be put in a plastic bag, labelled (with date 
and code), and taken back to the laboratory for identification to the species level for Aedes, 
otherwise to genus. After identification they will be taken to NAMRU-2 in Phnom Penh where 
entomologists will confirm identification of a random sample of 50 percent of immature 
mosquitoes. 
 
Survey teams will also record the number, size, and type of all water containers in the household. 
The team will complete a rapid assessment tool (Premise Condition Index) (PCI) [54] to identify 
whether the scores can predict household risk for Aedes aegypti infestation. If proven useful as 
an indicator of risk, PCI could be used to streamline future surveys and program activities and 
possibly reduce program costs.  
 
Knowledge, attitudes, and practices  
The KAP survey was designed around the results of the FGDs and IDIs to create questions based 




community and revised where necessary. Questions are close ended or are categorized by data 
collectors at the time of response. 
KAP surveys will be conducted at the same time as baseline and endline entomology surveys. 
Only the household head will be asked to respond. The data will be collected by experienced 
government staff who will be given two days training before implementation. Each team will 
have a supervisor who can monitor data integrity and quality. All paper forms are submitted to 
the MC supervisor who performs a final check making sure all questions receive a response and 
skip patterns are followed correctly.  
 
Community health worker monthly monitoring 
The coverage of guppy fish and PPF Sumilarv® 2MR will be assessed by ocular inspection of 
water containers via entomology surveys and the CHW monthly reporting form as described in 
the adherence section. Coverage is expressed as percentage of containers with guppy fish or 
Sumilarv® 2MR of the total households or containers examined. 
 
Location 
The geographical location of each village within the trial and all households in the 
Entomology/KAP surveys will be recorded by a handheld Global Positioning System and plotted 
using ArcGIS® version 10 (Environmental System Research Institute, California) for spatial 






General climate data (rainfall, temperature and humidity) will be recorded at one of the 
intervention health centres using a rain gauge and a Hobo onset data logger (all villages have 
virtually the same climate). Data from the all United States National Aeronautics and Space 
Administration (NASA) satellites on climate will also be available including air pressure, air 
temperature, atmospheric moisture, evaporation, precipitation, and wind [56].  
 
Data management 
Double data entry into EpiData (EpiData Association, Denmark) is completed by an experienced 
data entry company. The process of data cleaning is being handled by MC staff. The original 
forms are kept in a secure locked cabinet in the MC Phnom Penh office, and will be available 
during data cleaning and analysis. Surveys will be maintained in storage for a period of two 
years after completion of the study.  
 
Statistical methods 
All statistics will be performed in R (Murray Hill, New Jersey) and Stata® (College Station, 
Texas) 
 
Primary outcome  
Adult female Aedes density will be summed over follow-up time points to give a single rate per 
cluster. This will be analysed by negative binomial regression using the number of adults as the 
response, and the logarithm of the sampling effort (that is, person-time spent aspirating) as an 
offset. Hence, this analysis will yield density ratios. The primary analysis will not be adjusted, 






Secondary outcomes including entomological indices such as HI, CI, BI, PPH, and PPP and 




Missing data will be reported as recommended by Díaz-Ordaz et al. [57] and their impact may be 
explored in secondary analyses. 
 
Data monitoring 
In accordance with the findings of Grant et al., we have not established a Data Safety Monitoring 
Board for this study as it is not a “clinical trial evaluating a therapy with a mortality or 
irreversible morbidity endpoint” [58]. However, a Technical Steering Committee (TSC) was 
established which will meet at least every six months and address any safety or other concerns 
that may arise. The TSC will have one member from each of the partner organizations including 
the government and WHO. HC and CHW staff have been advised to contact MC staff should any 
adverse event be detected through passive monitoring as a result of project activities. CHW 
monthly monitoring forms will also record any adverse events (such as tingling in the hands after 
touching PPF or gastrointestinal effects after potential exposure of PPF to the mouth in that are 
reported. Any event will be promptly reported to the ethics committees and government partners. 




harms are foreseen, and trials of similar products have not experienced any adverse events or 
unintended effects [16, 17].  
 
Access to data 
All co-principal investigators and partners will be given access to the cleaned data sets without 
identifiers, which will be stored on the Malaria Consortium SharePoint site and will be password 
protected. The final dataset will also be stored in the Cambodian National Centre for 
Parasitology, Entomology, and Malaria Control central repository.  
 
Ancillary and post-trial care 
In the event of any harm associated with the protocol Malaria Consortium will be responsible as 
the trial sponsor. The control group will be receiving routine interventions from CNM as 
described above and will continue to receive them after the close of the project. After the end of 
the project the lead institution, Malaria Consortium, will continue to advocate for and encourage 
uptake of any policy recommendations that come from the study 
 
Dissemination policy 
The principal investigator (Jeffrey Hii) will ensure that the results of the trial are published 
regardless of outcome. At least every six months results will be shared with the Technical 
Steering Committee. In addition to reporting the results in peer-reviewed journals, the results 
will be disseminated at the provincial level and national level to all project stakeholders. All 
documents and study materials will be made available in a tool kit that will be given to all 




international scientific conferences. Reporting will follow the guidelines in the CONSORT 
statement [59]. Authorship will follow Malaria Consortium authorship guidelines, which require 
substantive contributions to the design, conduct, interpretation, and reporting of a trial. The full 
protocol, household-level dataset, and statistical code will be placed in the Cambodian Ministry 
of Health’s central repository within six months of completion where all interested researchers 
can request access. 
 
3.3 Discussion 
Due to the rise in dengue cases [3], and the current lack of effective vaccines and therapeutics 
there is an urgent need to develop more effective vector control methods [22]. These methods 
together with the development of new vaccines [12], genetic control of mosquitoes [14, 15], and 
new therapeutic drugs [60] will be essential in reducing dengue prevalence throughout the world. 
Additionally, evidence suggests that the main vector tool in Cambodia (temephos) is becoming 
less effective [19, 20], and a need to assess new sustainable vector control methods in this 
context exists [22].  
 
Recent studies have suggested use of larvivorous fish to be effective in vector control [21, 22], 
however many were methodologically flawed, and none have used a randomized controlled 
design [37]. The studies on previous products similar to Sumilarv® 2MR showed positive 
results [16, 17], however the new product has not been tested externally beyond small ongoing 
semi-field trials in Thailand (personal communication, 2015, Muney Serit). Evidence from larger 
trials is essential when trying to understand the true impact of these vector control tools and in 





The study area is suitable for the current trial as the disease is prevalent in the selected districts, 
and the province has a history of dengue outbreaks [20]. The study team is also familiar with the 
area having conducted multiple dengue research projects in the area and have good relationships 
with the local authorities and communities in the area.  
 
It would be preferable to have a primary outcome directly related to dengue incidence rather than 
an entomological one. Finding the appropriate metric to measure disease impact is bedevilled by 
the effect of human movement on patterns of transmission, and the pronounced temporal and 
spatial heterogeneity in transmission, which will necessitate very large cluster-randomized study 
designs. We considered passive surveillance for dengue with rapid diagnostic tests in HCs. 
Although sensitivity among currently available tests was considered acceptable for routine 
clinical diagnostics [61] it was not considered high enough for seroconversion studies. No 
studies had used rapid diagnostics to estimate seroprevalence. Therefore, more expensive and 
labour-intensive efforts were preferable, such as cohort studies or capture-recapture methods 
(which have their own limitations [62]) to estimate the true number of cases and using a more 
sensitive diagnostic tool such as RT-PCR. However, due to budget limitations it was not possible 
to employ them. Additionally, unpublished data from a recent cohort study in the proposed 
districts suggest that, given similar number of cases during this study timeframe, and the 
resources available to the current project, there would not be enough statistical power to show an 
impact of the likely size on case numbers. (personal communication, Agus Rachmat, 2015). 
Therefore, the endpoint chosen was the density of adult Aedes mosquitoes, which are on the 




There is always a need to balance potential benefits and harms during a trial. The potential 
benefits of the trial are substantial, and trials of similar interventions in the past have not 
experienced any adverse events or unintended effects [16, 17, 21, 22]. Additionally, because of 
the low acute toxicity of pyriproxyfen it considered extremely safe and is recommended by 
WHO for use in drinking water [44]. 
 
This trial is designed to measure the reduction in adult and juvenile mosquitoes due to these 
vector control methods, relative to a control. However, one limitation is that the study was 
powered to detect a statistically significant difference between each arm compared with the 
control, and not between the intervention arms. This reduces the ability to see the impact of the 
PPF. A possible source of bias may be not having data collectors blind to the intervention; 
however, in this case it is unavoidable as data collection teams will be able to see the 
interventions in the containers which they sample. Contamination (spill over) of COMBI 
activities from intervention villages could affect our study by increasing knowledge or use of 
guppy fish in control areas. However, in the previous study it was found that only about 5% of 
containers had guppies in the control area at the end of the project [22]. Measurements of guppy 
fish coverage will also be conducted in control villages to identify the extent of any 
contamination. 
 
Although these data are being collected within one province in Cambodia, it is likely that the 
result of this trial could be generalizable to areas with similar ecology within the country and in 
neighbouring countries. Each country or province will have to make their own decision based on 




types of containers and community practices in two regions, and interest from government 
officials in introducing guppies to water containers in response to dengue outbreaks (personal 
communication, Jeffrey Hii, 2015). However, the decision was made to not introduce guppies in 
the Philippines as the community acceptance was low and the cool climate in higher altitudes 




At the time of submission of this manuscript the trial had completed the baseline data collections, 
enrolment of villages, and randomized allocation of the villages to three study arms.  
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Figure 3. 3: SPIRIT figure with schedule of enrolment, interventions, and assessments 
 STUDY PERIOD 
 Enrolment Allocation Post-allocation 







ENROLMENT:       
Eligibility screen X      
Randomization X      
Informed consent X      
Allocation  X     
INTERVENTIONS:       
Guppies, 
Sumilarv® 2MR and 
COMBI activities, 
Arm 1 




      
Control, Arm 3       
ASSESSMENTS:       
The population 
density of adult 
female Aedes 
(primary outcome) 
  X X X X 
Dengue virus 
infection rate in 
adult female Aedes 
mosquitoes 
  X X X X 
House index   X X X X 
Container index    X X X X 
Breteau index   X X X X 
Pupae Per House   X X X X 
Pupae Per Person   X X X X 
Guppy fish coverage   X X X X 
Sumilarv® 2MR 
coverage 


















Chapter 4: Field efficacy of guppies, pyriproxyfen (Sumilarv® 2MR), and 
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Background: Evidence on the effectiveness of low-cost, sustainable biological vector control 
tools for Aedes mosquitoes is limited. The purpose of this trial is to estimate the impact of guppy 
fish, in combination with the use of the larvicide Pyriproxyfen (Sumilarv® 2MR) and 
Communication for Behavioural Impact (COMBI) activities to reduce entomological indices in 
Cambodia. 
 
Methodology/Principle Findings: In this cluster randomized controlled trial, 30 clusters 
comprising of one or more villages each were allocated, in a 1:1:1 ratio, to receive either a) three 
interventions (guppies, Sumilarv® 2MR, and COMBI activities), b) two interventions (guppies 
and COMBI activities), or c) control (standard vector control). Entomology surveys among 40 
randomly selected households per cluster were carried out quarterly. The primary outcome was 
the population density of adult female Aedes mosquitoes (i.e. number per house) trapped using 
adult resting collections. Adult female Aedes density and mosquito infection rates were 
aggregated over follow-up time points to give a single rate per cluster. The results from this trial 
indicate that the interventions resulted in a statistically significant reduction in immature and 
adult Aedes mosquito density when compared to the control. There were no statistical differences 
identified between intervention arms, although lower guppy coverage in intervention arm two 
suggests that PPF did help keep mosquito densities low. Data from the KAP and qualitative 
assessments showed that the interventions were accepted by communities and that they were 





Conclusions/Significance: The number of Aedes females was reduced by roughly half compared 
to the control in both the guppy and PPF arm (Density Ratio (DR)=0.54 [95% CI 0.34-0.85], 
p=0.0073), and guppy arm (DR=0.49 [95% CI 0.31-0.77], p=0.0021). The extremely low cost of 
including guppy rearing in community-based health structures along with the effectiveness 
demonstrated suggest guppies should be considered as a vector control tool as long as the 
benefits outweigh any potential environmental concerns. PPF was also highly accepted and 
preferred over current vector control tools used in Cambodia, however product costs and 
availability are still unknown.  
 
Trial Registration: Current Controlled Trials ISRCTN85307778; October 25, 2015 






Dengue is one of the most rapidly spreading mosquito-borne viral diseases in the world, is 
caused by bites of infected Aedes mosquitoes, and can sometimes lead to death. Cambodia has 
one of the highest per-capita incidence rates in Asia. Without a cure or routinely available 
efficacious vaccine, dengue control relies largely on reduction and avoidance of mosquitoes. In 
Cambodia, dengue mosquito control activities are focused on larviciding with temephos and 
pyrethroid based adulticide sprays to which Aedes have been shown to be increasingly resistant. 
This study was designed to evaluate novel biological vector control tools (guppy fish and a 
controlled release larvicidal matrix) utilizing an integrated vector management approach with 
community-based methods tailored to the local context. The results indicate that the tools 
resulted in a statistically significant reduction in immature and adult Aedes mosquito density. 
The interventions were accepted by and communities were willing to pay for them. The results 
suggest guppies are an ideal vector control tool as long as the benefits outweigh any potential 
environmental concerns. PPF was also highly accepted and preferred over current vector control 





Dengue is the most rapidly spreading mosquito-borne viral disease in the world, and is caused by 
bites of infected Aedes mosquitoes, principally Aedes aegypti [1]. Dengue is concentrated in the 
Asian region, which shoulders 70% of the global disease burden. Although a number of 
promising vaccine candidates are in preclinical and clinical development [2], innovative methods 
of genetic control of mosquitoes are being developed [3–6], however these interventions are 
unlikely to eliminate dengue on their own [7]. Therefore, vector control will remain a key 
component of dengue control in the short and medium term. 
 
In Cambodia, a total of 194,726 dengue cases were reported to the National Dengue Control 
Program (NDCP) between 1980 and 2008 [8]. However, the real number of cases and cost to 
society is estimated to be many times higher [9,10]. Previous work showed household water 
storage jars contained over 80% of Ae. aegypti larvae in Cambodia, and these jars became the 
main target for dengue vector control activities [11].  
 
Since the early 1990s, NDCP has used the larvicide temephos (Abate®) to target large (200-
400L) household water containers as the primary means of vector control [12]. This has 
continued despite tests published in 2001, 2007, and 2018 showing resistance of Ae. aegypti in 
several provinces across Cambodia [12–14]. Khun and Manderson (2007) concluded that 
“continued reliance on temephos creates financial and technical problems, while its inappropriate 
distribution raises the possibility of larvicide resistance.”[12] These problems led researchers to 
consider alternative control methods including chemical and biological substances (pyriproxyfen 




larvivorous copepods and fish [17–19]. The interventions that had the most effective results 
included the use of larvivorous fish and PPF [1,18]. 
 
The use of a larvivorous guppy fish (Poecilia reticulata) was evaluated in 14 Cambodian 
villages [17], and subsequently in a larger study of 28 Cambodian villages [18]. Results from the 
initial study conducted from 2006-2007 were encouraging as even with low coverage of guppies 
(in 56% of eligible containers one year after project commencement) there was a 79% reduction 
in Aedes infestation compared to the control area. Despite not having guppies, the smaller or 
discarded containers in the intervention area had 51% less infestation than those in the control 
area, suggesting a community-wide protective effect [17]. These results led the WHO and the 
Asian Development Bank (ADB) to fund a larger scale-up in 2010-2011 which included 
Communication for Behavioural Impact (COMBI) activities. At the end of the implementation 
period, an evaluation found that 88% of water jars, tanks, and drums contained guppy fish, 
suggesting successful establishment of breeding sites. In addition, the Container Index (the 
percentage of water holding containers infested with Aedes larvae or pupae) and the number of 
indoor resting adult females in the intervention area were near zero, while the control area had a 
Container Index of 30 [18]. Similarly encouraging results were found in Laos as a part of the 
same project, although many water containers in the implementation area were too small for 
guppy survival. This experience indicates that additional tools beyond larvivorous fish are 
required to target smaller water containers as well as hard-to-reach and cryptic breeding sites. 
 
One potential solution to increase coverage of water containers in the communities is the use of 




mosquitoes, preventing their development. It can be used in small or contaminated containers 
unsuitable for larvivorous fish [20]. Studies of the efficacy of PPF in Cambodia showed 
inhibition of adult emergence (IE) greater than 87% for six months in 2003 [15], and IE above 
90% for 20 weeks, and above 80% for 34 weeks in 2007 [1]. A slow-release PPF matrix release 
formulation (Sumilarv® 2MR) has been developed and shown to be effective in Myanmar [21]. 
This new product only requires one distribution every six months (the entirety of the rainy 
season) so reduces operational costs as compared to temephos or Bti which have residual 
efficacy of 2-3 months [16,22].  
 
Yet the efficacy of these measures, like other vector management approaches in the 
communities, is not only dependent on their entomological efficacy, but requires mobilization 
and coordination of resources to sustain behaviour changes [23]. In particular, a key challenge 
for vector control in the communities is how local residents can be involved in and sustain vector 
breeding source reduction efforts [18]. Recent reviews indicate that a strong communication and 
behaviour change approach, such as COMBI, has the potential to support vector management 
programs with very good outcomes [24,25]. For example, two new cluster randomized trials 
found that educational messages embedded in a community-based vector control approach were 
effective at reducing Ae. aegypti measured through entomological indices [26,27]. 
  
Need for a trial 
Although there is evidence suggesting the use of guppy fish can be beneficial in dengue vector 
control, recent reviews show there has never been a cluster randomized trial to evaluate their 




community-based distribution of Pyriproxyfen and larvivorous fish in an outbreak, during inter-
epidemic periods or for broad scale application. This trial will also be the first to our knowledge 
to evaluate the widescale use of the new Sumilarv® 2MR product in the field. Furthermore, they 
have never been tested in combination. Therefore, our study is intended to fill the knowledge 
gaps identified above. 
 
Hypothesis 
This trial aims to demonstrate community effectiveness of guppies, PPF, and COMBI activities. 
The main hypotheses are: 
1. Use of guppies, Sumilarv® 2MR and COMBI activities will reduce numbers of Aedes 
mosquitoes, and their infection rates, more than guppies and COMBI alone, or standard 
vector control activities (such as larval control and information and education material 
dissemination during outbreaks) as assessed through entomology surveys; 
2. COMBI activities will improve the community’s knowledge, attitudes, and behaviour 
related to water use and vector borne disease prevention (such as burning or burying 
discarded containers, cleaning the environment around the house, and sleeping under a 
bed net) as assessed through baseline/endline surveys and Focus Group Discussions 
(FGDs); 
3. Guppies and pyriproxyfen will be acceptable among the target villages as assessed by an 








Study design and setting 
The study is designed as a cluster randomized, controlled trial with three arms. Reporting follows 
the guidelines in the CONSORT statement [59] (Appendix 4.1). The study has 30 clusters, where 
each cluster is a village or group of villages with on average 170 households (range 49-405) or 
757 individuals (range 250-1769). The rainy season runs from April to November, and the peak 
dengue season is from May to July. The province of Kampong Cham was selected for its high 
dengue incidence rate of 1.6 cases per 1000 people in 2014 (personal communication, Hy Ra) 
and its environmental characteristics similar to most dengue-endemic areas of Cambodia. The 
clusters were selected based on availability of entomological surveillance data from previous 
surveys. To minimize potential spill over effects, clusters had to be at least 200 meters from the 
nearest household outside the cluster since Ae. aegypti in this region have an average flight range 
of 50-100m [29].  
 
Eligibility criteria 
Every house within the cluster boundaries was invited to participate in the trial. 
 
Interventions 
Selected villages were randomized into one of three study arms (See Table 4.1). Reasons for 
selecting the interventions for each arm are described above and in more detail in the study 





Two guppy fish (Poecilia reticulata) were placed into each water container greater than 50L in 
intervention villages (Arm 1 and 2). This is based on larval consumption of guppies determined 
by Seng et al. [17] and past experiences using guppies in vector control in Cambodia [18]. The 
guppies were sourced from the original NDCP colony, which was started from guppies found in 
a rural waterway near Phnom Penh roughly fifteen years earlier. The guppy fish were distributed 
after the baseline activities through a local community network managed by provincial 
government authorities [30]. CHWs were provided two jars for rearing. Each month CHWs 
conducted visual checks and ensured all their assigned households have guppies in all large 
containers and replaced them if necessary (Appendix 4.2).  
 
Pyriproxyfen matrix release (Sumilarv® 2MR) 
The product contains pyriproxyfen incorporated in an ethylen copolymer resin disk, and the PPF 
is gradually released from the polymer material until it reaches an equilibrium state of the 
dissolved active ingredient with that in the matrix formulation [31]. Each device is designed to 
provide coverage for 40 L of water and can be cut into smaller sizes for smaller containers [30]. 
PPF devices were distributed to containers of size 10-50 litres at the beginning of the trial and 
replaced after 6 months. Additional devices were left at the HC for CHWs to distribute during 
their monthly monitoring visit if some were lost or needed to be replaced. The exceptional safety 
of PPF is reflected in WHO’s statements that it is “unlikely to present acute hazard in normal 
use", "pyriproxyfen does not pose a carcinogenic risk to humans", and PPF “is not genotoxic." 




pyriproxyfen for mosquito control [32]. Animal models suggest a very favourable mammalian 
toxicity profile, and extremely low risk for humans using this product [30]. 
 
Communication for behavioural impact activities 
A rapid formative assessment consisting of FGDs and In-Depth Interviews (IDIs) regarding 
knowledge, attitudes, and behaviours of community members was completed. The results formed 
the basis of well-informed COMBI interventions and were used in a message and material 
development workshop held with key community and district stakeholders [30]. A two-day 
training was given to CHWs on communication and facilitation skills, roles and responsibilities, 
and community participation following which they took the lead role in conducting health 
education sessions twice every month in their community [30]. Monthly meetings were also 
conducted with CHWs to assess progress, address issues and challenges, and provide them 
continuous training.  
 
Adherence 
In order to improve adherence to the intervention protocols, CHWs performed monthly 
monitoring checks on each household within the intervention arms, and entomology surveys 
recorded the presence or absence of each intervention in containers [30]. Project staff also 
randomly visited CHWs and intervention households to confirm the reliability of data provided. 
 
Primary outcome measures 
The primary outcome measure is the population density (i.e. number of mosquitoes per unit of 




Secondary outcome measures 
The secondary outcomes for the trial include: 
1. Dengue virus infection rate in adult female Aedes mosquitoes 
2. House index (HI): Proportion of houses surveyed positive for Aedes larvae and/or pupae 
in any water container 
3. Container index (CI): Proportion of surveyed containers containing Aedes larvae and/or 
pupae 
4. Breteau index (BI): Number of containers positive for Aedes larvae and/or pupae per 100 
houses surveyed 
5. Pupae Per House (PPH): Number of Aedes pupae per household 
6. Pupae Per Person (PPP): Number of Aedes pupae per person 
7. Guppy fish coverage: proportion of eligible water containers with ≥1 guppy fish 
8. Sumilarv® 2MR coverage: proportion of eligible water containers with ≥1 MR resin disc 
9. Percentage of respondents with knowledge about Aedes mosquitoes causing dengue 
 
Sample size 
The guppy fish and pyriproxyfen interventions were assessed by four entomology surveys. A 
sample size of 10 clusters per arm and 40 HHs per cluster for the survey was devised using the 
Hemming and Marsh method [33] assuming a mean of 0.1 adult female resting Aedes per 
household in the intervention arms compared to 0.25 in the control arm for each collection based 
on previous studies. The households were randomly selected each collection. The intra cluster 
correlation (ICC) was assumed to be 0.01 based on previous studies [30]. Additionally, a 




as found by an analysis conducted by Campbell et al. [34]. Our analysis determined that ICC 
values between 0.01 to 0.03 would have 91 to 75% power, respectively. 
 
The impact of COMBI activities in the communities was evaluated through Knowledge, 
Attitudes, and Practice (KAP) surveys. A sample size of 10 clusters per arm and 20 HHs per 
cluster was devised, again using the Hemming and Marsh method [33], assuming a 22.5% 
change in KAP indicators from 40% to 62.5% in intervention villages and no change in the 
control villages over the course of one year [30].  
 
Allocation 
Clusters were randomly assigned with a 1:1:1 allocation through a public randomization process. 
Village chiefs from all clusters and HC chiefs from all HCs were invited to a central point along 
with local and national authorities, where allocation took place. Allocation concealment was 
accomplished by having each cluster representative choose one folded up paper with a printed 
label referring to arm one, two, or three.  
 
Data collection methods 
Data were collected at 0, 4, 8, 12 months post-intervention, unless otherwise mentioned. The 
timing was also meant to capture data over different season (e.g. heavy rain, light rain, and dry 








A baseline survey was conducted prior to start of interventions. An endline survey was 
conducted one year after the baseline. Two additional surveys during the dry season (4 months 
post intervention) and light rain (8 months post intervention - peak dengue season) were also 
conducted. The survey methodology was developed following the WHO guidelines for 
entomological collections [35] and detailed in the study protocol [30]. The survey team also 
completed a rapid assessment tool (Premise Condition Index) (PCI) [36] to identify whether the 
scores can predict household risk for Ae. aegypti infestation (Appendix 4.3).  
 
Knowledge, attitudes, and practices  
KAP surveys were conducted at the same time as baseline and endline entomology surveys. 
Details on the methods can be found in the study protocol [30]. The secondary outcome measure 
included was whether participants knew dengue is transmitted by Aedes mosquitoes; however, it 
should be noted that the word Aedes when translated into the local language (Khmer) is “kala” 
which means feline and is most often interpreted as tiger (Appendix 4.4).  
 
Community health worker monthly monitoring 
The coverage of guppy fish and PPF Sumilarv® 2MR were assessed by ocular inspection of 
water containers via entomology surveys and the CHW monthly reporting form as described in 
the adherence section. Coverage is expressed as percentage of containers with at least two guppy 







General climate data (rainfall, temperature and humidity) were recorded at one of the 
intervention health centres using a rain gauge and a Hobo onset data logger (all villages have 
virtually the same climate).  
 
Data management 
The first two entomology surveys and the first KAP survey were recorded on paper, and double 
data entry was performed using EpiData (EpiData Association, Denmark) by an experienced data 
processing company. Due to factors including budget, timeliness, and need for data cleaning, the 
subsequent two entomology surveys and final KAP survey were recorded electronically on 
Samsung tablets (Samsung Group, South Korea) and uploaded to ONA servers (ONA, USA).  
 
Mosquito Testing 
Adults female Aedes mosquitoes were pooled together by cluster with a maximum of 10 per 
pool, and an expected minimum infection rate of 3-7% based on other studies [37,38] . Flavivirus 
detection in adult female mosquitoes followed the protocol set out by Pierre et al. [39] using a set 
of universal oligonucleotide primers. Samples identified as positive for flavivirus were then put 
into a rapid assay for detecting and typing dengue viruses [40]. All pools had positive and 
negative controls to ensure the tests were working properly.   
 
Statistical methods 
All statistical analyses were performed in R version 3.5.0 (Murray Hill, New Jersey) and Stata® 




Primary outcome  
Adult female Aedes density was summed over follow-up time points to give a single rate per 
cluster. This was analysed by negative binomial regression using the number of adults as the 
response, and the logarithm of the sampling effort (that is, person-time spent aspirating) as an 
offset. Hence, this analysis yielded density ratios. 
 
Secondary outcomes 
Secondary outcomes including entomological indices such as BI, PPH, and PPP were also 
analysed by the above methods. The indicators which were proportions (CI and HI) were 
analysed using binomial regression.  
 
Data monitoring 
In accordance with the recommendations of Grant et al., we did not establish a Data Safety 
Monitoring Board for this study as it is not a “clinical trial evaluating a therapy with a mortality 
or irreversible morbidity endpoint” [41]. However, a Technical Steering Committee (TSC) was 
established which met at least every six months and addressed any concerns that arose [30]. 
Additionally, participants were told to report any adverse events directly to project staff or 
CHWs and seek medical attention immediately. CHW monthly monitoring forms include a line 
to report any adverse events that have taken place. Any report of harm or adverse events was 







Access to data 
All co-principal investigators and partners were given access to the cleaned data sets without 
identifiers, which were stored on the Malaria Consortium SharePoint site and were password 
protected. The final anonymized dataset is attached as supporting material and will also be stored 
in the Cambodian National Centre for Parasitology, Entomology, and Malaria Control central 
repository. Entomological specimens are stored for two years at Malaria Consortium offices 
should other researchers be interested in accessing them. 
 
Ethical approval and consent to participate 
Ethical clearance for this trial was received by the Cambodian National Ethics Committee for 
Health Research on Oct 9th, 2014 (ethics reference number 0285). Additionally, ethics approval 
was received from the London School of Hygiene and Tropical Medicine Observational / 
Interventions Research Ethics Committee (ethics reference number 8812). CHWs explained the 
trial and received informed consent from the head of the household before providing the 
interventions [30]. Those who were illiterate or otherwise could not sign their name were given 
the option of giving their thumb print. All village and respondent names were deleted to ensure 
no identifying information was included. Data from surveys were stored in a password-protected 
computer. All qualitative data were collected in concordance with the guidelines of the Code of 








intervention arms (Table 4.2). The sex and age distribution of household heads was similar 
between the three arms. The mean number of containers, positive containers, BI, and PPP at 
cluster level were all larger in the guppy only arm (arm 2) than others, while the mean number of 
adult Aedes females per cluster was similar between arms. 
 
Primary outcome 
Over the intervention period, the population density of adult female Aedes was significantly less 
in both the guppy + PPF arm (Arm 1) (Density Ratio (DR)=0.54 [95% CI 0.34-0.85], p=0.0073), 
and guppy arm (Arm 2) (DR=0.49 [95% CI 0.31-0.77], p=0.0021) relative to control (Arm 3). 
However, the difference between the two intervention arms was not significant (DR=1.10 [95% 
CI 0.69-1.74], p=0.6901) (Table 4.3). The mean number of adult Aedes females was the highest 
in the light rain season and lowest in the rainy season. (Figure 4.2). 
 
Secondary outcomes 
None of the mosquito pools tested were positive for dengue virus; consequently, the minimum 
infection rate was 0%. The most commonly used entomological indexes (BI and PPP) are 
reported here, where correlated indices (CI, HI, and PPH) are listed in the supplementary tables 
(Table S4.1).  
 
Breteau index  
Over the intervention period, the BI was significantly less in both the guppy + PPF arm (Arm 1) 
(DR=0.65 [95% CI 0.50-0.85], p=0.0016), and guppy arm (Arm 2) (DR=0.63 [95% CI 0.48-




was not significant (DR=0.97 [95% CI 0.73-1.27], p=0.7982) (Table 4.4). The biggest difference 
between arms was seen during the dry and light rain or rainy seasons (Figure 4.3). 
 
Pupae per person  
Baseline results show significantly higher PPP in the guppy arm (Arm 2) than the other arms 
(Figure 4.4). Over the intervention period, the PPP was significantly less in both the guppy + 
PPF arm (Arm 1) (DR=0.56 [95% CI 0.35-0.91], p=0.0193), and guppy arm (Arm 2) (DR=0.52 
[95% CI 0.32-0.84], p=0.0075) relative to control (Arm 3). The difference between the two 
intervention arms was not significant (DR=0.92 [95% CI 0.60-1.49], p=0.7385) (Table 4.4).  
 
Knowledge, attitudes, and practice survey 
The secondary outcome related to the KAP survey is reported here, while the full data set from 
the KAP survey is in the supplementary files. High levels of knowledge that dengue is 
transmitted by Aedes mosquitoes were reported at baseline among all arms (95.5-98%). Endline 
surveys showed 100% of participants with this knowledge. Ratios of increased knowledge 
between baseline and endline were not significantly different between arms with the guppy + 
PPF arm (Arm 1) (RR=0.99 [95% CI 0.86-0.1.14], p=0.915), and guppy arm (Arm 2) (RR=1.01 
[95% CI 0.87-1.16], p=0.943) relative to control (Arm 3) (Table 4.4).  
 
Coverage of guppy fish and Sumilarv® 2MR 
Coverage of guppy fish (proportion of eligible water containers with ≥1 guppy fish) before 
replacement in Arm 2 rose to nearly 80% after one month and stayed close to 70% for most of 




water containers with ≥1 Sumilarv® MR) rose to 80% after two months and stayed high until 
dropping in March, after which continued health education messages increased coverage back to 
near 70-80%. Guppy coverage in Arm 1 was notably lower (near 50%) until guppy use was 




The average maximum daily temperature in the shade decreased from 34.4o C in the dry season 
to 31.3o C in the light rain season. The average relative daily humidity and monthly rainfall 
increased from 60.0% and 10.7 millimetres to 75.2% and 139 millimetres from the dry to light 
rain season, respectively (Figure 4.6). The rainy season saw much larger amounts of rainfall 
(near 300 millimetres) than all other seasons.  
 
Adverse events 
No adverse events, harms, or unintended effects were recorded during the trial.  
 
4.4 Discussion 
Guppies, whether or not in combination with PPF, were able to decrease the number of Aedes 
females (DR=0.49-0.54) and PPP (DR=0.52-0.56) by roughly half compared to the control and 
resulted in approximately 35% decrease in the BI (DR=0.63-0.64). All other entomological 
indices also showed similar and statistically significant reductions in intervention arms as 
compared to the control. There were no statistical differences identified between the two 




differences. Regardless, the lack of difference between the arms could also be due to coverage. 
Guppy coverage was much lower in intervention Arm 1 than in Arm 2 (54% vs 70%), therefore 
suggesting the use of PPF may have contributed to keeping entomological indicators similar to 
those in Arm 2.  
 
Although none of the mosquito pools were found to be positive for dengue virus, all the positive 
and negative controls performed as expected. Additionally, one recent study used a model to 
simulate the process of mosquito sampling, pooling, and virus testing and found that mosquito 
infection rates commonly underestimate the prevalence of arbovirus infection in a population. 
More specifically, they found that in simulated tests with low virus detection ability virus 
detection (even among pools with 20-50 mosquitoes) failed in a large number of positive 
samples and most had minimum infection rates of 0 [43]. This suggests that either 1) the 
minimum infection rate found in this study was the true rate in the population, 2) there was some 
degradation of RNA which resulted in untrue rates (despite proper cold chain management), or 
3) the amount of virus in the pools was not enough to be detected.   
 
It was observed that adherence to guppies was high (70-80%) and consistent when only one 
intervention requiring behaviour change (guppies) was assigned. In the intervention arm with 
guppies and PPF adherence to one intervention was highest when focused health education 
messages were given on that intervention specifically (e.g. guppy coverage in March was highest 
when guppy use was emphasized and lowest in December to February when PPF usage was 
emphasized). Similar dynamics have been found with the use of other vector control tools. A 




effective at suppressing entomological indices. However, the same effect was not present when 
applied in combination with other interventions [44]. This suggests that unfortunately no single 
vector control intervention may be enough to reach elimination of dengue and using multiple 
interventions which require behaviour change may reduce individual intervention effectiveness. 
Some studies have suggested combining imperfect vector control with an imperfect medium-
high efficacy vaccine could be more efficacious and cost-effective way to reduce dengue 
cases [45,46].  
 
The results of the KAP survey showed very high baseline knowledge levels which may have 
resulted from the high number of cases in the study site and from previous government-led anti-
dengue efforts in these areas. The knowledge that dengue is transmitted by Aedes mosquitos rose 
to 100% of respondents by the end of the intervention, however even that was not statistically 
significant between baseline and endline surveys. Similarly, high levels of knowledge on other 
dengue topics was found in the baseline survey and reported earlier [47]. Interestingly, self-
reported vector control practices did not match observed practices recorded in the surveys, and 
no correlation was found between knowledge and observed practices either [48]. Therefore, an 
education campaign regarding dengue prevention in this setting with high knowledge levels is 
unlikely to have any significant effect on practices unless it is incorporated in a more 
comprehensive strategy for behavioural change (e.g. use of the COMBI method). In addition, to 
bridge the knowledge-practice gap, there is a need to create an enabling environment at the 
household, community and health facility level to follow the required behaviours. For example, 




recommended interventions (e.g. guppies, PPF, Bti) in order to follow the recommended 
behaviours. 
 
In the previously reported 12 Focus Group Discussions (FGDs) and nine In-Depth Interviews 
(IDIs) nearly all participants perceived that the interventions resulted in a reduction in Aedes 
mosquitos (both adults and immatures) and dengue cases (Shafique et al., in press). Participants 
showed high demand for both interventions (guppies and PPF) and were willing to pay between 
100-500 riel (0.03-0.13 USD). In addition, several participants began rearing guppies in their 
home for their personal use, for the children to play with, and to possibly sell in the market. The 
presence of larvae in the water despite the use of PPF was a source of concern for some 
participants, although this was overcome in most cases with proper health education through 
health volunteers. Interpersonal communication through health volunteers was the most preferred 
method of transmitting prevention messages. Together the entomological, KAP, and qualitative 
results suggest that the interventions were efficacious and accepted by the community. 
 
However, there is always a need to balance potential benefits and harms of any intervention. 
Following the recent Zika outbreaks in 2015-2016, there were two groups of ecologists that 
noticed public health authorities utilizing non-native larvivorous fish (including guppies) in 
Aedes control [49,50]. Both of these groups wrote opinion pieces that gave three strong 
messages; 1) the use of larvivorous fish in vector control is not effective, 2) the chances of 
accidental guppy introduction into local ecosystems are large, and 3) that guppies can easily 
establish populations and damage these aquatic ecosystems. The first point is contradicted by 




regarding the other points, guppies are indeed known to be highly plastic and acclimate to new 
environments [51]. For example, as far back as 1963 guppies have been highly effective in Culex 
control in highly polluted ground pools and waterways in Bangkok, Yangon, and Taipei [52]. In 
one study it was postulated that female guppies are capable of routinely establishing new 
populations in mesocosms, and that over 80% of these populations persist for at least two 
years [53]. Therefore, the key question is what is the ecological impact of guppies being 
accidentally released into the environment? Despite the strong statements made in the opinion 
pieces, the underlying evidence seems to be weaker than implied with most introductions made 
before proper baseline assessments were completed. Studies have shown some effects of guppies 
on resident fish densities in lab conditions [54,55] , and nitrogen levels in water [56–58], 
however the extent of these effects across the ecosystem - especially in areas where introduction 
and naturalization took place many decades ago (such as Cambodia) - are far from settled. A 
book on evolutionary ecology of the Trinidadian guppy noted that in regard to the impact of 
exotic guppies “the literature is scant, and the area ripe for research” [57]. The author also noted 
that manner in which introduced fish species impact native assemblages is incompletely 
understood, and that issues such as anthropogenic changes to the habitat, such as rise in water 
temperature, could favour introduced over native species [57].  
 
Measures available to control programs to mitigate the risks of introduction include; 1) 
restricting breeding sites to areas which can be locked and controlled by the breeders; 2) only 
distributing fish to key containers in at-risk areas and away from lakes and streams); 3) only 
distributing male fish to avoid breeding after accidental release by households; or 4) evaluating 




consider their use. It should be noted that male guppies have been found to consume less larvae 
than males (123 per day compared to 74 per day) [17], however that consumption rate was more 
than enough to clear the main breeding jars in Cambodia.  
 
In addition to concerns on accidental release of guppies to the environment, some lab 
experiments have raised the possibility that putting guppies in containers used for drinking water 
could increase Escherichia coli and other bacteria [59]. However, a recent study (Sidavong et al., 
submitted manuscript) found the addition guppy fish in Lao and Cambodia made no significant 
difference to high pre-existing baseline levels of contamination. Therefore, the authors 
concluded that any contaminating effect may be insignificant when compared with the potential 
for reducing dengue fever cases and advocated for the inclusion of advice on safe water use to be 
included in any behaviour change communication programs for guppy introduction. 
 
This study has several limitations. The most important of which is the absence of a primary 
outcome directly related to dengue incidence rather than an entomological one. Finding the 
appropriate metric to measure disease impact is bedevilled by the effect of human movement on 
patterns of transmission, and the pronounced temporal and spatial heterogeneity in transmission, 
which will necessitate very large cluster-randomized study designs [60,61]. We considered 
passive surveillance for dengue with rapid diagnostic tests in HCs. Although sensitivity among 
currently available tests was considered acceptable for routine clinical diagnostics [62] it was not 
considered high enough for seroconversion studies and no studies were identified that had used 
rapid diagnostics to estimate seroprevalence. Therefore, more expensive and labour-intensive 




own limitations [63]) to estimate the true number of cases, or using a more sensitive diagnostic 
tool such as RT-PCR. However, due to budget limitations it was not possible to employ them. 
Additionally, unpublished data from a recent cohort study in the proposed districts suggest that, 
given similar number of cases during this study timeframe, and the resources available to the 
current project, there would not be enough statistical power to show an impact of the likely size 
on case numbers. (personal communication, Agus Rachmat, 2015). Therefore, the endpoint 
chosen was the density of adult Aedes mosquitoes, which are on the causal pathway to disease.  
 
Nevertheless, determining the effect of an entomological outcome on dengue transmission is 
difficult. Multiple studies in Cuba have suggested that a BI of greater than five can be used to 
predict dengue transmission, although they note that their results can probably not be 
extrapolated to areas were dengue transmission is endemic [64,65]. A recent study from Peru did 
show a statistically significant association between 12-month longitudinal data on Aedes aegypti 
abundance (1.01-1.30) and categorical immature indices (1.21-1.75) on risk ratios dengue virus 
seroconversion (over six months) [64]. However, even the existence of an association remains 
less clear across geographies, and what the strength of that association would be in Cambodia 
(with much higher incidence rates) remains difficult to quantify. These efforts are frustrated by 
the many intersecting factors which determine dengue infection in communities including the 
probability of infecting and being infected by a mosquito bite, the duration of infection, 
treatment-seeking behaviour, the risk of fever, which serotypes are present, acquired immunity in 
the host, coverage of interventions and background prevalence of dengue infections. The 
availability of quality data for each of these factors is limited in most tropical countries where the 





Additional entomological limitations include only having one data collection point in each 
season, and no measure in the change of parity rate of adult females. The indoor resting 
collection of Aedes adult mosquitoes is subject to many challenges including: (i) individual 
collector performance & efficiency; (ii) density being time dependent; (iii) and housing 
conditions, architecture, objects, etc. Another possible source of bias is not having data collectors 
blind to the intervention; however, in this case it was unavoidable as data collection teams were 
able to see the fish in the containers which they sample. Additionally, as these data are being 
collected within one province in Cambodia generalizability could be a concern. However, it is 
likely that the result of this trial could be generalizable to areas with similar ecology and 
mosquito densities within the country and in neighbouring countries.  
 
Regardless of which products or methods control programs select, a common limitation of 
control programs is the lack of resources to reach all at-risk premises or geographical areas, 
which can make identifying key premises or geographical hotspots important to success. This is 
particularly true in Cambodia, where funds are limited and mostly focused on procurement rather 
than operational costs. In a concurrent study reported elsewhere, the authors collected PCI data 
during each of the entomology surveys. Regression models showed that the density of adult 
Aedes females was positively associated with PCI at the household (ratio of means= 1.16 
per point on the PCI scale) and cluster level (ratio of means=1.54) (Hustedt et al, submitted 
manuscript). However, the number of Aedes pupae was negatively associated with PCI at the 
household level (rate ratio = 0.74) and did not have a statistically significant association at the 




at identifying top-quartile premises in terms of adult female Aedes and pupae, respectively. 
These results suggest that although identification of key households is important, caution is 
warranted in the programmatic use of PCI in areas of similar geography and mosquito 
abundance. Future research could focus on confirming these results and testing additional 
indexes or methods could be devised to better identify key premises or hot spots.  
 
In conclusion, the results from this trial indicate that the interventions resulted in a statistically 
significant reduction in immature and adult Aedes mosquito density when compared to the 
control. There were no statistical differences identified between intervention arms, although 
lower guppy coverage in intervention arm two suggests that PPF did help keep mosquito 
densities low. Data from the KAP and qualitative assessments showed that the interventions were 
accepted by communities and that they were willing to pay for them. The extremely low cost of 
including guppy rearing in community-based health structures along with the effectiveness 
demonstrated here suggests guppies should be considered as a vector control tool as long as the 
benefits outweigh any potential environmental concerns. PPF was also highly accepted and 
preferred over current vector control tools used in Cambodia, however product costs and 
availability are still unknown. The qualitative assessment suggests that a context specific and 
well-informed COMBI and community engagement by giving an active role to communities is 
the key to the successful dengue control. Additional studies could be done to confirm these 
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Table 4. 1: Interventions randomized to each study arm 
Intervention Arm 1 Arm 2 Arm 3 
Guppy Fish in key containers (>50L) X X  
COMBI activities X X  
Direct PPF application (Sumilarv® 2MR) in 
smaller containers (10-50 L) 





Table 4. 2: Baseline summary measures of containers, houses, and people per cluster 
        
  Control Guppies PPF + Guppies 
Number of Clusters 10 10 10 
Number of houses  2016 1641 1435 
Number of people 8475 7542 6700 
  
Number of houses surveyed  400 400 400 
Percentage of Male Household Heads (Range) 22 (10-45) 23 (10-32) 20 (10-35) 
Median Age of Household Head (Range) 42 (17-78) 42 (18-84) 45 (18-88) 
Mean Number of Containers Per Cluster (Range) 154 (121-190) 186 (160-219) 165 (110-213) 
Mean Number of Positive Containers Per Cluster* 
(Range) 24.7 (18-62) 36.5 (18-62) 27.7 (11-69) 
Mean Breteau Index Per Cluster (Range) 62 (20-115) 91 (45-155) 69 (28-173) 
Mean Pupae Per Person (Range) 0.9 (0.2-2.7) 4.0 (0.2-17.1) 1.1 (0.5-2.3) 
Mean Adult Aedes Female Density Per Cluster 
(Range) 10 (1-15) 9 (3-24) 11 (2-20) 
    
*Positive is defined as having either Aedes pupae 





   
Table 4. 3: Mean population density of adult female Aedes trapped using adult resting 
collections per cluster by arm and survey 
        
  Control Guppies Guppies + PPF 
Baseline (Range) 10 (1-15) 9 (3-24) 11 (2-20) 
  
Dry Season (Range) 20 (3-49) 11 (3-17) 14 (2-25) 
Light Rain (Range) 75 (17-181) 29 (4-71) 35 (12-63) 
Heavy Rain (Range) 10 (4-23) 12 (2-25) 8 (1-23) 
Total (Range)  35 (3-181) 17 (2-71) 19 (1-63) 
  
Density Ratio (95% CI), p-value* 1 (Ref) 0.49 (0.31-0.77), p=0.0021 0.54 (0.34-0.85), p=0.0073 
Density Ratio (95% CI), p-value* ** 1 (Ref) 1.10 (0.69-1.74), p=0.6901 
    
*The ratios do not include the baseline data   
**The ratio is not given here as it would be redundant 




Table 4. 4: Immature Aedes indices per cluster by arm and survey 
  Breteau Index 
  Control Guppies Guppies + PPF 
Baseline (Range) 62 (20-115) 91 (45-155) 69 (28-173) 
  
Dry Season (Range) 88 (18-153) 48 (13-93) 54 (15-93) 
Light Rain (Range) 130 (73-188) 81 (40-150) 74 (35-125) 
Heavy Rain (Range) 58 (20-150) 51 (15-105) 45 (15-73) 
Total (Range)  92 (18-188) 60 (13-150) 58 (15-125) 
  
Density Ratio (95% CI), p-value* 1 (ref) 0.65 (0.50-0.85), p=0.0016 0.63 (0.48-0.82), p=0.0006 
Density Ratio (95% CI), p-value* ** 1 (ref) 0.97 (0.73-1.27), p=0.7982 
  
  Pupae Per Person 
  Control Guppies Guppies + PPF 
Baseline (Range) 0.9 (0.2-2.7) 4.0 (0.2-17.1) 1.1 (0.5-2.3) 
  
Dry Season (Range) 1.0 (0.1-3.3) 0.3 (0-0.9) 0.7 (0-1.7) 
Light Rain (Range) 2.2 (0.5-7.0) 1.2 (0.1-3.3) 0.60 (0-1.4) 
Heavy Rain (Range) 0.7 (0.1-2.1) 0.6 (0.1-2.9) 0.7 (0-1.8) 
Total (Range)  1.3 (0-7.0) 0.7 (0-3.3) 0.7 (0-1.8) 
  
Density Ratio (95% CI), p-value* 1 (ref) 0.56 (0.35-0.91), p=0.0193 0.52 (0.32-0.84), p=0.0075 
Density Ratio (95% CI), p-value* ** 1 (ref) 0.92 (0.60-1.49), p=0.7385 
     
*The ratios do not include the 
baseline data    
**The ratio is not given here as it 





Table S4.1: Remaining secondary outcome tables 
  Container Index 
  Control Guppies Guppies + PPF 
Baseline (Range) 16% (5-38) 20% (8-31) 17% (6-35) 
  
Dry Season (Range) 10% (3-14) 5% (1-10) 6% (2-13) 
Light Rain (Range) 21% (10-39) 12% (5-21) 14% (8-27) 
Heavy Rain (Range) 10% (3-19) 9% (2-17) 7% (2-14) 
Total (Range)  13% (3-39) 8% (1-21) 8% (2-27) 
  
Density Ratio (95% CI), p-value* 1 (ref) 0.61 (0.55-0.67), p<0.001 0.61 (0.55-0.67), p<0.001 
Density Ratio (95% CI), p-value* ** 1 (ref) 1.00 (0.90-1.11), p=0.991 
  
  Pupae Per House  
  Control Guppies Guppies + PPF 
Baseline (Range) 4.2 (1.0-11.6) 17.8 (0.8-69.4) 5.3 (2.4-11.4) 
  
Dry Season (Range) 4.8 (0.5-16.7) 1.6 (0.2-4.9) 3.0 (0.2-7.9) 
Light Rain (Range) 9.8 (2.5-32.9) 5.4 (0.3-14.2) 2.6 (0.1-6.0) 
Heavy Rain (Range) 3.1 (0.4-8.9) 2.7 (0.6-11.7) 3.1 (0.4-8.1) 
Total (Range)  5.9 (0.4-32.9) 3.2 (0.2-14.2) 2.9 (0.1-8.1) 
  
Density Ratio (95% CI), p-value* 1 (ref) 0.55 (0.34-0.88), p=0.0130 0.49 (0.30-0.79), p=0.0032 










  Know Dengue is Transmitted by Aedes Mosquitoes  
  Control Guppies PPF + Guppies 
  
Baseline (%, 95% CI) 98% (96.0-1.00) 95.5% (92.6-98.4) 97.0% (94.6-99.4) 
Endline (%, 95% CI) 100% (NA) 100% (NA) 100% (NA) 
Ratio (95% CI), p-value 1 (ref) 0.99 (0.86-1.14), p=0.915 1.01 (0.87-1.16), p=0.943 
  
*The ratios do not include the 
baseline data    
**The ratios are not given here as 






Figure 4.1: Flow chart for enrolment, follow up, and analysis of clusters 
 
Clusters assessed for eligibility (n=37)
Clusters excluded (n=7)
- Houses within 200 metres (n=3)
- Too large (>500 households) (n=3) 
- Declined to participate (n=1)
Number of clusters  (10)
Number of households surveyed per 
cluster  (1600)*
*each cluster had 400 randomly 
selected households surveyed during 
each of the  baseline and three follow 
up time periods
Clusters lost to follow-up (0)
Arm 1: Guppy fish, PPF, and COMBI 
Allocated: (n=10 clusters)
Median size: 155 Households
Average: 144 Households
Clusters lost to follow-up (0)
Number of clusters.   (10)
Number of households surveyed per 
cluster  (1600)*
*each cluster had 400 randomly 
selected households surveyed during 
each of the  baseline and three follow 






Arm 2: Guppy fish and COMBI 
Allocated: (n=10 clusters)




Median size: 190 Households
Average: 202 Households
Clusters lost to follow-up (0)
Number of clusters   (10)
Number of households surveyed per 
cluster  (1600)*
*each cluster had 400 randomly 
selected households surveyed during 







































Figure 2: Mean Number of Adult Aedes Females per Household by Arm and Survey, October 2015 - October 2016





































Figure 3: Breteau Index by Arm and Survey, October 2015 - October 2016 















































Figure 4: Pupae Per Person by Arm and Survey, October 2015 - October 2016   
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Aedes-transmitted diseases, especially dengue, are increasing throughout the world and the main 
preventive methods include vector control and the avoidance of mosquito bites. A simple 
Premise Condition Index (PCI) categorizing shade, house, and yard conditions was previously 
developed to help prioritize households or geographical areas where resources are limited. 
However, evidence about the accuracy of the PCI is mixed. The current study aimed to 
contribute to a better understanding of the relevance by collecting data from 2,400 premises at 
four time points over one year in Kampong Cham, Cambodia. Regression models were then used 
to identify associations between PCI and Aedes adult female mosquitoes and pupae. 
Additionally, Receiver Operating Characteristic (ROC) curves were used to measure the ability 
of PCI to identify premises in the top quartile of mosquito abundance. The density of adult Aedes 
females was positive associated with PCI at the household (ratio of means= 1.16 per point on the 
PCI scale) and cluster level (ratio of means=1.54). However, the number of Aedes pupae was 
negatively associated with PCI at the household level (rate ratio = 0.74) and did not have a 
statistically significant association at the cluster level. ROC curves suggest the PCI score had 
“rather low accuracy” (AUC=0.52 and 0.54) at identifying top-quartile premises in terms of adult 
female Aedes and pupae, respectively. These results suggest that caution is warranted in the 







Dengue is the most rapidly spreading mosquito-borne viral disease in the world, and is caused by 
bites of infected Aedes mosquitoes, principally Aedes aegypti [1]. Dengue is endemic worldwide, 
with a high concentration in the Asian region, which shoulders 70% of the global disease burden. 
Although a number of promising vaccine candidates are in preclinical and clinical 
development [2], methods of genetic control of mosquitoes are being developed [3,4], and 
Wolbachia infected mosquitoes show promise [5,6] these interventions are unlikely to eliminate 
dengue on their own [7]. Therefore, vector control will remain a key component of dengue 
control in the short and medium term. 
 
One important aspect of vector control is the elimination of the most productive breeding 
sites [8]. For example, one study in Australia found that one well and one rainwater tank were 
responsible for 28% of all immature larvae out of 1,349 premises inspected [9]. Similarly, in 
Cambodia large water jars, drums, and concrete tanks were found to harbour 90% of the pupal 
biomass [10]. In addition, studies documented that particularly high levels of Aedes productivity 
can be found in “key premises” [11–14], defined as those with three or more positive 
containers [9]. In Australia, 1.9% of premises accounted for 47.2% of positive containers [9]. In 
Ecuador, 11% of households contained 81.7% of pupae during the rainy season and 5% of 
households contained 80% of pupae during the dry season [12]. Thus, it is clear that the 
identification of key premises is crucial to inform vector control operations – an activity which 
can be conducted through pupal/demographic surveys of household water containers. 
However, the ubiquity of water containers tends to make pupal/demographic surveys 
laborious [15]. Therefore, additional methods have been explored to identify key premises 
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without needing to do extensive pupal/demographic surveys, or enter premises, because owners 
refusing access to premises has been reported as a key challenge [16]. The Premise Condition 
Index (PCI) is one such approach that could help prioritize outbreak response in terms of Aedes 
infestation risk [9]. This index evaluates the shade, house, and yard conditions of premises to 
produce risk strata. In addition to targeting treatment of key premises, this method could 
potentially be used to prioritize villages or other geographical areas when funding or human 
resources are insufficient to treat all outbreak areas.  
 
Existing evidence of the value of the PCI to inform vector control programs is mixed. The PCI 
was first described and evaluated in Queensland, Australia, where it was found that inspecting 
9.5% of premises with a high PCI score of 8-9 (out of 9) identified 54.4% of infested premises. 
Comparison of highest to lowest scores indicated a risk of infestation 5.6 times higher, with the 
number of positive containers 14.3 times higher [9]. Other studies found a association between 
PCI and the number of positive containers [17–21] and/or positive premises [19,20,22]. PCI has 
also been used to create risk strata, where a positive correlation (r=0.968, p<0.01) was identified 
in Brazil between risk strata and houses positive for Aedes albopictus eggs [23]. By contrast, 
other studies found no association of Aedes mosquitoes with PCI [24,25]. Further, serious 
limitations or missing information exist in many of the past studies. Some studies report 
associations but do not provide data related to PCI in their paper [18,21,24,26,27] or relied on 
low sample sizes with wide confidence intervals [19].  
 
Considering these uncertainties, this study aimed to assess whether higher mean densities of 
adult female Aedes mosquitoes and Aedes pupae are associated with worse premise conditions, 
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as measured by PCI; and whether this association leads to reliable predictions of which premises 
should be targeted for interventions. The study was conducted in Cambodia, a country with one 
of the highest per-capita incidence rates in Asia, at 0.7–3.0 per 1000 population per year [28,29], 
and recurring outbreaks every three to five years [30]. The Cambodia National Dengue Control 
Program (NDCP) developed a protocol to respond to outbreaks, defined as three or more cases in 
one village per year, which includes applying larvicides (e.g. temephos), adulticides (e.g. thermal 
fogging with pyrethroids), and distributing information, education, and communication 
materials. These activities are implemented throughout the entire outbreak villages and can 
require significant financial and human resources, especially if distances between villages and 
the number of outbreaks is large. In this setting, if shown to be effective, PCI could potentially 
be used to prioritize interventions when funds are insufficient to treat all houses or geographic 
areas. An advantage of the index is that it can be completed quickly and there is no need to enter 
houses. Although previously published evidence on the relevance of the PCI varies by geography 
and mosquito life stage, no studies and field evaluations have previously been reported from 
Cambodia or South-east Asia. 
 
5.2 Materials and Methods 
Study setting 
The data used in this study were collected during a cluster randomized trial on the effect of 
guppy fish and pyriproxyfen on entomological outcomes [31], conducted in 30 clusters in two 
operational districts (ODs) within Kampong Cham province. Each cluster had an average of 
approximately 200 households or 1000 individuals and included one or more villages that were 
separated by neighbouring villages by at least 200 meters. Kampong Cham has one of the highest 
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dengue incidence rates in Cambodia (1.6 cases per 1000 people per year) and the environmental 
characteristics are similar to most dengue-endemic areas of Cambodia (personal communication, 
Hai Ra, 2016). The dry season lasts from December to April, the light rain season from April-
July, and the heavy rain season from August-October. This study only utilizes data from the pre-
intervention baseline surveys and control clusters, which did not receive an intervention, of the 
aforementioned trial, and are considered to be more representative of the typical conditions in the 
area. More detailed information about the study site can be found in the trial protocol [31].  
 
Outcomes 
The primary outcome was the association between PCI (defined below) and the mean density of 
adult female Aedes aegypti at household level. Secondary outcomes include the association 
between (1) PCI and the mean density of adult female Aedes aegypti at cluster level, and (2) 
association between PCI and the number of Aedes pupae per household and per cluster.  
 
Mosquito collection and PCI scoring  
Data were collected at four time points covering all three main seasons: survey 1 was in 
October/November 2015 during the rainy season, survey 2 was in February/March 2016 during 
the dry season, survey 3 was in May/June 2016 during the light rain season, and survey 4 was in 
September/October 2016 in the heavy rain season. The survey methodology was developed 
following the WHO guidelines for entomological collections [30]. The survey team consisted of 
experienced government staff who received three days’ training before the start of the surveys. 
All tools and materials were pre-tested during training. Houses within each cluster were selected 
using a random-number generator applied to the village list managed by the village head.  
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Larvae and pupae collection were completed using the five-sweep net method [15] for containers 
larger than 50 litres. For this method, a net of size 20 cm by 33 cm was used. Surveyors turned 
the net in an anti-clockwise manner five times, then waited 1 min and performed one sweep from 
the bottom. This method can sample around 35% of larvae and 31% of pupae, and the total 
number estimated by an adjustment factor [15] (See Table 5.1). For containers of less than 50 L, 
all the water was poured through the sweep net. All containers within selected households were 
inspected. All pupae and larvae were put in a plastic bag, labelled, and taken back to the 
provincial laboratory for identification to the species level for Aedes, otherwise to genus.  
 
The adult resting catch was completed using a battery-powered, portable aspirator (Camtech, 
Phnom Penh, Cambodia) for 10 min per house in the bedrooms and living spaces, starting in the 
bedroom and aspirating up and down the wall (from floor to 1.5 m) around the home in a 
clockwise manner. The mosquitoes were kept in a screw-top container inside a cold box and 
transported to the provincial laboratory for identification to the species level for Aedes, otherwise 
to genus. All adult Aedes mosquitoes were sexed. After identification all mosquitoes were taken 
to the United States Naval Medical Research Unit-2 in Phnom Penh where entomologists 
confirmed identification of a random sample of 50% of immature and adult mosquitoes. 
  
Each house in the survey was scored on the degree of shade, condition of house, and condition of 
yard according to the method developed by Tun-Lin et al. [9]. Each category is scored from 1 to 
3, and the sum represents the PCI score. The teams were provided with objective measures for 
scoring in each category (see Table 5.2), a laminated sheet including pictures of example 
premises for each score and given training to standardize scoring between the three teams. In 
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addition, a fourth category representing the source of water was scored, however due to the 
homogeneity of water infrastructure the results are not reported here.  
 
Climate 
General climate data (rainfall, temperature and humidity) were recorded at one of the 
intervention health centres using a rain gauge and a Hobo™ onset data logger (Onset Computer 
Corporation, Massachusetts, USA) (all villages included in the study have virtually the same 
climate). Data from the all United States National Aeronautics and Space Administration 




Sample size was determined for the needs of the corresponding trial and is discussed in length in 
the protocol [31]. However, the sample size is at least as large as four other studies which 
reported a significant association or correlation of PCI with houses or containers with Aedes 
mosquitoes [19–21,32].  
 
Statistical analysis 
All analyses were performed in R Studio version 3.5.0 (Murray Hill, NJ, USA) and Stata® 
version 14.2 (College Station, TX, USA). The association between Aedes density and PCI was 
assessed through negative binomial regression using the number of adults per household as the 
response and a logarithmic link function. Hence, this analysis yields density ratios as an outcome 
measure. Models combined data from all seasons and included survey as a fixed effect term. 
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Additional models including an interaction term of survey and PCI were also run. A likelihood 
ratio test showed the interaction term to not be statistically significant (p=0.07) and therefore the 
model with interaction was not included in the results. A similar model was used for the 
secondary outcomes, with the numbers of pupae, rather than adults, as the response. All models 
used the robust sandwich estimator of standard errors [33] to account for correlation of responses 
within clusters. 
 
Associations between PCI and vector density are necessary but not sufficient for PCI to have 
sufficient sensitivity and specificity to be efficient in practice. Receiver operating characteristic 
(ROC) curves were used to ascertain the ability of PCI to predict the premises in the top quartile 
of mosquito biomass. Their accuracy was classified according to the value of the area under the 
ROC curve (AUC): not informative (AUC≤0.5), rather low accuracy (0.5<AUC AUC≤0.7), 
accuracies useful for some purposes (0.7<AUC ≤0.9), and rather high accuracy (0.9<AUC)[34]. 
 
Ethical approval  
Ethical clearance was received by the Cambodian National Ethics Committee for Health 
Research on 9 October 2014 (ethics reference number 0285). Additionally, ethics approval was 
received from the London School of Hygiene and Tropical Medicine Observational/Interventions 
Research Ethics Committee (ethics reference number 8812).  
 
5.3 Results 
During the study period a total of 2,400 premises were inspected for the presence of immature 
and adult Aedes and assigned PCI scores. The average monthly rainfall during the study was 11 
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mm during the dry season (December-April), 139 mm during the light rain season (May-July), 
and 276 during the heavy rain seasons (August-November). As reported in Table 5.3, the 
majority of premises (89%) were assigned a PCI score between 5-7, and only 3% and 0.4% were 
assigned a PCI score of 8 or 9 respectively. 
 
Distribution of adult female Aedes mosquitoes by PCI ranking 
Table 5.4 shows 26% of houses overall had some adult female Aedes, with an average of 0.56 
each. The percentage of positive houses and Aedes females per house increased during the light 
rain season, to 58% and 1.88, respectively. The percentage of houses positive for Aedes females 
varied among overall PCI scores (17-33%) and among different seasons (17-58%). The average 
number of Aedes females per house also varied widely among overall PCI scores (0.21-0.73) and 
over seasons (0.24-1.88). The highest numbers of positive houses and average number of adult 
female Aedes was among premises with PCI scores of 6 and 7.  
  
Table 5.4 shows that 46% of premises and 15% of containers were positive for Aedes pupae 
and/or larvae with an average of seven pupae per house. The proportion of positive premises 
varied quite widely between PCI scores (22-51%), and between surveys (36-71%) with light rain 
(peak) season having by far the highest proportion of positive houses (71%). The percent of 
containers positive for larvae or pupae also varied among PCI scores (7-20%) and surveys (10-
21%). Only 1% of premises received a PCI score of three and a few of those premises had 
extremely high numbers of Aedes pupae. The particular reason for the large number of pupae is 
that two premises had a large water container used for animal husbandry that were not often 
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cleaned and held hundreds of pupae.  
  
Table 5.5 shows the results of the negative binomial regression models for adult female Aedes 
mosquitoes. The model including two dependent variables (PCI scores and survey) was found to 
fit best for this analysis. The number of adult Aedes females was positively associated with PCI 
(rate ratio (RR) per point = 1.16, 95% confidence interval (CI): 1.02-1.31). A cluster-level model 
of adult Aedes females by cluster had a slightly higher rate ratio although wider confidence 
intervals (RR=1.54, 95% CI 1.11-2.08).  
 
Association of immature Aedes mosquitoes with PCI 
Table 5.5 also shows the results of regression models for Aedes pupae. As for adults, the 
association between the number of Aedes pupae and a combination of the three variables was 
completed. At the house level, the number of pupae were statistically significantly negatively 
associated with PCI scores (RR=0.74, 95% CI 0.59-0.93). The model investigating the 
association between number of Aedes pupae and PCI/survey at the cluster level was not 
significant. 
 
ROC curve analysis for predicting the top quartile of adult Aedes mosquitoes 
The PCI score (at household level) was considered to have “rather low accuracy” predicting 
premises in the top quartile of adult female Aedes mosquitoes, with an AUC of 0.54 (95% CI 
0.52-0.56, Figure 5.1). A cut point of 5 had high sensitivity (94%) and low specificity (7%), 
while 7 had low sensitivity (19%) and high specificity of (83%). For clusters, the PCI score was 
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also considered to have “rather low accuracy”, with an AUC of 0.64 (95% CI 0.44-0.80, Figure 
5.2). No cut points for either curve gives an adequate combination of sensitivity and specificity.  
 
ROC curve analysis for predicting the top quartile of Aedes pupae 
The PCI score (at the household level) was considered to have “rather low accuracy” when 
predicting premises in the top quartile for Aedes pupae, with an AUC of 0.52 (95% CI 0.50-0.54, 
Figure 5.3). A cut point of 5 had high sensitivity (93%) and low specificity (7%), while 7 had 
low sensitivity (16%) and a high specificity of (83%). For clusters, the PCI score was again 
considered to have “rather low accuracy” when predicting the clusters in the top quartile for 
Aedes pupae, with an AUC of 0.62 (95% CI 0.44-0.80, Figure 5.4). No cut point for either curve 
gives an adequate combination of sensitivity and specificity. This low degree of accuracy is 
consistent with the negative association presented earlier.  
 
5.4 Discussion 
The PCI was found to be weakly associated with the density of adult female Aedes at the 
household and cluster level, and negatively associated with the number of Aedes pupae at the 
household level. Therefore, our hypothesis that higher mean densities of Aedes would be 
associated with worse premise conditions was correct for adult females, but not for pupae. The 
five premises with the highest number of Aedes pupae (representing 0.1% of total premises) had 
25% of the total pupae and had relatively lower PCI scores (one house had a PCI of three). This 
may have been because the most productive containers were large water storage containers for 
animal husbandry that are not frequently changed or replaced. More wealthy families and those 
with nicer houses may be more likely to have more farm animals and therefore need these large 
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water storage drinking containers. In contrast, 30 premises with the most adult female Aedes 
mosquitoes (representing 0.6% of total premises) had 25% of adult females and they tended to 
have relatively higher PCI scores (none had scores below five). Therefore, the relative impact of 
one or two households has less weight on the overall measure with the adults than with 
immatures. 
 
Similar results have been found in other studies and resulted in affirmations of PCI’s 
effectiveness and suggestions on how to incorporate it into national control programs. Similar 
positive associations in Mexico (OR 1.27, p=0.001) between PCI and Aedes larvae resulted in 
researchers concluding that the PCI can be an adequate estimator of the Aedes Aegypti infestation 
rate [22]. In Brazil, researchers found a positive correlation between PCI and houses positive for 
Aedes eggs (r=0.97, p<.01), and stated that the results clearly showed the usefulness of the 
method [23]. They went one step further and suggested “in the case of dengue outbreaks, by 
having all representative house indices of the region, it will be much easier and less expensive to 
control the epidemic”. Positive correlations between PCI and house positivity for larvae, pupae, 
and adult Aedes aegypti (p>0.05) led authors to advocate to the Brazilian Dengue Control 
Programme the use of PCI to schedule the vector control teams’ visits with different frequencies 
based on PCI scores [17]. In Mexico, a significant positive correlation between average PCI of a 
location and the house index was found (OR=1.37, p=0.007), and it was noted that in the near 
future the authors expected to use information derived from PCI to “focalize integrated dengue 
vector control on houses/city blocks/neighbourhoods/areas with high levels of PCI (6–9)”[20]. 
These examples show how relatively weak evidence has been used to advocate for PCI’s use and 
integration into national policy. 
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However, finding statistically significant correlations does not always mean that the variables 
will be good predictors [35]. In our study, ROC curves showed that PCI had “rather low 
accuracy” (AUC=0.54 and 0.52 respectively) to predict premises in the top quartile for Aedes 
adult females and pupae. Additional ROC curves measuring the ability of PCI to predict clusters 
(as opposed to houses) which represent the top quartile of Aedes adult females and pupae also 
found it to have “rather low accuracy” (AUC= 0.64 & 0.62, respectively). This is especially true 
when using highly variable outcomes such as immature measures. Therefore, control programs 
may want to use care when interpreting PCI associations in their area. 
 
There are also several limitations of the PCI methodology to consider including that non-
residential premises, public areas, vacant lots and construction worksites are often not inspected 
and ranked. Andrighetti et al. [17] noted that 21% of the premises in their study could not be 
ranked as they were empty lots or construction sites and harboured 11.6% of larvae, 20.9% of 
pupae and 20.8% of adults. In our study we did not include vacant lots, schools, monasteries, or 
other public areas and therefore results may not be representative of those areas. Additionally, 
the inability of the inspector to inspect or see into rear yards in some study settings may lead to 
misclassification [19]. One of the key weaknesses that has been widely reported is that the 
scoring may not be standardized across individuals, teams, or organizations [19]. One potential 
way to reduce this variability would be to use unmanned aerial vehicles (or drones) to take aerial 
photographs that could be scored by one individual or team [36]. Another useful way of using 
PCI is to classify geographical locations where it has been shown useful would be to assign one 
team to categorize the areas in known dengue hotspots in advance of outbreaks. Then, the scores 
could be used to try to identify which hot spots or villages to target and to prepare warnings and 
 
191 
awareness when resources are scarce. Nevertheless, it is unknown how use of PCI to prioritize 
households or geographical areas would be accepted within the communities [25]. Additionally, 
this would only work if PCI was not variable between seasons and years.  
 
These results may not be generalizable to areas with more variability in housing conditions, 
different ecological conditions, or different mosquito abundance profiles. Considerable resources 
need to be invested in ensuring teams have standardized scoring of PCI, the corresponding PCI 
cut offs are followed correctly, and evaluating the acceptance of individuals or communities who 
are not prioritized. These resources may be better spent evaluating other methods to target 
premises or spent generally on Aedes control. Future studies could evaluate the use of PCI in 
other geographical settings, the effectiveness of PCI to identify premises with dengue infection, 
or the acceptance by the community of PCI’s use where it is found to be effective.  
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Table 5. 1: Type of containers, average volume, and multiplication factors from Kampong 
Cham, Cambodia 








Cement Basin (CB) 9.28% 613 559 - 667 4.9 
Cement Tank (CT) 9.48% 825 666 - 984 4.3 
Water Storage Jar (J) 41.62% 393 380 - 405 3 
Miscellaneous- Domestic 
Use (M) 16.71% 27 25 - 30 1 
Small Pot (P) 9.98% 35 18 - 53 1 
Flower Vase/Pot/Tray (F) 0.94% 22 1 - 2 1 
Tyre (T) 0.82% 45 31 - 59 1 
Can/Bottle (C) 0.34% 7 1 - 12 1 
Drum (D) 2.61% 138 115 - 160 3 
Others (O) 8.24% 31 23 - 38 1 



















Table 5.2: Measures for scoring the Premise Condition Index 
Premise variables Description Classification score 
P1. House condition 
a. Well maintained, eg newly painted or new house 1 
b. Moderately well-maintained house 2 
c. Not well-maintained house, eg paint peeling, broken 
items visible, dilapidated old house 3 
 
   
P2. Yard condition 
a. Tidy yard, eg no rubbish or trash evident, well-
maintained gardens and lawn 1 
b. Moderately tidy yard 2 
c. Untidy yard, rubbish and trash abundant and the 
garden or lawn with overgrown grass 3 
    
P3. Shade condition 
a. Very little or no shade (<25%), eg no major trees or 
bush 1 
b. Some shade (>25% but <50%) 2 
c. Plenty of shade, >50%, e.g. large trees evident, layers 
of shrubs, green house, plastic tarp sheet or overhanging 
roofs used 
3 
    
P4. Water supply and 
storage 
a. Piped water supply only 1 
b. Well water supply only 2 




Table 5. 3: Adult female Aedes indicators by Premise Condition Index ranking over seasons 
All Time Points Combined (n=30 clusters) 
PCI Score Number (%) of 
Houses 
Houses with at least 
one Aedes female 
(%) 
Aedes Females Aedes females per 
house (mean) 
3 30 (1) 5 (17) 11 0.37 
4 138 (6) 32 (23) 50 0.36 
5 623 (26) 133 (21)  224 0.36 
6 1178 (49) 329 (28) 791 0.67 
7 327 (14) 97 (30) 239 0.73 
8 71 (3) 15 (21) 22 0.31 
9 9 (0) 3 (33) 3 0.33 
missing 24 (1) 4 (17) 5 0.21 
Total  2400 (100) 618 (26) 1345 0.56 
          
October 2015 (Heavy Rain Season) - Control at Baseline (n=10 clusters)  
3 3 (1) 0 (0) 0 0.00 
4 31 (8) 8 (26) 10 0.32 
5 126 (32) 23 (18) 38 0.30 
6 183 (46) 25 (14) 33 0.18 
7 41 (10) 11 (27) 19 0.46 
8 11 (3) 1 (9) 1 0.09 
9 0 (0) 0 (0) 0 0.00 
missing 5 (1) 0 (0) 0 0.00 
Total  400 (0) 68 (17) 101 0.25 
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February 2016 (Dry Season) (n=10 clusters)  
3 3 (1) 1 (33) 5 1.67 
4 14 (4) 4 (29) 7 0.50 
5 187 (47) 42 (22) 71 0.38 
6 161 (40) 47 (29) 106 0.66 
7 23 (6) 6 (26) 7 0.30 
8  6 (2) 1 (17) 1 0.17 
9 3 (1) 0 (0) 0 0.00 
missing 3 (1) 0 (0) 0 0.00 
Total  400 (100) 101 (25) 197 0.49 
          
June 2016 (Light Rain Season) (n=10 clusters)  
3 4 (1) 1 (25) 1 0.25 
4 32 (8) 10 (31) 22 0.69 
5 54 (14) 29 (54) 64 1.19 
6 230 (58) 148 (64) 505 2.20 
7 78 (20) 42 (54) 160 2.05 
8 2 (1) 0 (0) 0 0.00 
9 0 (0) 0 (0) 0 0.00 
missing 0 (0) 0 (0) 0 0.00 
Total  400 (100) 230 (58) 752 1.88 
          
October 2016 (Heavy Rain Season) (n=10 clusters)  
3 4 (1) 1 (25) 1 0.25 
4 13 (3) 2 (15) 2 0.15 
5 42 (11) 11 (26) 14 0.33 
6 280 (70) 50 (18) 68 0.24 
7 56 (14) 7 (13) 9 0.16 
8 4 (1) 2 (50) 2 0.50 
9 1 (0) 0 (0) 0 0.00 
missing 0 (0) 0 (0) 0 0.00 




Table 5. 4: Immature Aedes indicators by Premise Condition Index ranking over seasons  
All Time Points Combined (n=30 clusters) 
PCI Score Number (%) 
of Houses 
Houses Positive 
(%) for Aedes 









3 30 (1) 12 (40) 179 (1) 32 991 33 
4 138 (6) 59 (43) 723 (5) 109 887 6 
5 623 (26) 250 (40) 3548 (26) 431 5739 9 
6 1178 (49) 578 (49) 7016 (52) 1060 8588 7 
7 327 (14) 167 (51) 1610 (12) 283 1450 4 
8 71 (3) 35 (49) 283 (2) 56 286 4 
9 9 (0) 2 (22) 46 (0) 3 9 1 
missing 24 (1) 11 (46) 124 (1) 18 49 2 
Total  2400 (100) 1102 (46) 13529 (100) 1992 17999 7 
              
October 2015 (Heavy Rain Season) - Control at Baseline (n=10 clusters)  
3 3 (1) 1 (33) 18 (1) 2 11 4 
4 31(8) 12 (39) 117 (8) 23 92 3 
5 126 (32) 51 (40) 483 (31) 78 594 5 
6 183 (46) 72 (39) 726 (47) 105 759 4 
7 41 (10) 18 (44) 142 (9) 28 205 5 
8 11 (3) 3 (27) 33 (2) 7 3 0 
9 0 (0) 0 (0) 0 (0) 0 0 0 
missing 5 (1) 4 (80) 25 (2) 4 12 2 
Total  400 (100) 161 (40) 1544 (100) 247 1676 4 
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February 2016 (Dry Season) (n=10 clusters)  
3 3 (1) 1 (33) 35 (1) 10 124 41 
4 14 (4) 6 (43) 169 (5) 10 98 7 
5 187 (47) 59 (32) 1517 (42) 136 653 3 
6 161 (40) 62 (39) 1584 (44) 167 947 6 
7 23 (6) 10 (43) 224 (6) 17 81 4 
8 6 (2) 3 (50) 46 (1) 8 18 3 
9 3 (1) 0 (0) 22 (1) 0 0 0 
missing 3 (1) 1 (33) 23 (1) 2 0 0 
Total  400 (100) 142 (36) 3620 (100) 350 1921 5 
              
June 2016 (Light Rain Season) (n=10 clusters)  
3 4 (1) 2 (50) 16 (1) 5 6 2 
4 32 (8) 20 (63) 152 (6) 33 272 9 
5 54 (14) 33 (61) 364 (15) 53 607 11 
6 230 (58) 174 (76) 1480 (61) 342 2741 12 
7 78 (20) 52 (67) 411 (17) 86 296 4 
8 2 (1) 1 (50) 5 (0) 1 0 0 
9 0 (0) 0 (0) 0 (0) 0 0 - 
missing 0 (0) 0 (0) 0 (0) 0 0 - 
Total  400 (100) 282 (71) 2428 (100) 520 3922 10 
              
October 2016 (Heavy Rain Season) (n=10 clusters)  
3 4 (1) 1 (25) 40 (2) 2 32 8 
4 13 (3) 7 (54) 99 (4) 15 115 9 
5 42 (11) 19 (45) 250 (10) 33 180 4 
6 280 (70) 96 (34) 1698 (70) 146 807 3 
7 56 (14) 20 (36) 312 (13) 30 98 2 
8 4 (1) 4 (100) 26 (1) 7 13 3 
9 1 (0) 0 (0) 4 (0) 0 0 0 
missing 0 (0) 0 (0) 0 (0) 0 0 - 
Total  400 (100) 147 (37) 2429 (100) 233 1245 3 
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Table 5. 5: Association between each PCI point and the mean density of Aedes adult 
females and pupae at household and cluster level over multiple seasons 
By Household  
  
Adult Aedes Aedes Pupae 
Unadjusted  1.25 (1.11-1.39), p=<0.01 0.74 (0.57-0.96), p=0.02 
Adjusted for survey 1.16 (1.02-1.31), p=0.02 0.74 (0.59-0.93), p=0.01 
By Cluster 
  Adult Aedes Aedes Pupae 
Unadjusted  1.80 (1.12-2.88), p=0.01 0.79 (0.32-1.93), p=0.60 






Figure 5. 1: ROC curve of PCI and prediction values in predicting the premises with the 
top quartile of adult mosquito density 
Figure 5. 2: ROC curve of PCI and prediction values in predicting the clusters with the top 
quartile of adult mosquito density 
Figure 5. 3: ROC curve of PCI and prediction values in predicting the premises with the 
top quartile of immature mosquito density 
Figure 5. 4: ROC curve of PCI and prediction values in predicting the clusters with the top 
quartile of immature mosquito density 
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Figure 4: ROC Curve of PCI and Prediction Values in Predicting the
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Chapter 6: Discussion 
 
The overall aim of this thesis was to determine the effectiveness of new approaches to dengue 
vector control in Cambodia. The specific objectives of the PhD are listed below: 
1. Perform a systematic literature review on the impact of Pyriproxyfen (PPF) of Aedes 
mosquitoes including to (1) Determine the effect of PPF on a range of endpoints 
including percentage inhibition of emergence, larval mortality, and resistance ratios; and 
(2) Determine the different uses, strengths, and limitations of PPF in vector control of 
Aedes.  
2. Design a cluster randomized trial in which villages were randomized to either (1) three 
interventions (guppies, Sumilarv® 2MR, and COMBI activities), (2) two interventions 
(guppies and COMBI activities), or (3) control (standard vector control). 
3. Carry out the trial, analyse the data and report the results of the trial. 
4. Determine the ability of the Premise Condition Index (PCI) to identify premises with 
adult and immature Aedes mosquitoes in Cambodia.  
 
This chapter provides further discussion and future directions relating to each of the results 
chapters. In addition, the chapter provides an overall summary which brings in evidence from 
other fields such as ecology and discusses public and stakeholder engagement in the material 
contained in the thesis. 
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6.1 Systematic literature review of the use of pyriproxyfen in control of Aedes 
mosquitoes	
As described in Chapter 2, the results of the review suggest PPF increases Aedes larval mortality 
and Inhibition of Emergence (IE) is strong and consistent. However, the strength of the evidence 
for different products varies considerably, with PPF granules having highly documented and 
consistent results and newer products such as PPF dust for auto-dissemination and the use of PPF 
in Ultra-low Volume sprays, Thermal Fogging, and fumigants showing promise. Many 
additional novel products have been evaluated (e.g. Sumilarv® 2MR), however evidence for 
these products is less clear at the moment. The trial described in this thesis will provide some 
additional evidence for the effectiveness of Sumilarv® 2MR, but it will likely require further 
testing to determine its true effectiveness in the region.  
 
One additional limitation of the review is that as it was focused on tools that would support the 
National Dengue Control Program, search terms including other Aedes-borne arboviruses were 
left out. Especially when trying to determine the cost-effectiveness of vector control tools (when 
disease incidence is known), the inclusion of other Aedes-borne diseases could change the 
conclusion. However, being able to determine a reliable estimate of incidence for other 
arboviruses in countries like Cambodia where surveillance is challenging (with most of the focus 
is on dengue) may be difficult.  
 
Future research should focus on these areas where the evidence is less strong such as the 
development of additional products. Seven of the 19 auto-dissemination studies were published 
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since 2016, and there has been renewed interest in this method in particular. However, there are 
several questions still to be answered and obstacles to be overcome. Some of the main research 
questions still outstanding are (1) the need to develop a basic trap that is affordable for low-
income countries, (2) design a method to standardize the application and lethal dose of the PPF 
dust, (3) determine which surface is optimal, (4) and determine how far apart the devices need to 
be separated in different ecological environments. Some innovative ideas for new research could 
include the use of cheap CO2 emitting devices to enhance numbers of visiting female mosquitoes 
to dissemination points. In addition to these questions, Sumitomo informed me of their belief that 
the PPF dust produced in their laboratory is more effective than that produced by pulverizing 
PPF granules, however that dust is not commercially available, and the potential list price is 
unknown (personal communication, John Lucas, 2015). In2Care traps do have lots of potential 
for control of immature and adult stages of invasive container-inhabiting Aedes mosquitoes but 
they are also likely to be priced out of range for most lower income countries like Cambodia. 
 
Additional research is also needed to better clarify the cross-resistance between PPF, temephos, 
and other insecticide classes to allow control teams to make better informed decisions on which 
products to recommend and procure for control of Aedes-borne diseases. One of the limitations 
reported is the issue of compliance by the community due to false perceptions by the community 
that PPF is ineffective as it mainly acts on late instars and people may continue to observe live 
early instar larvae [1]. Therefore, further studies are required to better understand what 
communication methods and materials would be most effective to increase community 
participation in vector control activities. It will also be important to understand the effectiveness 
of these products in Africa. The majority of studies represented here come from Central/South 
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America and Asia, with none from India or Africa, despite Africa’s significant dengue burden 
roughly equivalent to that of the Americas (16%) while together Africa and India contribute 50% 
of dengue cases [2]. It will be important to document the effectiveness of these products in these 
highly endemic areas [3].  
	
6.2 Trial Protocol  
 
The selection of the primary outcome is one of the most important decisions to make when 
designing a trial. One of the key limitations of the study was the absence of a primary outcome 
directly related to dengue incidence rather than an entomological one. This is particularly 
important given that the World Health Organization (WHO) Vector Control Advisory Group 
recently noted that modelling based on entomological surrogates is not currently recommended 
as a replacement for epidemiological RCT data, and should not be used as the primary evidence 
supporting decisions on the efficacy to public health of new product classes. Malaria Consortium 
had purchased SD Dengue Duo® RDTs for one of the previous projects and could have used 
those for the baseline and purchased additional RDTs for follow-up surveys. However, we 
needed to ascertain the required sample size to determine if we had enough funds to purchase 
additional tests. It was already known that there was not enough budget for additional lab-based 
diagnostics. The United States Naval Medical Research Unit-2 provided unpublished data from 
their previous fever cohort study done in 2011, which was done in many of the same villages as 
we selected for the study.  
 
Using that data, it was determined that if we assumed that the rate of fever is the same as 2011 
rainy season then there would be 672 fever cases per month. If we chose to test all fever cases 
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during the quarterly entomology survey months, it would require the purchase an additional 
2,016 tests. The actual number used may be slightly less since the calculations were based on the 
rainy (peak) season and some of the surveys would be done during the dry season where the 
number of cases is expected to be less.  
 
Simultaneously, discussions with Professor Rosanna Peeling from LSHTM and publications on 
the evaluation of commercially available diagnostic tests [4] suggested that although sensitivity 
among currently available tests were considered acceptable for routine clinical diagnostics, it 
may not be considered high enough for seroconversion studies. The study also showed that out of 
currently available test kits the SD Dengue Duo® had the best performance [4]. In preparation for 
a potential systematic review on the subject two initial scoping reviews were completed. The 
first review aimed to determine the reported specificity and sensitivity of Dengue Duo RDTs 
(Appendix 6.1). A total of 10 studies were then included in the review. The included studies 
were published between 2012 and 2015. Nine of the studies had original data and one was a 
meta-analysis. The sensitivity ranged from 58-96% and the specificity ranged from 83-99%. 
However, four studies did not report what was used as the gold standard for comparison, and the 
ones who did mention it did not use a standardized method. Therefore, there are limitations to 
comparing the results across studies. Regardless, the results show that it may be difficult to use 
RDTs in place of more accurate lab-based diagnostics. The second scoping review focused on 
determining the use of Dengue Rapid Diagnostic Tests in Sero Surveys (Appendix 6.2). A total 
of 13 studies were then included in the review and none of the studies used RDTs data as the 




Due to the results of the literature search, and the determination there would likely not be enough 
funds to purchase the RDTs (or employ nurses needed to properly administer the tests), we 
decided not to pursue a systematic review or include disease-based endpoints in the study. 
However, a recently published systematic review on the ability of RDTs to determine dengue 
serostatus found similar results with four dengue IgG RDTs used in ten studies (with serum used 
in most of the studies). None of the studies reported RDT data for determining dengue 
serostatus [5]. The review concluded that modifications to current RDTs are feasible that could 
optimize the performance of the test in future which could possibly make them feasible for use in 
seroprevalence studies. Future studies should test this feasibility, which could possibly make 
doing sero surveys cheaper and easier.  
 
6.3 Trial Results	
As discussed in Chapter 4, the results from this trial indicate that the interventions resulted in a 
reduction in immature and adult Aedes mosquito density when compared to the control. There 
were no statistical differences identified between intervention arms, although lower guppy 
coverage in intervention arm two suggests that PPF did help keep mosquito densities low. Data 
from the KAP and qualitative assessments showed that the interventions were accepted by 
communities and that they were willing to pay for them. PPF was also highly accepted and 
preferred over current vector control tools used in Cambodia, however product costs and 






Ecological Concerns about Introduction of Non-Native Fish 
As discussed in Chapter 4, concerns about the ecological effect of introduction of non-native fish 
used for vector control (including several different species) have been raised by some 
ecologists [7]. However, following the recent Zika outbreaks in 2015-2016, there were two high 
profile groups of ecologists that wrote opinion pieces trying to dissuade public health authorities 
utilizing guppies in Aedes control [8,9]. Science magazine wrote their own piece on the 
subject [10]. They contacted me and, following an hour-long interview, wrote a piece on their 
website which, at the very least, allowed for the perspective of a public health practitioner in the 
debate (Appendix 6.3).  
 
The topic again arose as Malaria Consortium was fundraising for an expansion of the guppy fish 
intervention to five high-risk provinces in Cambodia. A potential donor had concerns raised by 
the aforementioned opinion pieces and was not satisfied and given the lack of available evidence 
to show the environmental impact of guppies declined to donate to the project.  
 
Due to these experiences, a protocol was developed for a systematic review on the impact on the 
ecosystem associated with introduction of guppy fish (Poecilia reticulata) (Appendix 6.4). I 
recruited an interdisciplinary team of statisticians, public health practitioners, and ecologists. 
Hopefully, this review will elucidate what evidence exists or missing and suggest some potential 
studies that ecologists or public health experts could take on in order to close the knowledge 
gaps. It may also hold more weight for academically minded scholars and practitioners than 




6.4 The association of the Premise Condition Index with Aedes mosquitoes 
 
As discussed in Chapter 5, The Premise Condition Index (PCI) was found to be weakly 
associated with the density of immature and adult female Aedes at the household and cluster 
level. Similar results have been found in other studies and resulted in affirmations of PCI’s 
effectiveness and suggestions on how to incorporate it into national control programs. However, 
finding statistically significant correlations does not necessarily mean that the variables will be 
good predictors [11]. In our study, Receiver Operating Characteristic (ROC) curves showed that 
PCI had “rather low accuracy” [12] to predict premises in the top quartile for Aedes adult 
females and pupae. Additional ROC curves measuring the ability of PCI to predict clusters (as 
opposed to houses) which represent the top quartile of Aedes adult females and pupae also found 
it to have “rather low accuracy”. Therefore, control programs may want to use care when 
interpreting PCI associations in their area and assess their ability as predictors before utilizing 
them in public policy.  
 
ROC curves are also based on cut points, and control programs should be careful in assigning 
those cut points as it will affect their predictive capacity. In the study presented in this thesis, the 
cut points were set at the top quartile of premises in terms of Aedes immatures or adults, however 
there are many different theories and suggestions on how to determine cut points [13,14]. Most 
focus on assessing the value at which sensitivity and specificity are closest to the area under the 
curve. As discussed earlier, there were a small number of premises which harboured a large 
number of immature and adult Aedes, and this was particularly true with Aedes pupae. In our 
case if you included premises much higher into the top 35-50% you would reach those houses 
which did not harbour any mosquitoes therefore making those predictions not very useful in 
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practical terms. Although control programs should try to assess the predictive value of any index, 
they should also be mindful of selecting useful cut-points when completing any analysis. More 
research could be done into how to determine the most useful cut points for vector control 
indexes such as those presented here.  
 
If PCI was found to be useful in predicting and prioritizing vector control activities, there are still 
limitations that would require further research to improve. One of the limitations of PCI is that 
scoring may not be standardized across individuals, teams, or organizations [15]. One potential 
way to reduce this variability would be to use unmanned aerial vehicles (or drones) to take aerial 
photographs that could be scored by one individual or team. Similar methods have been tried in 
the past and not found useful, however drones and cameras have improved vastly since this was 
done twenty years ago [16]. Another way could be to use PCI to classify geographical locations 
where it has been shown useful and assign one team to categorize the areas in known hotspots in 
advance of outbreaks. Then, the scores could be used to try to identify which hot spots or 
villages to prioritize when resources are scarce. Nevertheless, it is unknown how use of PCI to 
prioritize households or geographical areas would be accepted within the communities [17]. 
Research would have to be conducted to better understand the best methods for collecting PCI, 
and how to work with communities so they understand why one area may be prioritized over 
another. Additionally, this would only work if PCI was not variable between seasons and years.  
 
One important item to note is that the PCI may not have been useful in predicting the density of 
adult Aedes mosquitoes, but it could have been successful in predicting other measures of dengue 
risk.  Risk measures that could be incorporated in the future include the number of infected 
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Aedes females, the change in parity rate in Aedes females, and/or the number of 
suspected/confirmed dengue cases. The most direct measure of risk would be the dengue 
incidence rate; however, the accuracy of this measure is complicated by individuals traveling and 
possibly being infected outside the areas outside those being evaluated. Additional predictors 
that might be included in PCI are water bodies such as rivers, streams, lakes, large areas of 
standing water, or specific containers that were found to be higher risk such as large water 
containers used for animal husbandry.   
 
These results may not be generalizable to areas with more variability in housing conditions, 
different ecological conditions, or different mosquito abundance profiles. Considerable resources 
need to be invested in ensuring teams have standardized scoring of PCI, and the corresponding 
PCI cut-offs are followed correctly. These resources may be better spent evaluating other 
methods to target premises or spent generally on Aedes control. Future studies could also 
evaluate the use of PCI in other geographical settings, the effectiveness of PCI to identify 
premises with dengue infection, or the acceptance by the community of PCI’s use where it is 
found to be effective.  
 
6.5 Overall Summary 
In summary, the trial presented in Chapters 3 and 4 indicated that the interventions resulted in a 
reduction of nearly fifty percent in immature and adult Aedes mosquito density when compared 
to the control. As the guppies were found to be effective and locally accepted the 
recommendation is to consider their use in future vector control activities. Although, the trial 
itself did not show a statistical difference between intervention arms with and without Sumilarv® 
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2MR, the results from Chapter 2 suggest PPF (in granule form) have highly documented and 
consistent results when used in higher doses and distributed every 30-40 weeks. The reason for 
not detecting a statistical difference between intervention arms could be that it was used only in 
smaller containers rather than large water containers where the majority of mosquitoes are found 
in traditional pupal surveys. In addition, the trial was not powered to detect the difference. As 
Sumilarv® 2MR is not yet registered in Cambodia and the cost is unknown, it is difficult to 
formulate a recommendation at this time. The results from Chapter 5 suggest that PCI should not 
be used as a predictor of households with greater Aedes densities in this context. Further details 
on sustainability of the interventions one year after the end of the trial, efforts to use the trial 
results to draft a National Dengue Strategic Plan, public reactions to the project, and future 
research directions are discussed in the following sections. 
 
Trial follow-up 
In 2016, Break Dengue launched the Community Action Prize which was a competition to 
reward the best grassroots initiatives that combat dengue in an innovative way. A proposal was 
developed to go back and assess the community’s views about dengue control a year after the 
project ended and promote the inclusion of community-based vector control (as discussed in 
Chapter 3 and 4) into the Cambodian National Dengue Strategic Plan for 2017-2020. The 
proposal was one of two selected out of 67 submitted. Break Dengue also wrote a blog post 
about the trial discussed in Chapter 4 after the Prize was announced and mentioned how the prize 
winnings (10,000 Euros) would allow teams to follow up one year after the trial (Appendix 6.5). 
The prize funds were partially allocated to conduct focus group discussions (FGDs) and 




The results of the FGDs and interviews were encouraging showing that although the number of 
individuals using guppies in project villages decreased after the project ended, there has been an 
overall increase with several control villages and those outside the project area beginning to raise 
the fish. There were also excerpts suggesting that villagers believed that using the fish will stop 
all dengue infection in villagers, suggesting CHWs should continue to explain that even 100% 
coverage may not completely stop transmission and villagers are at-risk when they travel outside 
their villages. Overall the results are quite positive and show that in many villages the 
larvivorous fish were still being used for vector control in the communities one year after the 
project has ended. Additionally, together with WHO, Malaria Consortium was able get 
larvivorous fish introduction included as one potential vector control method in draft version of 
the National Dengue Strategic Plan for 2017-2020. The final report submitted to the Synergist 
with some additional results is attached here (Appendix 6.6). 
 
Public reaction to the project 
The trial results were presented at scientific conferences (Asian Congress of Paediatric Infectious 
Diseases (ACPID), American Society of Tropical Medicine and Hygiene Annual Meeting, and 
the Joint International Tropical Medicine Meeting) and at the project dissemination meeting 
where journalists were invited. There was also a short film made about the project which was 
circulated to the media which can be accessed here (https://www.youtube.com/watch?v=vcR7-
RCXMMg&t=37s). The presentation at ACPID won the award for best e-poster discussion. 
Following the dissemination events, Reuters wrote an article that highlighted our preliminary 
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findings and talked about the need to find cheap, low cost solutions to medical problems 
(Appendix 6.7).  
 
Local media also wrote reports which highlighted quotes from project staff, WHO officials and 
the government (Appendix 6.8). Interestingly, they highlighted the reluctance of the government 
stating that “despite acknowledging that the government’s current plan [of using temephos] is 
more costly than using guppy fish… [they were] not convinced” that the fish were a long-term 
alternative and did not “know how sustainable it is yet”. This was also the sentiment from NDCP 
government officials when they presented the local dissemination meeting with community 
health workers in Kampong Cham (i.e. a preferred focus on top-down centrally run 
interventions). However, the article highlights the positive reactions from all other stakeholders 
including participants, community health workers, provincial health department officials, and the 
WHO which said guppy fish are the best solution for Cambodia at the moment. The regional 
entomologist at WHO said the scale and frequency of dengue outbreaks will fall if deployment 
of guppy fish was expanded as suggested, which would reduce the dependency on pesticides. In 
an effort to encourage the government to expand the use of guppy fish the WHO published an 
article on their website titled “WHO supports targeting Aedes mosquito larvae through Integrated 
Vector Management in Cambodia” (Appendix 6.9). Despite the push from WHO and local 
stakeholders there still has not been funding received to expand the project or do any further 





Following the end of the project, a project dissemination and policy uptake workshop was 
organized to invite government officials and experts from around the region to hear the results of 
the project and make recommendations for the way forward. This included working groups that 
discussed particular topics including prioritization of vector control tools, behavior change 
communication, case management, and outbreak response. Key stakeholders also met following 
the workshop where the results of the working groups were discussed and a key summary of 
recommendations and action points for follow up was agreed. The summary which included 
future research topics was agreed on by all stakeholders including NDCP, WHO, non-
government organizations, and donors (Appendix 6.10). This summary of recommendations 
along with the notes from the working groups was then used as one of the resources at future 
working group meetings to design the Cambodia National Dengue Strategic Plan for 2017-2020. 
The key recommendations for further research included (1) comparing the cost of activities in the 
strategic plan with economic costs of dengue, (2) determining how best to integrate routine 
entomological surveillance (including adult mosquitoes) in high risk locations, (3) determining 
the best strategies for vector control in urban areas, and (4) evaluating the use of different 
insecticides and others tools. In addition to the recommendations that came from the project, 
there were some additional ideas for future research. Some of which have already been started or 
accomplished. 
 
School-based dengue control programs 
A joint proposal between Malaria Consortium and Global Health Asia was submitted to the 
WHO Special Programme for Research and Training in Tropical Diseases (TDR). The grant 
opportunity focused on using multidisciplinary teams to develop socio-ecological strategies to 
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prevent infectious disease. This was based on the trial results, but expanded the focus to include 
schools and developing a new dengue prevention school curriculum with the Ministry of 
Education. The proposal was focused around using Social Ecological Systems and Resilience 
theory to develop transdisciplinary dengue vector control strategies.  
 
The project is now in its second year and is investigating whether a set of disease-specific 
interventions, including integrated vector management-based source reduction tools (e.g. guppy 
fish targeting immature mosquitos and community developed mosquito traps targeting adult 
mosquitoes), COMBI-based health education, and socio-ecological systems approach will 
significantly reduce mosquito immatures and adults in rural primary schools and households in 
two districts in Cambodia. While this project also adds to our knowledge on the use of guppy 
fish for vector control in Cambodia, it also provides important new experience developing 
community developed mosquito traps with recycled materials. It also is helping to establish new 
links between the Ministry of Health and the Ministry of Education and will provide inter-
ministerial school curriculum that can be adapted for use nationwide in the future. The baseline 
results have not been made publicly available yet, but information on the key findings is meant 
to be updated frequently on the public website [18]. There was also a video produced on the 
project which can be accessed here: https://www.youtube.com/watch?v=U5Sl7TiKQSk. 
 
An additional proposal arose out of this work which looked at the effect of student-controlled 
interventions, consisting of both mosquito control and education, to reduce dengue and 
entomological risk factors in the school environment and communities in Yangon, Myanmar. 
The proposal was selected by the Research Council of Norway’s program on Global Health and 
 
222 
Vaccination Research. The project will benefit from the previous experiences in both the trial 
presented in this PhD and the WHO TDR project mentioned above. This trial is the first cluster 
randomized trial to examine the effect of using larvivorous fish on dengue incidence and will 
provide some evidence on how mosquito indices are associated with dengue incidence. The trial 
protocol has been developed and submitted to the ethics review board in Myanmar for approval. 
The project plans to have activities running from 2019-2022. It is hoped that the information 
gained in this project will help fill some knowledge gaps, but also open up new research 
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Appendix 2.1: PRISMA checklist 
 
PRISMA 2009 Checklist 
Section/topic  # Checklist item  Reported on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  37 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
37-40 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  41 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
42 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
37 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
42 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
42 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
42-43 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
43-44 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
44 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
44 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
44 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  N/A 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
N/A 
 




PRISMA 2009 Checklist 
Section/topic  # Checklist item  Reported on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
N/A 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
44 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
44 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  73-76 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 




Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  N/A 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  N/A 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  N/A 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
51-54 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
53 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  53-54 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
54-55 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
































Appendix 3.2: SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents 
Section/item Item 
No 




Title 1 Descriptive title identifying the study design, population, interventions, 
and, if applicable, trial acronym 
Title page, p. 
80 
Trial registration 2a Trial identifier and registry name. If not yet registered, name of intended 
registry 
ISRCTN, p.82 
2b All items from the World Health Organization Trial Registration Data Set see Registry 
ISRCTN. P.82 
Protocol version 3 Date and version identifier Title page, p. 
80 
Funding 4 Sources and types of financial, material, and other support Acknowledgem
ent p. 109 
Roles and 
responsibilities 









5b Name and contact information for the trial sponsor Malaria 








 5c Role of study sponsor and funders, if any, in study design; collection, 
management, analysis, and interpretation of data; writing of the report; 
and the decision to submit the report for publication, including whether 
they will have ultimate authority over any of these activities 
Acknowledgem
ent, p. 109-110 
 5d Composition, roles, and responsibilities of the coordinating centre, 
steering committee, endpoint adjudication committee, data management 
team, and other individuals or groups overseeing the trial, if applicable 




section, pg. 102 
Introduction 
   
Background and 
rationale 
6a Description of research question and justification for undertaking the 
trial, including summary of relevant studies (published and unpublished) 
examining benefits and harms for each intervention 
Introduction p. 
83-88 
 6b Explanation for choice of comparators Introduction p. 
83-88 
Objectives 7 Specific objectives or hypotheses Introduction, p. 
89 
Trial design 8 Description of trial design including type of trial (eg, parallel group, 
crossover, factorial, single group), allocation ratio, and framework (eg, 





Methods: Participants, interventions, and outcomes 
 
Study setting 9 Description of study settings (eg, community clinic, academic hospital) 
and list of countries where data will be collected. Reference to where list 
of study sites can be obtained 
Study setting, 
p. 90 
Eligibility criteria 10 Inclusion and exclusion criteria for participants. If applicable, eligibility 
criteria for study centres and individuals who will perform the 
interventions (eg, surgeons, psychotherapists) 
Eligibility 
criteria, p. 90 
Interventions 11a Interventions for each group with sufficient detail to allow replication, 
including how and when they will be administered 
Interventions, 
p. 90-91 
11b Criteria for discontinuing or modifying allocated interventions for a given 
trial participant (eg, drug dose change in response to harms, participant 




11c Strategies to improve adherence to intervention protocols, and any 




11d Relevant concomitant care and interventions that are permitted or 
prohibited during the trial 
N/A 
Outcomes 12 Primary, secondary, and other outcomes, including the specific 
measurement variable (eg, systolic blood pressure), analysis metric (eg, 
change from baseline, final value, time to event), method of aggregation 
(eg, median, proportion), and time point for each outcome. Explanation 






13 Time schedule of enrolment, interventions (including any run-ins and 
washouts), assessments, and visits for participants. A schematic 
diagram is highly recommended (see Figure) 
Interventions 





Sample size 14 Estimated number of participants needed to achieve study objectives 
and how it was determined, including clinical and statistical assumptions 
supporting any sample size calculations 
Sample size, p. 
96 




Methods: Assignment of interventions (for controlled trials) 
 
Allocation:    
Sequence 
generation 
16a Method of generating the allocation sequence (eg, computer-generated 
random numbers), and list of any factors for stratification. To reduce 
predictability of a random sequence, details of any planned restriction 
(eg, blocking) should be provided in a separate document that is 






16b Mechanism of implementing the allocation sequence (eg, central 
telephone; sequentially numbered, opaque, sealed envelopes), 






16c Who will generate the allocation sequence, who will enrol participants, 





17a Who will be blinded after assignment to interventions (eg, trial 
participants, care providers, outcome assessors, data analysts), and 
how 
N/A 
 17b If blinded, circumstances under which unblinding is permissible, and 
procedure for revealing a participant’s allocated intervention during the 
trial 
N/A 







18a Plans for assessment and collection of outcome, baseline, and other trial 
data, including any related processes to promote data quality (eg, 
duplicate measurements, training of assessors) and a description of 
study instruments (eg, questionnaires, laboratory tests) along with their 
reliability and validity, if known. Reference to where data collection forms 




 18b Plans to promote participant retention and complete follow-up, including 
list of any outcome data to be collected for participants who discontinue 





19 Plans for data entry, coding, security, and storage, including any related 
processes to promote data quality (eg, double data entry; range checks 
for data values). Reference to where details of data management 






20a Statistical methods for analysing primary and secondary outcomes. 
Reference to where other details of the statistical analysis plan can be 
found, if not in the protocol 
p. 102 




analyses, p. 102 
 20c Definition of analysis population relating to protocol non-adherence (eg, 
as randomised analysis), and any statistical methods to handle missing 
data (eg, multiple imputation) 
Handling of 




Data monitoring 21a Composition of data monitoring committee (DMC); summary of its role 
and reporting structure; statement of whether it is independent from the 
sponsor and competing interests; and reference to where further details 
about its charter can be found, if not in the protocol. Alternatively, an 







 21b Description of any interim analyses and stopping guidelines, including 
who will have access to these interim results and make the final decision 
to terminate the trial 
Monitoring, 
p.102 
Harms 22 Plans for collecting, assessing, reporting, and managing solicited and 
spontaneously reported adverse events and other unintended effects of 
trial interventions or trial conduct 
Monitoring, p. 
102 
Auditing 23 Frequency and procedures for auditing trial conduct, if any, and whether 
the process will be independent from investigators and the sponsor 
Monitoring, p. 
102 











25 Plans for communicating important protocol modifications (eg, changes 
to eligibility criteria, outcomes, analyses) to relevant parties (eg, 







26a Who will obtain informed consent or assent from potential trial 




 26b Additional consent provisions for collection and use of participant data 
and biological specimens in ancillary studies, if applicable 
Not applicable 
Confidentiality 27 How personal information about potential and enrolled participants will 
be collected, shared, and maintained in order to protect confidentiality 






28 Financial and other competing interests for principal investigators for the 
overall trial and each study site 
Competing 




Access to data 29 Statement of who will have access to the final trial dataset, and 
disclosure of contractual agreements that limit such access for 
investigators 




30 Provisions, if any, for ancillary and post-trial care, and for compensation 






31a Plans for investigators and sponsor to communicate trial results to 
participants, healthcare professionals, the public, and other relevant 
groups (eg, via publication, reporting in results databases, or other data 
sharing arrangements), including any publication restrictions 
Dissemination 
policy, p. 103 
 31b Authorship eligibility guidelines and any intended use of professional 
writers 
Dissemination 
policy, p. 103 
 31c Plans, if any, for granting public access to the full protocol, participant-
level dataset, and statistical code 
Access to data, 
p. 103 
Appendices 




32 Model consent form and other related documentation given to 




33 Plans for collection, laboratory evaluation, and storage of biological 
specimens for genetic or molecular analysis in the current trial and for 





*It is strongly recommended that this checklist be read in conjunction with the SPIRIT 2013 Explanation & Elaboration for 
important clarification on the items. Amendments to the protocol should be tracked and dated. The SPIRIT checklist is 






Appendix 4.1: CONSORT checklist 








Title and abstract 
 1a Identification as a randomised trial in the title 126 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance 





2a Scientific background and explanation of rationale 130-133 
2b Specific objectives or hypotheses 133 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 91-92 
3b Important changes to methods after trial commencement (such as eligibility criteria), 
with reasons 
None 
Participants 4a Eligibility criteria for participants 134 
4b Settings and locations where the data were collected 134 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how 
and when they were actually administered 
91-95 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including 
how and when they were assessed 
135-138 
6b Any changes to trial outcomes after the trial commenced, with reasons None 
Sample size 7a How sample size was determined 137-138 
7b When applicable, explanation of any interim analyses and stopping guidelines None 
Randomisation:   138 
 Sequence 
generation 
8a Method used to generate the random allocation sequence  







9 Mechanism used to implement the random allocation sequence (such as sequentially 
numbered containers), describing any steps taken to conceal the sequence until 
interventions were assigned 
138 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who 
assigned participants to interventions 
138 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, 
care providers, those assessing outcomes) and h 
138 
11b If relevant, description of the similarity of interventions 140-142 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 140-141 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 140-141 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received 
intended treatment, and were analysed for the primary outcome 
167 
13b For each group, losses and exclusions after randomisation, together with reasons 167 
Recruitment 14a Dates defining the periods of recruitment and follow-up 138 
14b Why the trial ended or was stopped N/A 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 162 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and 




17a For each primary and secondary outcome, results for each group, and the estimated 
effect size and its precision (such as 95% confidence interval) 
161-164 
17b For binary outcomes, presentation of both absolute and relative effect sizes is 
recommended 
161-164 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted 
analyses, distinguishing pre-specified from exploratory 
none 




Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, 
multiplicity of analyses 
149-150 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 150 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering 
other relevant evidence 
146-151 
Other information  




Protocol 24 Where the full trial protocol can be accessed, if available 136 










Total Jars Number < 2   Guppies
Number of 
Guppies Added
How many days 
each week do you 
use large jars?
Total Jars Number with PPF
Number of PPF 
Added
How many days 





























Small Water Jars (<50L)
CHW Monthly Monitoring
Large Water Jars (>50L)
List Any Adevere Events Reported 




Appendix 4.3: Entomology survey forms 
 
Date DD MM YY
Village name code Collector 1 name
Collector 2 name
Supervisor name
Present Absent Culex Anopheles Other Total






sleep in HH 
last night
Indoor Resting Adult Summary Form 
Name of HH Cup IDs







Village name  code Collector 1 name

































































Fill in new forms for >4 containers per household [use a new form(s) for more than 4 containers]







Village name code Date DD MM YY
Household name code Collector 1 name






















































On Stilts               
Q6. Ownership of Bednets
Yes
No










Village name  code Date






















Tidy yard, eg no rubbish or trash evident, 
well-maintained gardens and lawn
Moderately tidy yard
Untidy yard, rubbish and trash abundant 







Well maintained, eg newly painted or 
new house
Moderately well-maintained house
Not well-maintained house, eg paint 
peeling, broken items visible, dilapidated 
old house
Piped water supply only
Well water supply only




Very little or no shade (<25%), eg no 
major trees or bush
Some shade (>25 but <50%)
Plenty of shade, >50%, eg large trees 
evident, layers of shrubs, green house, 










អត$ស&' ណកម+ IDENTIFICATION 
េលខកូដសិក3ខ4ងផ7ះ    |_____|_____|_____|_____|  
 Household Study ID Number   
 
Q1. េលខទូរស័ពJ  (ខLងផJះ) 
Tel: (+855)__________________ 
Q4. GPS (location in GPS name) _________ 
X: ____________________________ 
Y: ____________________________ 
Q2. េខត$                           |____| 
Province name/code: ___________________ 
Q5. Zរ [\ល័យសុ_ភិbលcស dកcបតិបត$  |____|____| 
 OD name/code:_______________________ 
Q3. ភូមិ                   |___|___|___|___| 
Village name/code:  
Q6. េh+ ះអLកសំjសន៍             |____|____| 
Name of Interviewer/code:  
 
េសចកV ីែណZំៈ ជ^_បសួរ ខc d ំeទ Zងខc d ំេgh ះ____________________ខc d ំេធj klរmមួយ^កសួងសុqភិeល និងអងulរ
_៉wxខុនសតេធzម េដkម{ីមកេរzនសូ^ត និងែសj ងយល់សV ីពីវ ធីៃនlរlរÅរជំងឺ^គ Ñនgម។ េយkងខc d ំចង់េរzនពី 
lរយល់ដឹង ឥរ àបទ និង វ ធីlរÅរZZែដលអ4កeនអនុវតâន៍េãផ7ះ។ េដkម{ីសិក3េរzនសូ^តពីវ ធីេនះ េយkងខc d ំ
សូមសួរនូវសំណួរ មួយចំនួនដូចqងេ^lម។ េយkងខc d ំនឹងេធj klរអេងåតពីទីកែនçងបងåកំេណkតរបស់មូស 
និងវ ធីéèសâ ៃនlរlរÅរេãកê dង និងេ^ëផ7ះរបស់អ4ក។ េយkងខc d ំនឹងសួរចំនួន២០Zទី។  
lរចូលរមួេឆç kយសំនួររបស់អ4កគឺរក3េïយសំñត់ និងេïយ សh ័^គចិតâ។ េបkអ4កយល់^ពមេឆç kយសំនួរ 
អ4កក៏ôចបដិេសធ ឬក៏ឈប់េឆç kយសំនួរក៏eន។ xល់ចំេលkយរបស់អ4កនឹង 
ជួយដល់េយkងខc d ំកê dងlរអភិវឌùន៍នូវlរបñå រ និងទំនួលខុស^តûវចំេÅះជំងឺ^គ Ñនgមកê dង^បេទសកមü dm។ 
mងេនះេ†េទzត នឹងជួយដល់lរបេងå kតនូវចំេណះដឹង ែដលអ4កនឹងេរzនពីវ ធីដ៏_នតៃមçេដkម{ីlរÅរជំងឺ
^គ Ñនgម និងក°â ជំងឺចមçង ZZេãកê dងផ7ះ និងសហគមន៍របស់អ4ក។ 




ហត™េលq/េgh ះ (Signature/Name): __________________ ៃថÆទីែខØ4  ំ(Date): _________ (DD/MM/YYYY) 
 
អ4កប±≤ ≥លទិន4ន័យ (Data entry) 1st : ___________________ ៃថÆទីែខØ4  ំ(Date): _________ (DD/MM/YYYY) 
 
















 How old are you? 




េភទអè ី?  
What is your gender? 
cប dស  
(Male)          1 
 
cសី 




What ethnic group do you identify with? 
 
(ចេមë àយâនែតមួយ) 









េផóងៗ ប&ô ក់ _____________________ 






What was the highest level of school 








(None)  0 
 
qúេcùផû üវZរ (េរïនេ†វត$.....)  
(Unofficial school) 1 
បឋមសិក¢ (1-6)  
(Primary school, 1-6) 2 
អនុវ [ទ£លយ័ (7-9)  
(Secondary school, 7-9)  3 
វ [ទ£ល័យ (10-12)  
(High school, 10-12) 4 











ក បcម dងក© ™ងcគ̈qរ?  
What is your main occupation? 
 
(ចេមë àយâនែតមួយ) 
(Only 1 answers) 
 
≠+ នមុខរបរ ឬ េ†ផJះ  
















 Farmer 1 
បុគØលិកមxន$ ី∞ជZរសីុវ [ល  
Civil government staff 2 
បុគØលិកមxន$ ី∞ជZរ cប±ប់äវុធ 
(បូ៉លីស/≥ßន...) 
Security government staff  
3 
បុគØលិកcក dមហុ៊នឯកជន  












បុគØលិកមxន$ ីេcùរ±t ភិbល  








Labor worker 6 
អLកលក់ដូរ∑មផJះ ឬផ¢រ 




































































អគØ ីសនី (បñ$ ញអគØ ីសនី រដt ឬឯកជន)  
Electricity (electricity cable state or private)  1 0 
វ [ទΩd   
Radio  1 0 
ទូរទសóន៍  
TV  1 0 
ទូរស័ពJ   
Mobile Phone 1 0 
ទូរទឹកកក  
Refrigerator 1 0 
ទូពΩ¨  េ_äវ  
A Wardrobe 1 0 
â៉សីុនេដរ  
A sewing machine or loom 1 0 
កøលìក់ឌីស  












â៉សីុនេភë àង äគុយ ឬ បនJះេcបàពនë ឺ 
cពះäទិតΩ Generator/ Battery/Solar 













































េតàâនសâ∏ រៈអè ីខëះ េ†ក© ™ងផJះរបស់អLក
ដូច_ងេcZម? 
 











































 Hand Watch  1 0 
កង់  
Bicycle/cyclo  1 0 
មូ៉តូ  
Motorcycle/scooter  1 0 
  មូ៉តូកង់បី  
Motorcycle-cart 1 0 
 េ≠ cកបី 
Oxcart/Horse cart 1 0 
 ƒន  
Car/Truck/Van 1 0 
ទូកâនâ៉សីុន  
Boat with motor 1 0 
 ទូក  



































េតàអLកេcបàចំេហះអè ីខëះ សcâប់ចំអិនម∆ üបäßរ
េ†ក© ™ងផJះរបស់អLក 
 





 Yes No  
អគØ ីសនី  
Electricity  1 0 
ចx«» នß» ស  
LPG  1 0 
 ឡឧស+ ័ន/ជីវៈឧស+ ័ន  
Biogas  1 0 
ធΩ ង  
Charcoal 1 0 
ឪΩស  




 ចេម®àង ឬ សë ឹករុកÃwតិ  
Straw/shrubs/grass 1 0 
c≠ប់ធÕ'wតិ (ឧ. ស© üលលេŒត....) 
Agriculture crop 1 0 
 úមក សតè  
Animal Dung 1 0 
≠+ នäßរចំអិនក© ™ងផJះ  
No food cooked in household 1 0 





ែផ.កទី ២ ចំេណះដឹងស;ីពីជំងឺ"គ@នAម Section 2: Knowledge about dengue  
ល/រ. 






Q201 េតàជំងឺcគ dនhម ឆëងេ±យqរអè ី? 













េផóងេទïត ប&ô ក់_________________  
Other (Specify)  98 
មិនដឹង  
Don’t know 99 
Q202 េតàjគេcចàនមូសបង»ជំងឺcគ dនhម (មូស_ë ) 
_េំ†េពលñ? 
 
When do dengue mosquitos most often 
bite? 
(ចេមë àយâនែតមួយ) 
(Only 1 answers) 
មូស_ ំេ†េពលៃថ“  




 មូស_ ំេ†េពលយប់ 
 Bite during the night time  2 
មិនដឹង 
 Don’t know 99 
 
Q203 េតàមូសäចបេង»àតកូនេ†កែនëងñខëះ? 






















Don’t know 1 0 
ក© ™ងទឹកŒង  
Water storage jars 1 0 
ក© ™ងទឹក ដក់ក© ™ងសំបកដូង កំបុ៉ង  
Coconut shells /Cans 1 0 
ក© ™ងäងងូតទឹក (Cement baths) 1 0 
ទឹកដក់ក© ™ងសំបុកេc∑ស ឬ cបេßង 





Anything with water around your 
environment  
1 0 
ក© ™ងសំបកកង់ƒន មូ៉តូ (Tires) 1 0 
េផóងេទïត ប&ô ក់ ______________ 1 0 
Q204 េតàអLកេធàèដូចេម$ចខëះ េដàម®ីZរŒរមូសមិន 
េäយបេង»àតកូនតេ‘េទïតbន? 




 Yes No  
 
 មិនដឹង  
Don’t know 1 0 
±ក់¶L äំែបត  















MULTIPLE RESPONSES POSSIBLE 
CIRCLE ALL MENTIONED 
PROBE ONCE: ANYTHING ELSE? 
 េcបà PPF  
Use PPF  1 0 
ប÷ üរទឹកក© ™ងŒងញឹក◊ប់  
Changing stored water frequently 1 0 
ÿ» ប់ធុងìស់ៗចុះេcZម  
Turn containers upside down 1 0 
េcបàគំរបŒង  
Put lids on water jars 1 0 
±ក់cតីក© ™ងŒង 
 Put fish in water jars 1 0 
bញ់xqõ យ (¶L មូំស)  
Spraying insecticide 1 0 
េផóងេទïត__________________ 



































How can you prevent mosquitos from biting 






MULTIPLE RESPONSES POSSIBLE 
CIRCLE ALL MENTIONED 
PROBE ONCE: ANYTHING ELSE? 





Don’t know 1 0 
ដុត ឬ កប់ សំបកដូង  
Burn/Bury Coconut Shells 1 0 
េសë ¤កŒក់េ_äវែវងៗ  
Wear long sleeves/long pants 1 0 
úប¶L កំំìត់មូស  
Use mosquito repellent 1 0 
េដកក© ™ងមុងេពលេដកៃថ“  
Use mosquito net during day  1 0 
Zប់េ‹+ គុេâõ តស៊ប់cទ dបេ†ជិតផJះ  
















Use mosquito coils during the day 1 0 
សំäតជំុវ [ញបរ [េវណផJះ  
Keep household environment clean 1 0 
បត់េ_äវឲΩâនរេបïប  
Keep cloths tidy  1 0 
cប±ប់ឆក់មូស 
Electricity trap 1 0 
េcបàក«fi រេដញមូស 
Use fan 1 0 












េតàេ∞គស&' ជំងឺcគ dនhមâនអè ីខëះ? 
 





MULTIPLE RESPONSES POSSIBLE 
CIRCLE ALL MENTIONED 
PROBE ONCE: ANYTHING ELSE? 
 Yes No  
មិនដឹង (Don’t know) 1 0 
cគ dនេù·  (Fever) 1 0 
 ឈឺកøល (Headache) 1 0 
សនë ឹម (Somnolence) 1 0 
ក‚ Ÿត ចេ«„ រ (Nausea/vomiting) 1 0 
កន‰ Ÿលcកហមៗ (Rash) 1 0 
ឈឺឆ„ ឹងែឆ„ង និងចុកìប់ 
Aches and Pains/Body pain 1 0 





Muscular Pain 1 
0 
េផóងៗ __________________ 












Q207 េតàអLកដឹងពី េពលែដលជម“ ឺ cគ dនhមេកàត
េឡàង ែដរ ឬ េទ េ†ក© ™ងេពលមួយéL ំៗ ? 
Are there certain times a year when you 
recognize that more people in your 
family /village get sick of dengue?  
េទ  





Yes   1 
មិនដឹង  
Don’t know 99 
Q208 េតàជម“ ឺcគ dនhមេកàតេឡàងេ†េពលñ? 
(ែខñ ដល់ែខñ) 
If yes, when? 
ìប់ពីែខ: ________ ដល់ែខ: ________ 


















Q301 េបàâនសâជិកcគ̈qររបស់អLកcគ dនេù$  
េតàអLកនឹងេធè àអè ីមុនេគបង„ស់? 
 
If you think you or someone in your family 
has fever, what would you do First? 
 
(ចេមë àយâនែតមួយគត់) 
(Only 1 answer) 
 
េសÁសុខjពqÂរណៈ(រដt) 
Go to Health Facility   
1 
 
េពទΩឯកជន (Go to Private Provider) 2 
អLកស+ ័cគចិត$សុខjពភូមិ 
Go to Community Health Worker 
3 
 ទិញ¶L េំ†ßè â៉សីុ (Take Drugs From Pharmacy) 4 
សំ∞កេ†ផJះ ឬ រងìរំហូតbត់ cគ dនេù$  
េ±យខû Ÿនឯង 
Stay at home/wait for fever to go away 
5 
េផóងៗ __________________ 6 
មិនដឹង (Don’t know) 99 
Q302 cបសិនេបàâនសâជិកcគ̈qរñâL ក់âនេ∞
គ ស&' cគ dនេù$  េតàរយៈបុ៉å+ នៃថ“េទàបអLក 
េ‘រកZរព£bល?  
If your family member gets fever, how many 
days do you wait to seek care after 
symptoms start? 
|____|____| 
កc∑េលខ ០ េcបàសិនេបàក© ™ងៃថ“cគ dនេù$   
កc∑េលខ ៩៩ cបសិនេបàមិនដឹង 
Record “0” if they respond in the same day 
Record “99” if they respond Don’t Know 
 
 
Q303 េបàសិនwអLកសងó័យ¶នñâL ក់េកàតជម“ ឺ 
cគ dនhម េតàកែនëងñែដលអLកនឹងែណå ំ
ឬក៏េ‘េធè àេ∞គវ [និចÏ ័យ?  
 
If you suspect someone in your family has 





 Yes No 
 
េសÁសុខjពqÂរណៈ(រដt) 
Go to Health Facility   1 0 
េពទΩឯកជន  
Go to Private Provider 1 0 
េ‘រកអLកស+ ័cគចិត$សុខjពភូមិ 
Go to Community Health Worker 1 0 
 ទិញ¶L េំ†ßងលក់¶L  ំ(Pharmacy) 1 0 
េ‘ជួបអLកដឹកåqំសå (cពះសងÌ 
äìរΩ ឬ អLកផû ™ំ េq$ ះwេដàម) 
Religious Leader 
1 0 
េផóង ___________________ 1 0 
ែផ.កទី ៤ ឥរEFបទ (Section 4: Attitude)  
ល/រ. 
No. សំណួរ QUESTION: 
 ^បេភទេលខកូដ CODING CATEGORIES 
រ“លង 
Refuse  
Q401 េតàជំងឺcគ dនhម wជំងឺធ“ន់ធ“រែមនែដរ ឬ េទ? 
Dengue is a serious illness?  
េទ  





No. សំណួរ QUESTION: 
 ^បេភទេលខកូដ CODING CATEGORIES 
រ“លង 
Refuse  
 bទ  
Yes   1  
មិនដឹង  
Don’t know 99 
Q402 េតàអLកពិតwcបឈមនឹងេc≠ះ¶L ក់ែដរ ឬ េទ 
េ†េពលេកàតជំងឺcគ dនhម? 
 
You are at risk of getting dengue 
េទ  
No  0  
bទ  
Yes   1 
មិនដឹង  
Don’t know 99 
Q403 េតàជំងឺcគ dនhមäចប«» រមុនbនែដរឬ េទ? 
 
Dengue fever can be prevented 
 
េទ (No) 0  
bទ (Yes)   1 














Q501 េតàអLកបÓ üរទឹក (Œង äង….) ញឹក◊ប់បុ៉ñÔ ? 




(Only 1 answers) 
 
 
មិនែដរបÓ üរេqះ  
Not at all 0 
 
 េcចàនwងមួយäទិតΩម$ង  
More than once a week 1 
ម$ងក© ™ងមួយäទិតΩ  
Once time per week 2 
ពីរដងក© ™ងមួយែខ  
Twice per month 3 
េcចàនwង ១ ែខម$ង 
More than 1 time per time 4 
េផóងៗ ________________________ 
Other (Specify) 5 
Q502 េតàអLកâនŒងទឹកធំៗ ìប់ពី ៥០ លីcត
ចំនួនបុ៉å+ ន? េហàយâនគcមប បុ៉å+ ន? 
ចំនួនŒង±ក់cតី? 
 
How many large water jars (>50L) do you 
have and how many are covered  
1.ចំនួនŒង |______|______| 







3. ចំនួនŒង±ក់cតី  |_______|_______| 
សូមរÖលងេ‘សំនួរ Q504 cបសិនេបàចេមë àយ េសà+ សូនΩ 
“០០” 
Number of jars put fish 
If record “០0” go to Q504 
Q503 េបàសិនwcតី«ប់ េតàអLកេ‘យកេ†ទីñ? 




  Yes No  
មិន±ក់ែថម  
Not Replace Them 
1 0 
េ†មណÒ លសុខjព  
Health Center 
1 0 
េ†ផJះអLកស+ ័cគចិត$សុខjពភូមិ  
Community Health Worker 
1 0 
េផóង ………………………………….. 





Q504 េតàអLកqØ ល់ PPF ែដរ ឬ េទ? 










Q505 េតàអLកេធè àដូចេម$ចខëះwមួយសំបកដូង ឬ 
វតÚ ™ែដល äច ដក់ទឹកbន? 
 
What do you do with empty coconuts or 
containers? 
(ចេមë àយâនែតមួយ) 
(Only 1 answers) 
 
អត់េធè àអè ី≥ងំអស់  
Nothing 
0  
 ÿ» ប់េìល  
Turn them upside down 
1 
ដុត ឬ cចកទុក  





Q506 េតàអLកចងមុងឬេទ េ†េពលសcâកេពលៃថ“? 
How often do you use mosquito nets during 
daytime naps? 
 
ចំនួនៃថ“ចងមុង ក© ™ង 1 សb$ ហ៍ |_____|  
day/week 
 
Q507 េតàwទâë ប់អLកេសë ¤កេ_äវែវងៗេ†េពលៃថ“ 
ញឹក◊ប់ កcមិតñក© ™ង ១ សb$ ហ៍ ? 
How often do you wear long sleeves/long 















pants during the day time? 
Q508 េតàអLកេcបàធូកមូសេពលៃថ“ញឹក◊ប់កcមិតñ? 
How often do you use mosquito coils 
during the day time? 




Q509 េតàអLកគិត¶ បរ [qr នក© ™ងសហគមន៍ 
និងជំុវ [ញផJះរបស់អLកq„ ត ែដរ ឬ េទ? 
Do you think your community and 










Q510 េតàអLកគិត¶ សេមë¤កបំŒក់ក© ™ងផJះរបស់អLក 
េរïបចំbនcតឹមcត វែដរ ឬេទ ? (សេង»ត) 













បÕv ប់បទសំjសន៍ END INTERVIEW 
សូមែថëងអំណរគុណដល់អLកែដលbនចំñយេពលចូលរមួក© ™ងZរសំjសន៍េនះ។ 









Search strategy and eligibility criteria  
This review was carried out between January and February 2015. All studies reporting on the 
sensitivity and specificity of the Dengue Duo test were eligible for inclusion.  
 
Data sources and search strategy 
Studies were identified by searching PubMed, scanning reference lists of articles and 
consultation with experts in the field. No limits were applied for language in case there was an 
available English translation. The only search term used was “Dengue duo”. 
 
Study selection 
Titles and abstracts were imported into Endnote (Thompson Reuters, Philadelphia, PA, USA), 
duplicates were removed, and the remaining records were screened. Full texts of potentially 
relevant records were retrieved and assessed for eligibility, contacting the author of the report as 




Initially 34 records were identified through database searches. After screening of the title and 
abstracts, the remaining 20 papers were assessed and reviewed in full, after which 10 articles 
were excluded. A total of 10 studies were then included in the review (Table 1). 
The included studies were published between 2012 and 2015. Nine of the studies had original 




from 83-99%. However, four studies did not report what the used as the gold standard for 
comparison, and the ones who did mention it did not use a standardized method. Therefore, there 
are limitations to comparing the results across studies. Regardless, the results show that it may be 
difficult use RDTs in place more accurate lab-based diagnostics. 
 





Author Type Year Country Senstivity Specificity Gold standard
Andries 2012 Cambodia 85.7-94.4 83.9-90
laboratory diagnosis was based on RT-PCR, isolation of DENV 
after inoculation into mosquito cell lines, detection of anti-
DENV IgM and measure of an increase of anti-DENV
antibodies titer measured by hemagglutination inhibition 
assay (HIA) between acute and convalescent sera.
IgM 72.7 89.4
NS1 48.5 99.4
IgM and NS1 92.9 88.8
Carter 2015 Cambodia 58 85
The Panbio Japanese Encephalitis Dengue IgM Combo ELISA 
was retrospectively used for reference serology
Gan 2014 Singapore 93 92
Plasma samples were subject to a two-stage real-time reverse 
transcriptase polymerase chain reaction comprising screening 
using SYBR green followed by a tetraplex probe-based serotype 
detection assay [18]. The serological suite used was: Platelia 
NS1 ELISA (Bio-Rad Laboratories, Marnes-la-Coquette, France), 
PanbioH Dengue IgG Indirect, IgG Capture, and IgM Capture 
ELISAs (Alere Inc., Waltham, MA, USA)
NS1 59 NA
IgM 89-98 NA
MMWR 2013 Micronesia 66 NA RT-PCR and anti-DENV IgM capture ELISA









Virus isolation was attempted for all acute samples, and DENV 
was identified using serotype-specific IFAs.  DENV IgM and IgG 
titers were determined by ELISA.
Blacksell 2011 Sri Lanka
Dengue virus infections were confirmed on an individual 
patient basis, with the paired admission and convalescent-




laboratory confirmed by the presence of DENV detected by RT-
PCR and/or virus isolation
Sanchez-Vargas 2013 Mexico 90.65 89.66
All serum samples were tested and diagnosed with 3 reference 
ELISA techniques: Platelia Dengue NS1 Ag Test (Bio-Rad 
Laboratories, Marnes-la-Coquette, France), overall sensitivity 
91% and specificity 100%; Panbio IgM Capture ELISA (Panbio 
Diagnostics, Brisbane,
Australia), overall sensitivity 94.7% and specificity 100%; and 
IgG capture ELISA (Panbio Diagnostics), overall sensitivity 
96.3% and specificity 91.4%. These ELISA kits were used 
following the guidelines of InDRE.
NS1 62.4 100
NS1/IgM 75.5 100
NS1/IgM /IgG 83.7 97.9
NS1 58 NA NA
IgM 96 98.4 NA
Zhang 2014
Meta 
Analysis 71 99 NA
Tricou 2010 Vietnam




Appendix 6.2: Determining the use of Dengue Rapid Diagnostic Tests in Sero Surveys 
	
Methods 
Search strategy and eligibility criteria  
This review was carried out between January and February 2015. All studies reporting on the use 
of Rapid Diagnostic Tests for dengue sero surveys were eligible for inclusion.  
 
Data sources and search strategy 
Studies were identified by searching PubMed, scanning reference lists of articles and 
consultation with experts in the field. No limits were applied for language in case there was an 
available English translation. The search terms used are found in Table 1.  
 
Table 1: Search terms used in the review 
dengue seroconversion  
dengue sero epidemiology  
dengue sero  
dengue sero*  
 
Study selection 
Titles and abstracts were imported into Endnote (Thompson Reuters, Philadelphia, PA, USA), 
duplicates were removed, and the remaining records were screened. Full texts of potentially 
relevant records were retrieved and assessed for eligibility, contacting the author of the report as 








Initially 624 records were identified through database searches. After screening of the title and 
abstracts, the remaining 48 papers were assessed and reviewed in full, after which 35 articles 
were excluded. A total of 13 studies were then included in the review (Table 1). 
The included studies were published between 2011 and 2015. None of the studies used RDTs in 
dengue sero surveys. 
 




Authors Year Test used
Anders 2015 RT-PCR, NS1-ELISA
Andayi 2014 A cross-sectional ELISA and sero-neutralisation-based sero-epidemiological analysis
Domingo 2011
A short nucleotide fragment located in the carboxyl terminus of the dengue E gene was used for the characterization 
of DENV strains and the identification of their sero- and genotype
Fox 2014 Dengue virus-reactive immunoglobulin G enzyme-linked immunosorbent assay
Leder 2013
Indirect enzyme-linked immunosorbent assay (ELISA), Dengue IgG Indirect ELISA and Dengue IgM Capture ELISA (PanBio 
Diagnostics, Brisbane, QLD, Australia). This assay has reported sensitivities in non-endemic populations as follows: IgM in 
primary infection of 94.7% (95% CI: 85.4–98.91%); IgM in secondary infection of 55.7% (95% CI 46.6–64.7%); IgG in 
primary infection of 91.4% (95% CIs not provided); IgG in secondary infection of 97% (range: 73.8–99.7%) 
(http://panbiodengue.com/product/dengue-igg-indirect-elisa; http://www.alere.com/us/en/product-details/panbio-




Infection status was determined by seroconversion based on plaque neutralization testing of sequential blood samples 
taken at approximately six-month intervals, with date of infection assigned as the middate between paired samples
Martins 2014 Indirect ELISA technique
Mazaba-Liwewe 2014 Differential antibody tests were done by ELISA
Poudel 2012 Enzyme linked immunosorbent assay (ELISA) kit
Pun 2011 Enzyme linked immunosorbent assay 
Soghaier 2014 The samples were analyzed using Panbio ELISA kits (DF IgG indirect)
Tiexeira 2012
The techniques used consisted of ELISA for the detection of IgG antibodies and modified haemagglutination 
inhibition (HI) assay 
Visser 2013
For DFV Pan Bio® kits (Inverness Medical Innovations Australia Pty Ltd, Queensland, Australia) were used (‘‘Dengue IgM





Appendix 6.3: Ecologists raise alarm over releases of mosquito-killing guppies 
 






























































































Appendix 6.4: PROSPERO registration 
PROSPERO International prospective register of systematic reviews 
Review title and timescale 
1 Review title 
Give the working title of the review. This must be in English. Ideally it should state succinctly the interventions or 
exposures being reviewed and the associated health or social problem being addressed in the review. 
Impact on the ecosystem associated with introduction of guppy fish(Poecilia reticulata) : a 
scoping review  
2 Original language title 
For reviews in languages other than English, this field should be used to enter the title in the language of the review. This 
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Appendix 6.5: WHO Supports targeting Aedes mosquito larvae through integrated vector 
























































Appendix 6.6: Summary of Recommendations  
 
Dengue Integrated Vector Management Project Dissemination and Policy Uptake 
Workshop and Key Stakeholders Meeting 
Dec, 1-2, Phnom Penh, Cambodia 
 
Attendees at Key Stakeholders Meeting: 
CNM: Bunleng Sam 
WHO: Rabindra Romauld Abeyasinghe, Tang Choon Siang, Prof. Juan Arredondo-Jimenez, 
Vibol Chan, Luciano Tuseo 
MC: John Hustedt, Yves Bourny, Sergio Lopes 
IPC: Sebastien Boyer 
GIZ: Maylin Meincke 
GEF: Shannon Conlon 
 
1. Policy, Strategy and Funding 
Revise and update plan of action and policy documents over next 3 months (Deadline for end of 
March): 
• National Dengue Strategic Plan (Situation Analysis, Objectives, Strategic 
Implementation, Action Plan and Indicator Monitoring Framework, Coordination 
Mechanisms, Detailed Budget) 
o Strategic plan will be harmonized with WHO Regional Strategic Plan 
o Mapping funding gaps identified in detailed budget to implement the National 
Strategic Plan (possibly look at climate funding)  
o Strengthen community based vector control activities  
o Communications strategy for private sector (Hotels / Private sector vector 
control companies) - Business analysis to make case for alternative methods 
o WHO will provide technical assistance and GIZ can support the elaboration 
process of the documents 
• Epidemic Preparedness and Response Plan 
o Possibility GEF will fund modeling to predict dengue cases (early warning 
system) in late 2017; actual funding may only be available in 2018. 
• Dengue Guideline for Diagnosis and Treatment  
o WHO consultant (Professor Lucy Lam) will come to assist in finalizing D&T 
guideline 
o A training document needs to be developed  
o 1 -2 Training of Trainers workshops should be conducted 
o WHO recommendation to test at least 10% of cases at each level by RDT - 







• Dengue Surveillance guidelines (based on strategic plan) 
o Need to integrate available data  
o Issue with funding for sentinel sites (CNM lab costs could be much cheaper 
than using IPC exclusively)  
o Possibility of GEF funding to expand high quality clinical diagnosis for adults 
in additional sentinel sites 
o Integrating data from CNM/IPC/CDC/NAMRU-2 should be considered 
o Possibility of adding data from Mobile Malaria Workers or other CHWs 
should be considered 
• Cambodia Business Plan for Dengue Control (Dengue Economic Impact in 
Cambodia and Costing) 
o Comparing cost of strategic plan to economic costs of dengue resulting in 
Return on Investment (ROI) for Cambodia 
o Consider raising funds for health economist to finish business plan by March  
o GIZ could possibly support if done by April/May 
o TOR/budget needs to be developed by 15 Jan and sent to GIZ 
 
2. Operational Challenges for Vector Control 
• Routine and outbreak response needed at lower levels to understand and respond 
correctly  
o Surveillance system strengthening needed  
• Strengthening proactive approach (including routine vector control in parallel with 
outbreak response) 
• Increase capacity of human resources in advance of outbreaks, use WHO 
recommended tools, and ensure they are accepted and used in the field (including 
participation by actors at CNM/PHD/OD/village level) 
• Routine entomological surveillance (including adult mosquitoes) needs to conducted 
in high risk locations 
• Community owned vector control needs to emphasized 
• Vector control in rural/urban areas needs to targeted separately 
 
3. Available Tools for vector control 
• Need for integrated strategy – encourage moving away from dependence on one 
product or method 
• Abate was found to be more expensive than other insecticides in cost effectiveness 
models and was found to be resistant in various areas around the country tested 
(Banteay Meanchey, Battambong, Kampong Cham, Kampot, Kandal, Kratie, Phnom 




• Deltamethrin/Permethrin was found to be resistant in all areas tested (Phnom Penh, 
Kampong Cham, Battambong, Siem Reap) – mapping of vector susceptibility needed 
in all provinces suggested to identify where it might still not be resistant 
• Need to evaluate different insecticides/other tools  
• Insecticides should only be used for outbreak control not for routine prevention  
• Routine prevention should include source reduction (e.g. guppy fish) 





Appendix 6.7: Dengue in Cambodia: using guppies and growth hormones to fight disease 
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CHWs  Community Health Workers 
COMBI  Communication for Behavioral Impact  
FGDs   Focus Group Discussions  
IDIs   In-depth Interviews  
IVM   Integrated Vector Management  
HC   Health Center  
NDCP  National Dengue Control Program  
NGOs   Non-government Organizations  







The Break Dengue team inform us that our initiative “Implementing integrated vector 
management for dengue control”, was chosen as the winning submission of the Break Dengue 
Community Action Prize on Feb 21, 2017. As much of our original idea had already been 
accomplished by that time, the project manager (Aaron) worked with us to develop some goals 
listed below: 
 
National Strategic Plan Development 
• Discussions for Development of Plan (April- May 2017) 
• Finalization of Plan (June-July 2017) 
• Promotion of Plan/Advocacy to Donors (July-September) 
Community Health Worker - Integrated Vector Management Project 
• Follow-up Survey including questions on vaccine barriers and community thoughts 
(May-June 2017) 
• Development of integrated VC/Vaccine health education materials (June-September) 
Activities 
 
National Strategic Plan Development 
The Dengue Integrated Vector Management (IVM) team participated in initial discussions with 
National Dengue Control Program (NDCP), World Health Organization (WHO), and other 
partners on the development of a National Dengue Strategic Plan. This included attending a 
stakeholder meeting on the proposed national plan on March 28, 2017 (See Annex 1). John 
attended a separate side meeting with Dr. Hasitha Korelege, WHO consultant, who was leading 
the development of the plan on the evening of March 28. During the meeting John shared his 
experience working with NDCP staff, gaps in the strategy, possible ways forward, and items to 
ensure make it into the plan. The introduction of a combination of vector control and vaccines 
was discussed. The plan has not as yet been finalized by the working group as planned, but our 
team has continued to give input and support to the NDCP where needed. 
 
Community Health Worker - IVM Project 
As proposed, a follow-up survey was completed on 07-08 August 2017. The team included two 
supervisors (from the IVM team), two experienced moderators, and two experienced note takers. 
An initial training for moderators and note takers was held the week before. Data collection 
included four Focus Group Discussions (FGDs) and two In-depth Interviews (IDIs) as described 
below: 
§ 2 FGDs with Community Health Workers (CHWs) (8 people each) 
§ 2 FGDs with Community Members (8 people each) 
§ 2 IDIs with Health Center (HC) Chief (2 people) 
 
The protocol for FGDs and IDIs followed that of the previous project which can be found in our 
published protocol (https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2105-
2). The topic guides and script (in short form) can be found in Annex 2 and 3, respectively. 




of vaccines. These drawings were used to add a section on vaccination in the Community Health 




FGDs with Community Health Workers  
CHWs suggest there is an increased understanding about dengue prevention, and improved 
health seeking behavior. CHWs believed that dengue caused a reduction in mosquito numbers 
and dengue incidence. When asked to list and rank all potential vector control options every 
participant preferred guppies. The reasons given include that they make the water clean, easy 
to look after, involve no financial costs, and the fish are beautiful. The option the majority liked 
the least was bringing smoke.  
 
The fish are very useful because guppy fish eat the larvae. The villagers clean and cut the forest 
around the house. Interestingly there have been no dengue cases in the village and when they 
have fever, they go to the hospital immediately. The villagers know mosquito bites cause 
dengue.  
 
“Now I do not bring the guppy fish to the villager house because they come to get the fish by 
themselves”  
 
However, a year after the conclusion of the Integrated Vector Management project there is 
relatively less focus on management of the breeding jars and less fish in villager’s homes. This is 
due to competing priorities with CHWs time, and less follow up at HC monthly meetings. 
Villagers also experienced difficulties with fish disappearing during rainy season, and frogs and 
geckos eating the guppy fish. Challenges in maintaining the guppies included not having support 
for travel to monthly meetings at the health center they sometimes were not able to take needed 
fish from guppy banks. The main disadvantages of guppies were that in some cases they had 
many children leading to large numbers of guppies in some jars, and some individuals 
(especially those that migrate for work) did not replace them after they died.  
 
“Other animals eat them such as frogs, the fish eat each other, and if there are no fish in the jar 






Most of the CHWs had not heard of the dengue vaccine although a few had heard of it through 
Facebook. Most are positive and were interested, although they want to know more about the 
efficacy and safety of the vaccine. Some CHWs also suggested they would feel more 
comfortable if the national program rolled it out for the whole country. However, the government 
should be careful about misconceptions and what communication messages are provided as 
many CHWs felt that one vaccination would prevent them from getting dengue for the rest of 
their life. It will also be important to install the message that using imperfect vaccines means 
they still need to carry on with environmental management, vector control, and continue 
encouraging proper health seeking behavior. They were willing to pay between $5-10 for the 
vaccine, however, would prefer the vaccine be provided free by the government. When asked 
who should be responsible for the vaccine, they all suggested the public sector through the 
Ministry of Health and Non-government Organizations (NGOs) rather than the private sector as 
is currently the case in Cambodia. 
 
“Only one time getting vaccinated can prevent dengue your whole life and you can stop 
worrying about dengue.” 
 
“Even the dengue vaccine is available we still do prevention because it is does not prevent 100% 





“Even the dengue vaccine is available we will still use the guppy fish, provide health education, 




FGD with Community Members  
 
Community members had a good understanding of dengue signs and symptoms and showed 
appropriate serious attitudes towards the disease. They were able to identify that dengue came 
from Aedes mosquitoes and identify the peak season of transmission. They understood 
prevention methods (including environmental management and methods to prevent biting). 
Vector control methods were ranked with Guppies as the most preferred followed by 
environmental management and sleeping under nets during the day. Mosquito sprays and 
repellents were disliked by all repellents due to fears of health effects and high costs.  
 
“The guppies were given by village chiefs and neighbors. We like the guppy fish because the 
guppy fish eat all the larvae in the jars and keep the jar clean.”  
 
“People dislike chemical insecticide; it does effect health and it costs a lot.” 
 
Health seeking behaviors were well understood with communities reporting that after suspecting 




most people did wait 1-2 days before bringing their child to care at the hospital. They reported 
the main barriers to treatment as issues related to transportation and payment (e.g. long travel 
distances to health centers, clinics closed during night times, and high costs of private clinics).  
 
“Mostly 2-3days after fever will go to the hospital. Parents play the most important role to 




Community members felt that the most important achievements of the project were to provide 
health education and start up the guppy fish distribution system. They also mention that there has 
not been dengue in their village, and they attribute this to the interventions. This is important to 
note and although encouraging that there is a reduction in perceived cases the true incidence is 
unknown. Additionally, even if there is a true reduction without elimination then additional cases 
in the future may make the community feel the interventions are no longer working. This 
highlights the importance of providing true information and realistic expectations among 
communities in the intervention.  
 






The community found that the greatest challenges to maintaining the guppies was that they are 
eaten by other animals such as lizards and frogs and disappearance when water jars overfill. 
Communities would be willing to pay around $0.10 for a guppy.  
 
None of the community members had heard about the dengue vaccine. Some community 
members noted that they preferred guppy fish or larvicides because they reduced mosquito bites 
(including nuisance biting). However, other community members would prefer a vaccine as 
guppy fish/larvicides can only be put in one place, while a vaccine could protect you wherever 
you go. Community members all suggested they would be willing to pay between $1.25-6.25 per 
dose, except for one person who was willing to pay up to $25. However, they all said they would 
take it should the government be willing to provide it for free. When asked who should be 
responsible for the vaccine, they all suggested the public sector through ministry of health and 
NGOs rather than the private sector as is currently the case in Cambodia.  
 
“Even if the vaccine is available, we need to do the interventions such as cleaning the house and 
distributing the guppy fish, because it can prevent the other people who don’t get the vaccine.”  
 
“If the dengue vaccine becomes available that will be great because it can prevent us from 
dengue, and we can stop worrying anymore and don’t have to spend the money on treatment.” 
 
“Only one person is willing to pay 50000-100000 riels ($12.5-25) because they say a one-time 






IDI with Health Center Staff 
 
Health center staff mentioned that they still have monthly CHW meetings and distribute guppy 
fish to CHWs from the HC bank. They both still viewed the cultivation and distribution of 
guppies as part of their responsibility at the HC after the project ended. Both feel the 
interventions resulted in decrease in dengue cases even after the project ended (although that is 
their opinion and the real incidence is unknown). They both said that villagers preferred guppies 
over other alternatives because the fish eat the larvae immediately, leave the jars very clean, 
relatively easy to take care of, and easily produce new babies. They both felt that villagers were 
continuing to use guppies, and that some even came to the health center themselves to take the 
fish. They felt the most preferred Communication for Behavioral Impact (COMBI) activity was 




“The people still use the fish and they come to take guppy fish from health center. The health 
center continues to advertise to the people visiting the health center every day.“ 
 
“Before when people are sick they pray first before bring to the hospital but now they are 
understand and change the behavior when sick go to hospital to check.” 
 
“There are five villages using guppies, they are watched after very well and have reduced the 
cases of dengue to nearly none.”  
 
“Using the guppy fish is preventing dengue. The villagers like the guppy fish because they are 
colorful, eat the larvae immediately, and leave no larvae in the container.”  
 
A year later, one said that he continues to have monthly meetings with the CHWs and 
encourages them to continue health education and provide guppies. They also requested that the 
guppy fish work be extended into other villages were not included in the pilot. Although the 
number of individuals using guppies in project villages has decreased some, there has been an 
overall increase with several other villages previously not involved that have begun raising the 
fish. The health center staff feel this is because the COMBI messages helped them understand 
and accept the interventions.  
 
 “Guppy fish are easy to take care, can eat the larvae immediately, and can produce a lot of new 
generations.” 
 
“Before when people are sick they pray first before bring to the hospital but now they are 
understand and change the behavior when sick go to hospital to check.” 
 
Both HC staff had heard of the new vaccine from media and colleagues and thought that the 
community would be very accepting of it. However, there is still some misunderstanding of the 
vaccine in general among one of the HC with them saying that the vaccine could prevent people 
their whole lives. The other mentioned that vaccines are not always able to prevent 100% of 
infections and they would continue with prevention activities and support positive health seeking 
behavior. They felt that the community would be willing to pay $1.5-5 for the vaccine, and that 
they would definitely take it if it was free. They both felt the responsibility for vaccine should be 
the responsibility of the government rather than the private sector.  
 
“If the vaccine available does not provide 100% prevention, we need to put the guppy fish for 






Impact and Achievements  
 
As the results of our IVM project are just starting to come out in peer-reviewed journals and 
being prepared for additional scientific conferences, the dengue prize funds were helpful in 
considering how sustainable such interventions may be in a community. The above FGDs and 
IDIs suggest that there is still demand in many villages for the interventions, and that even some 
villages which part of the project were not are now adapting them in their communities with 
support of the HCs. This shows that demand creation in villages over a relatively short period of 
time can lead to medium term acceptance in some cases. 
 
This work helps highlight some of the successes and challenges experienced in the communities 
after the end of the project. Important successes include the continued efforts by HC staff and 
CHWs to breed guppies and keep the system functioning. The sustained interest by the 
community in guppies and improved health seeking behaviors are great achievements of the 
COMBI activities. However, the work also highlighted continued challenges including the loss 
of guppies to frogs, lizards, and other animals, the reduced motivation in some CHWs after the 
end of the project, and the reduction in HC meetings in some areas. These are all important 





The dengue prize money also helped unearth health workers and community member’s feelings 
and attitudes about the dengue vaccine. The results show that most people are overwhelmingly in 
support of implementing a dengue vaccine, however some issues remain to be considered for 
COMBI activities should a vaccine be introduced. Most importantly these include the continued 
emphasis on environmental management in the house and efforts to reduce mosquito biting as 
this can reduce transmission of other vector borne diseases as well. It will also be important to 
ensure messages around proper health seeking behavior still become part of the package, and that 
the true efficacy of any vaccine is properly communicated (e.g. taking the vaccine may not mean 
lifelong immunity to all four serotypes and you should not abandon mosquito and disease 
prevention efforts). 
 
Additionally, support from the IVM team has helped inform and impact the national dengue 
control policy. This is evident by WHO staff insisting to include guppy introduction into the plan 
as one potential vector control method. The WHO staff in charge of climate change adaptations 
have also included a request for funds for guppy introduction into the Cambodia Climate Change 
Alliance proposal, and another internal proposal they are writing. Discussions about the 
introduction of the current or future dengue vaccines were also facilitated with both the WHO 
vector-borne disease unit and the expanded program for immunization. Continued discussion 
between the government and WHO on vaccine introduction will be important to create the right 
policy for Cambodia.  
 
Overall, the dengue prize money has been able to facilitate continued discussions around dengue 
control policies and has directly impacted the creation of such policy and funding related 
requests. Hopefully these activities will lead to better dengue control in Cambodia and better 





















































































By 	Hannah	Hawkins 	- December	3,	2016
A	man	holds	a	bag	of	guppy	fish	used	in	a	dengue	prevention	trial	in	Kompong	Cham	province	earlier	this	year.	(Malaria	Consortium)
The	project	zeroed	in	on	the	gup	py,	a	tropical	fish—referred	to	as	the	“seven-colored	fish”	by
Cambodians—that	feeds	on	the	larvae	and	adult	Aedes	aegypti	mos	quito,	which	carries	the	virus,
and	thrives	in	stagnant	water.
In	the	trial,	guppies	were	added	to	household	containers	holding	at	least	50	liters	of	water,	such	as
drums	and	water	jars.	When	the	water	was	tested	throughout	the	trial,	those	households	with	fish
had	less	than	half	the	adult	mosquitoes	of	those	without.
With	no	vaccine	or	widespread	treatment	currently	available	in	Cambodia,	prevention	that	relies	on
controlling	mosquito	populations	is	the	best	alternative,	according	to	Rabindra	Abeyasinghe,	a	World
Health	Organization	specialist.	“Even	if	we	have	vaccines,	we	still	need	vector	control,”	he	said	on
Thursday.	“Aedes	flourishes	better	in	our	cities	than	we	do.”
Mr.	Abeyasinghe,	whose	organization	endorses	the	Malaria	Consortium’s	project,	said	guppy	fish	are
the	best	solution	for	Cambodia	at	the	moment.
The	“guppy	fish	doesn’t	pollute	the	environment—we	are	happy	to	be	a	part	of	that,”	he	said,	adding
that	the	scale	and	frequency	of	den	gue	outbreaks	will	fall	under	the	plan,	reducing	the	dependency
on	pesticides.
There	were	14,303	reported	cases	of	dengue	in	Cambodia	last	year,	and	35	deaths,	National	Den	gue
Control	Unit	program	manager	Rithea	Leang	said	at	a	news	conference	organized	by	the	Ma	la	ria
Consortium	in	Phnom	Penh	on	Thursday.
According	to	the	consortium,	an	international	NGO	that	focuses	on	the	control	of	communicable
diseases,	about	13	percent	of	the	cases	were	found	in	Kompong	Cham	province,	the	location	of	its
trial.
Mr.	Leang	said	the	current	na	tional	strategy	was	to	treat	water	in	dengue-prone	areas	with	larvicide
once	a	year.	However,	John	Hus	tedt,	the	project’s	senior	technical	officer,	said	this	is	only	done	once
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an	outbreak—which	is	defined	by	the	government	as	three	or	more	cases	in	one	village—is	identified.
Despite	acknowledging	that	the	government’s	current	plan	is	more	costly	than	using	guppy	fish,	Mr.
Leang	said	his	department,	which	he	repeatedly	stressed	did	not	have	a	big	budget,	was	“not
convinced”	that	the	fish	were	a	long-term	alternative.
“We	don’t	know	how	sustainable	it	is	yet—it	is	too	early,”	he	said,	add	ing	that	they	were	concerned
about	the	plan’s	practicality	and	manageability.
Marian	Blondeel,	a	spokeswom	an	for	the	consortium,	said	the	government	still	“believes	there	is
some	value	in	conventional	methods,”	including	the	use	of	larvicides	and	insecticides.	“They	do	see
the	benefits	[of	guppy	fish],	but	change	is	always	hard.”
Although	Mr.	Leang	seemed	hes	itant	about	the	new	strategy,	Yves	Bourny,	country	director	for	the
Malaria	Consortium,	said	it	was	always	his	organization’s	in	tent	to	raise	the	funds	for	a	national	roll-
out.
It	would	cost	about	$1	million	to	expand	the	plan	to	2	million	people	across	five	provinces	that	are
most	prone	to	dengue	outbreaks,	but	donors	are	interested	in	supporting	a	plan	that	is	more
effective	and	sustainable	than	insecticides,	he	said.
“There	is	evidence	that	there	could	be	resistance	to	insecticides,”	Mr.	Bourny	said.	“The	era	of
insecticides	is	over.”
Ms.	Blondeel	said	community	members	involved	in	the	pilot	program	were	big	fans	of	the	fish—and
not	just	because	of	the	hard	data.
“We	asked	the	communities	what	they	thought	of	[the	project],	and	they	all	said	they	really	like	the
fish—they	see	the	fish	as	an	omen	of	good	luck	in	Buddhism,”	she	said.
Kim	Sourphirum,	director	of	Kompong	Cham’s	provincial	health	department,	said	dengue	cases	in
the	province	had	gone	down	from	last	year—1,031	cases	were	reported	this	year,	compared	to	1,556
last	year—but	he	could	not	confirm	a	direct	link	to	the	gup	py	project.
“It’s	a	good	project	because	the	guppy	fish	can	kill	mosquitoes	be	fore	they	are	born,”	he	said.	“I
hope	the	plan	keeps	going.”
Thai	Sokheng,	a	53-year-old	from	Kompong	Siem	district’s	Choeung	Kuok	village,	which	was	one	of
the	areas	treated	with	gup	py	fish,	said	villagers	did	not	trust	the	conventional	dengue	control
method.
“They	used	to	complain	and	wor	ry	about	larvicide,”	Ms.	Sokheng	said.	“In	my	area,	many	villagers
support	having	guppy	fish.”
“I	hope	this	project	continues	forever,”	she	said.
(Additional	reporting	by	Sek	Odom)
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